These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
Large accelerated filer
x
|
Accelerated filer
o
|
Non-accelerated filer
o
|
|
U.S. GAAP
x
|
International Financial Reporting
o
Standards as issued by the International
Accounting Standards Board
|
Other
o
|
| Page | ||
|
1
|
||
|
1
|
||
|
1
|
||
|
1
|
||
|
2
|
||
|
10
|
||
|
44
|
||
|
45
|
||
|
65
|
||
|
76
|
||
|
77
|
||
|
79
|
||
|
80
|
||
|
94
|
||
|
95
|
||
|
96
|
||
|
96
|
||
|
96
|
||
|
97
|
||
|
97
|
||
|
97
|
||
|
98
|
||
|
98
|
||
|
98
|
||
|
98
|
||
|
98
|
||
|
98
|
||
|
99
|
||
|
|
•
|
the scope and length of customer contracts;
|
|
|
•
|
governmental regulations and approvals;
|
|
|
•
|
changes in governmental budgeting priorities;
|
|
|
•
|
general market, political and economic conditions in the countries in which we operate or sell, including Israel and the United States among others;
|
|
|
•
|
differences in anticipated and actual program performance, including the ability to perform under long-term fixed-price contracts; and
|
|
|
•
|
the outcome of legal and/or regulatory proceedings.
|
|
Item 1.
|
Ident
ity
of Directors, Senior Management and Advisers.
|
|
Item 2.
|
Offer Statistics and Expected Timetable.
|
|
Item 3.
|
Key Inform
at
ion.
|
|
Years Ended December 31,
|
||||||||||||||||||||
|
2006
|
2007
|
2008
|
2009
|
2010
|
||||||||||||||||
|
(U.S. dollars in millions except for share and per share amounts)
|
||||||||||||||||||||
|
Income Statement Data:
|
||||||||||||||||||||
|
Revenues
|
$ | 1,523.2 | $ | 1,981.8 | $ | 2,638.3 | $ | 2,832.4 | $ | 2,670.1 | ||||||||||
|
Cost of revenues
|
1,149.7 | 1,454.9 | 1,870.9 | 1,982.9 | 1,872.2 | |||||||||||||||
|
Restructuring expenses
|
— | 10.5 | — | — | — | |||||||||||||||
|
Gross profit
|
373.5 | 516.4 | 767.4 | 849.5 | 797.9 | |||||||||||||||
|
Research and development expenses, net
|
92.2 | 127.0 | 185.0 | 216.8 | 234.1 | |||||||||||||||
|
Marketing and selling expenses
|
111.9 | 157.4 | 198.2 | 250.9 | 230.0 | |||||||||||||||
|
General and administrative expenses
|
77.5 | 107.4 | 134.2 | 119.3 | 131.2 | |||||||||||||||
|
Acquired in-process research and development (IPR&D) and other expenses
|
— | 16.6 | 1.0 | — | (4.7 | ) | ||||||||||||||
|
Total operating expenses
|
281.6 | 408.4 | 518.4 | 587.0 | 590.6 | |||||||||||||||
|
Operating income
|
91.9 | 108.0 | 249.0 | 262.5 | 207.3 | |||||||||||||||
|
Finance expense, net
|
21.5 | 19.4 | 36.8 | 15.6 | 21.3 | |||||||||||||||
|
Other income/(expense), net
|
1.8 | 0.4 | 94.3 | 0.4 | 13.3 | |||||||||||||||
|
Income before taxes on income
|
72.2 | 89.0 | 306.5 | 247.3 | 199.3 | |||||||||||||||
|
Taxes on income
|
20.7 | 13.8 | 54.3 | 38.1 | 24.0 | |||||||||||||||
|
Equity in net losses/earnings of affiliated companies
|
14.7 | 14.5 | 14.4 | 19.3 | 19.3 | |||||||||||||||
|
Consolidated net income
|
66.2 | 89.7 | 266.6 | 228.5 | 194.6 | |||||||||||||||
|
Less: net income (losses) attributed to non-controlling interests
|
(6.0 | ) | 13.0 | 62.4 | 13.6 | 11.1 | ||||||||||||||
|
Net income attributed to Elbit Systems’ shareholders
|
72.2 | 76.7 | 204.2 | * | 214.9 | 183.5 | ||||||||||||||
|
Earnings per share:
|
||||||||||||||||||||
|
Basic net earnings per share
|
1.75 | 1.82 | 4.85 | * | 5.08 | 4.30 | ||||||||||||||
|
Diluted net earnings per share
|
$ | 1.72 | $ | 1.81 | $ | 4.78 | * | $ | 5.00 | $ | 4.25 | |||||||||
|
*Including $74 million in net income ($1.73 diluted net earnings per share) from the sale of Mediguide Inc. (Mediguide) shares in 2008.
|
|
December 31,
|
||||||||||||||||||||
|
2006
|
2007
|
2008
|
2009
|
2010
|
||||||||||||||||
|
(U.S. dollars in millions except for share and per share amounts)
|
||||||||||||||||||||
|
Balance Sheet Data:
|
||||||||||||||||||||
|
Cash, cash equivalents and short-term investments
|
$ | 88 | $ | 376 | $ | 278 | $ | 280 | $ | 215 | ||||||||||
|
Working capital
|
112 | 177 | 290 | 392 | 382 | |||||||||||||||
|
Long-term deposits and marketable securities
|
6 | 42 | 41 | 44 | 52 | |||||||||||||||
| Long-term trade receivables | -- | -- | -- | 17 | 90 | |||||||||||||||
|
Property, plant and equipment, net
|
295 | 353 | 384 | 405 | 504 | |||||||||||||||
|
Total assets
|
1,773 | 2,789 | 2,940 | 3,054 | 3,611 | |||||||||||||||
|
Long-term debt
|
125 | 431 | 270 | 389 | 292 | |||||||||||||||
|
Series A Notes, net of current maturities
|
-- | -- | -- | -- | 273 | |||||||||||||||
|
Capital stock
|
301 | 307 | 300 | 284 | 294 | |||||||||||||||
|
Elbit Systems shareholders’ equity
|
493 | 536 | 724 | 833 | 967 | |||||||||||||||
|
Non-controlling interests
|
7 | 20 | 76 | 24 | 39 | |||||||||||||||
|
Total equity
|
500 | 556 | 800 | 857 | 1,005 | |||||||||||||||
|
Number of outstanding ordinary shares of NIS 1 par value
(in thousands)
|
42,017 | 42,060 | 42,079 | 42,531 | 42,693 | |||||||||||||||
|
Dividends paid per ordinary share with respect to the applicable year
|
$ | 0.61 | $ | 0.67 | $ | 1.42 | $ | 1.82 | $ | 1.44 | ||||||||||
|
|
•
|
unexpected changes in regulatory requirements;
|
|
|
•
|
changes in governmental defense budgets and national priorities;
|
|
|
•
|
imposition of tariffs and other barriers and restrictions;
|
|
|
•
|
burdens of complying with a variety of foreign laws;
|
|
|
•
|
political and economic instability; and
|
|
|
•
|
changes in diplomatic and trade relationships.
|
|
|
•
|
identify emerging technological trends in our current and future markets;
|
|
|
•
|
identify additional uses for our existing technology to address customer needs in our current or future markets;
|
|
|
•
|
develop and maintain competitive products and services for our current and future markets;
|
|
|
•
|
enhance our offerings by adding innovative features that differentiate our offerings from those of our competitors;
|
|
|
•
|
develop, manufacture and bring solutions to the market quickly at cost-effective prices;
|
|
|
•
|
develop working prototypes as a condition to receiving contract awards; or
|
|
|
•
|
effectively structure our business, through the use of joint ventures, teaming agreements and other forms of alliances, to reflect the competitive environment.
|
|
|
•
|
some foreign countries may not protect proprietary rights as comprehensively as the laws of the United States and Israel;
|
|
|
•
|
detecting infringements and enforcing proprietary rights may be time consuming and costly, diverting management’s attention and company resources;
|
|
|
•
|
measures such as non-disclosure agreements afford only limited protection;
|
|
|
•
|
unauthorized parties may copy aspects of our products or technologies to develop similar products or technologies or obtain and use information that we regard as proprietary;
|
|
|
•
|
our patents may expire, thus providing competitors access to the applicable technology;
|
|
|
•
|
competitors may independently develop products that are substantially equivalent or superior to our products or circumvent our intellectual property rights; and
|
|
|
•
|
competitors may register patents in technologies relevant to our business areas.
|
|
|
•
|
the difficulty in integrating newly-acquired businesses and operations in an efficient and cost-effective manner and the risk that we encounter significant unanticipated costs or other problems associated with integration;
|
|
|
•
|
failure to meet the challenges of achieving strategic objectives, cost savings and other benefits expected from acquisitions could lead to impairment of intangible assets related to the acquired companies;
|
|
|
•
|
the risk that our markets do not evolve as anticipated and that the technologies acquired do not prove to be those needed to be successful in those markets;
|
|
|
•
|
the risk that we assume significant liabilities that exceed the enforceability or other limitations of applicable indemnification provisions, if any, or the financial resources of any indemnifying parties, including indemnity for regulatory compliance issues that may result in our incurring successor liability;
|
|
|
•
|
the potential loss of key employees of the acquired businesses;
|
|
|
•
|
the risk of diverting the attention of senior management from our existing operations; and
|
|
|
•
|
the risk that certain of our newly acquired operating subsidiaries in various countries could be subject to more restrictive regulations by the local authorities after our acquisition.
|
|
Item 4.
|
Information on
the
Company.
|
|
|
•
|
military aircraft and helicopter systems;
|
|
|
•
|
helmet mounted systems;
|
|
|
•
|
commercial aviation systems and aerostructures;
|
|
|
•
|
unmanned aircraft systems;
|
|
|
•
|
naval systems;
|
|
|
•
|
land vehicle systems;
|
|
|
•
|
command, control, communications, computer and intelligence (C4I) systems;
|
|
|
•
|
electro-optic and countermeasures systems;
|
|
|
•
|
homeland security systems;
|
|
|
•
|
EW and signal intelligence systems; and
|
|
|
•
|
various commercial activities.
|
|
2008
|
2009
|
2010
|
||||||||||
|
(U.S. dollars in millions)
|
||||||||||||
|
Airborne systems:
|
$ | 635 | $ | 693 | $ | 791 | ||||||
|
Land systems:
|
699 | 450 | 363 | |||||||||
|
C4ISR systems:
|
844 | 1,169 | 1,019 | |||||||||
|
Electro-optic systems:
|
337 | 406 | 369 | |||||||||
|
Other (mainly non-defense engineering and production services):
|
123 | 114 | 128 | |||||||||
|
Total:
|
$ | 2,638 | $ | 2,832 | $ | 2,670 | ||||||
|
2008
|
2009
|
2010
|
||||||||||
|
Israel
|
18 | % | 22 | % | 24 | % | ||||||
|
United States
|
34 | % | 29 | % | 32 | % | ||||||
|
Europe
|
25 | % | 26 | % | 20 | % | ||||||
|
Others
|
23 | % | 23 | % | 24 | % | ||||||
|
Israel
(1)
|
U.S.
(2)
|
Other Countries
(3)
|
||||
|
Owned
|
2,215,000 square feet
|
713,000 square feet
|
1,063,000 square feet
|
|||
|
Leased
|
2,038,000 square feet
|
611,000 square feet
|
300,000 square feet
|
|
(1)
|
Includes offices, development and engineering facilities, manufacturing facilities, maintenance facilities, hangar facilities and a landing strip in various locations in Israel used by Elbit Systems, Elop, ESLC, Elisra, Cyclone, ELSEC, Tadiran Systems, Tadiran Spectralink, Kinetics, Soltam, Saymar, Azimuth and ITL.
|
|
(2)
|
Includes offices, development and engineering facilities, manufacturing facilities and maintenance facilities of Elbit Systems of America primarily in Texas, New Hampshire, Florida, Alabama and Virginia. Elbit Systems of America’s facilities in Texas, New Hampshire and Alabama are located on a total of approximately 153 acres of land owned by Elbit Systems of America. This does not include properties not held by Elbit Systems of America, including approximately 6,000 square feet leased by our wholly-owned subsidiary Elmec Inc. in Massachusetts.
|
|
(3)
|
Includes offices, design and engineering facilities and manufacturing facilities primarily in the U.K., Romania, Belgium, Germany, Austria, Brazil and Australia.
|
|
2008
|
2009
|
2010
|
||||||||||
|
(U.S. dollars in millions)
|
||||||||||||
|
Total Investment
|
$ | 217.2 | $ | 245.8 | $ | 268.6 | ||||||
|
Less Participation*
|
32.2 | 29.0 | 34.5 | |||||||||
|
Net Investment
|
$ | 185.0 | $ | 216.8 | $ | 234.1 | ||||||
|
*
|
See above – “Government Rights in Data” and see below – “Conditions in Israel – Chief Scientist (OCS) and Investment Center Funding.”
|
|
|
•
|
adequate service of process has been made and the defendant has had a reasonable opportunity to be heard;
|
|
|
•
|
the judgment and its enforcement are not contrary to the law, public policy, security or sovereignty of the State of Israel;
|
|
|
•
|
the judgment was not obtained by fraud and does not conflict with any other valid judgment in the same matter between the same parties;
|
|
|
•
|
an action between the same parties in the same matter is not pending in any Israeli court at the time the lawsuit is instituted in the foreign court; and
|
|
|
•
|
the judgment is no longer subject to a right of appeal.
|
|
Item 4A.
|
Unresolved Staff Com
men
ts.
|
|
Item 5.
|
Operating and Financial Review and P
ro
spects.
|
|
|
•
|
Revenue Recognition.
|
|
|
•
|
Business Combinations and Purchase Price Allocation.
|
|
|
•
|
Impairment of Long-Lived Assets and Goodwill.
|
|
|
•
|
Other-Than-Temporary Decline in Value of Investments in Investee.
|
|
|
•
|
Other-Than-Temporary Impairment of Debt Securities.
|
|
|
•
|
Useful Lives of Long-Lived Assets.
|
|
|
•
|
Taxes on Income.
|
|
|
•
|
Stock-Based Compensation Expense.
|
|
Year ended December 31,
|
||||||||||||||||||||||||
|
2010
|
2009
|
2008
|
||||||||||||||||||||||
| $ | % | $ | % | $ | % | |||||||||||||||||||
|
(in thousands of U.S. dollars except per share data)
|
||||||||||||||||||||||||
|
Total revenues
|
$ | 2,670,133 | 100.0 | $ | 2,832,437 | 100.0 | $ | 2,638,271 | 100.0 | |||||||||||||||
|
Cost of revenues
|
1,872,263 | 70.1 | 1,982,954 | 70.0 | 1,870,830 | 70.9 | ||||||||||||||||||
|
Restructuring expenses
|
— | — | — | — | — | — | ||||||||||||||||||
|
Gross profit
|
797,870 | 29.9 | 849,483 | 30.0 | 767,441 | 29.1 | ||||||||||||||||||
|
Research and development (R&D) expenses
|
268,578 | 10.0 | 245,812 | 8.7 | 217,176 | 8.2 | ||||||||||||||||||
|
Less – participation
|
(34,447 | ) | (1.29 | ) | (29,060 | ) | (1.0 | ) | (32,192 | ) | (1.2 | ) | ||||||||||||
|
R&D expenses, net
|
234,131 | 8.8 | 216,752 | 7.7 | 184,984 | 7.0 | ||||||||||||||||||
|
Marketing and selling expenses
|
229,942 | 8.6 | 250,963 | 8.9 | 198,274 | 7.5 | ||||||||||||||||||
|
General and administrative expenses
|
131,200 | 4.9 | 119,311 | 4.2 | 134,182 | 5.1 | ||||||||||||||||||
|
Acquired IPR&D and other expenses
|
(4,756 | ) | (0.2 | ) | — | — | 1,000 | — | ||||||||||||||||
| 590,517 | 22.1 | 587,026 | 20.7 | 518,440 | 19.7 | |||||||||||||||||||
|
Operating income
|
207,353 | 7.8 | 262,457 | 9.3 | 249,001 | 9.4 | ||||||||||||||||||
|
Financial expenses, net
|
(21,251 | ) | (0.8 | ) | (15,585 | ) | (0.6 | ) | (36,815 | ) | (1.4 | ) | ||||||||||||
|
Other income, net
|
13,259 | 0.5 | 458 | — | 94,294 | 3.6 | ||||||||||||||||||
|
Income before taxes on income
|
199,361 | 7.5 | 247,330 | 8.7 | 306,480 | 11.6 | ||||||||||||||||||
|
Taxes on income
|
24,037 | 0.9 | 38,109 | 1.3 | 54,367 | 2.1 | ||||||||||||||||||
| 175,324 | 6.6 | 209,221 | 7.4 | 252,113 | 9.6 | |||||||||||||||||||
|
Equity in net earnings of affiliated companies
and partnership
|
19,343 | 0.7 | 19,292 | 0.7 | 14,435 | 0.5 | ||||||||||||||||||
|
Net income
|
$ | 194,667 | 7.3 | $ | 228,513 | 8.1 | $ | 266,548 | 10.1 | |||||||||||||||
|
Less – net income attributable to
non-controlling interests
|
$ | (11,169 | ) | (0.4 | ) | $ | (13,566 | ) | (0.5 | ) | $ | (62,372 | ) | (2.4 | ) | |||||||||
|
Net income attributable to the Company’s
shareholders
|
$ | 183,498 | 6.9 | $ | 214,947 | 7.6 | $ | 204,176 | 7.7 | |||||||||||||||
|
Diluted net earnings per share
|
$ | 4.25 | $ | 5.00 | $ | 4.78 | ||||||||||||||||||
|
Year ended
|
||||||||||||||||
|
December 31, 2010
|
December 31, 2009
|
|||||||||||||||
|
$ millions
|
%
|
$ millions
|
%
|
|||||||||||||
|
Airborne systems
|
791.1 | 29.6 | 693.2 | 24.5 | ||||||||||||
|
Land systems
|
363.2 | 13.6 | 449.7 | 15.9 | ||||||||||||
|
C4ISR systems
|
1,019.1 | 38.2 | 1,168.8 | 41.3 | ||||||||||||
|
Electro-optic systems
|
368.8 | 13.8 | 406.4 | 14.3 | ||||||||||||
|
Other (mainly non-defense engineering and production services)
|
127.9 | 4.8 | 114.3 | 4.0 | ||||||||||||
|
Total
|
2,670.1 | 100.0 | 2,832.4 | 100.0 | ||||||||||||
|
Year ended
|
||||||||||||||||
|
December 31, 2010
|
December 31, 2009
|
|||||||||||||||
|
$ millions
|
%
|
$ millions
|
%
|
|||||||||||||
|
Israel
|
651.0 | 24.4 | 627.3 | 22.1 | ||||||||||||
|
United States
|
844.0 | 31.6 | 813.4 | 28.7 | ||||||||||||
|
Europe
|
541.7 | 20.3 | 728.2 | 25.7 | ||||||||||||
|
Other Countries
|
633.4 | 23.7 | 663.5 | 23.5 | ||||||||||||
| Total | 2,670.1 | 100.0 | 2,832.4 | 100.0 | ||||||||||||
|
Year ended
|
||||||||||||||||
|
December 31, 2009
|
December 31, 2008
|
|||||||||||||||
|
$ millions
|
%
|
$ millions
|
%
|
|||||||||||||
|
Airborne systems
|
693.2 | 24.5 | 634.7 | 24.1 | ||||||||||||
|
Land systems
|
449.7 | 15.9 | 699.5 | 26.5 | ||||||||||||
|
C4ISR systems
|
1,168.8 | 41.3 | 844.5 | 32.0 | ||||||||||||
|
Electro-optic systems
|
406.4 | 14.3 | 336.7 | 12.7 | ||||||||||||
|
Other (mainly non-defense engineering and production services)
|
114.3 | 4.0 | 122.9 | 4.7 | ||||||||||||
|
Total
|
2,832.4 | 100.0 | 2,638.3 | 100.0 | ||||||||||||
|
Year ended
|
||||||||||||||||
|
December 31, 2009
|
December 31, 2008
|
|||||||||||||||
|
$ millions
|
%
|
$ millions
|
%
|
|||||||||||||
|
Israel
|
627.3 | 22.1 | 474.4 | 18.0 | ||||||||||||
|
United States
|
813.4 | 28.7 | 907.1 | 34.4 | ||||||||||||
|
Europe
|
728.2 | 25.7 | 653.1 | 24.7 | ||||||||||||
|
Other Countries
|
663.5 | 23.5 | 603.7 | 22.9 | ||||||||||||
|
Total
|
2,832.4 | 100.0 | 2,638.3 | 100.0 | ||||||||||||
|
Forward
|
Notional Amount*
|
Unrealized
Gain (Loss)
|
||||||
|
Buy US$ and Sell:
|
||||||||
|
Euro
|
16,076 | (0.9 | ) | |||||
|
GBP
|
20,475 | (0.5 | ) | |||||
|
NIS
|
114,284 | 5.4 | ||||||
|
Other various currencies
|
30,412 | (0.5 | ) | |||||
|
Forward
|
Notional Amount*
|
Unrealized
Gain (Loss)
|
||||||
|
Sell US$ and Buy:
|
||||||||
|
Euro
|
240,830 | 3.6 | ||||||
|
GBP
|
85,980 | 4.2 | ||||||
|
NIS
|
-- | -- | ||||||
|
Other various currencies
|
54,572 | (0.3 | ) | |||||
|
Options
|
Notional Amount*
|
Unrealized
Gain (Loss)
|
||||||
|
Buy US$ and Sell:
|
||||||||
|
options
|
6,000 | 0.2 | ||||||
|
Sell US$ and Buy:
|
||||||||
|
NIS
|
6,000 | (0.1 | ) | |||||
|
__________
|
|
*
|
Notional amount information is based on the foreign exchange rate at year end.
|
|
Less than
1 year
|
1-3 years
|
4-5 years
|
More than
5 years
|
|||||||||||||
|
(U.S. dollars in millions)
|
||||||||||||||||
|
1. Long-Term Debt Obligations
|
10 | 292 | -- | -- | ||||||||||||
|
2. Series A Notes
|
34 | 61 | 61 | 153 | ||||||||||||
|
3. Operating Lease Obligations*
|
35 | 41 | 16 | 8 | ||||||||||||
|
4. Purchase Obligations*
|
721 | 308 | 17 | 8 | ||||||||||||
|
5. Other Long-Term Liabilities Reflected on the Company’s Balance Sheet under U.S. GAAP**
|
-- | -- | -- | -- | ||||||||||||
|
6. Other Long-Term Liabilities***
|
||||||||||||||||
|
Total
|
800 | 702 | 94 | 169 | ||||||||||||
|
___________
|
|
*
|
For further description of the Purchase Obligations see above “Long-Term Arrangements and Commitments – Purchase Commitments” and See Item 18. Financial Statements – Note 20(H).
|
|
**
|
The obligation amount does not include an amount of $395 million of pension and employee termination liabilities. See Item 18. Financial Statements – Notes 2 (T) and 17. The obligation amount also does not include an amount of $47 million of tax reserve related to uncertain tax positions. See Item 18. Financial Statements – Note 18.
|
|
***
|
See below “Off-Balance Sheet Transactions.”
|
|
Reconciliation of GAAP (Audited) to
Non-GAAP (Unaudited) Supplemental Financial Data
(U.S. dollars in millions)
|
||||||||||||
|
2010
|
2009
|
2008
|
||||||||||
|
GAAP gross profit
|
797.9 | 849.5 | 767.4 | |||||||||
|
Adjustments:
|
||||||||||||
|
Amortization of intangible assets
|
25.0 | 22.2 | 28.9 | |||||||||
|
Reorganization, restructuring and
other related expenses
(1)
|
12.8 | - | - | |||||||||
| Non-GAAP gross profit | 835.7 | 871.7 | 796.3 | |||||||||
|
Percent of revenues
|
31.3 | % | 30.8 | % | 30.2 | % | ||||||
|
GAAP operating income
|
207.4 | 262.5 | 249.0 | |||||||||
|
Adjustments:
|
||||||||||||
|
Amortization of intangible assets
|
47.7 | 44.0 | 40.1 | |||||||||
|
Reorganization, restructuring and
other related expenses
(1)
|
16.4 | - | 1.0 | |||||||||
|
Impairment of investments
(2)
|
1.3 | 1.4 | - | |||||||||
|
Gain from changes in holdings
(3)
|
(4.8 | ) | - | - | ||||||||
| Non-GAAP operating income | 268.0 | 307.9 | 290.1 | |||||||||
|
Percent of revenues
|
10.0 | % | 10.9 | % | 11.0 | % | ||||||
|
GAAP net income
attributable to Elbit Systems’
shareholders
|
183.5 | 214.9 | 204.2 | |||||||||
|
Adjustments:
|
||||||||||||
|
Amortization of intangible assets
|
47.7 | 44.0 | 40.1 | |||||||||
|
Reorganization, restructuring and
other related expenses
(1)
|
16.4 | - | 1.0 | |||||||||
|
Impairment of investments
(2)
|
1.3 | 1.4 | 29.2 | |||||||||
|
Gain from changes in holdings
(3)
|
(17.6 | ) | (1.0 | ) | (100.0 | ) | ||||||
|
Related tax benefits
|
(8.9 | ) | (9.0 | ) | 16.8 | |||||||
|
Non-GAAP net income
attributable to Elbit Systems’
shareholders
|
222.4 | 250.3 | 191.3 | |||||||||
|
Percent of revenues
|
8.3 | % | 8.8 | % | 7.3 | % | ||||||
|
Non-GAAP diluted net EPS
|
5.1 | 5.8 | 4.5 | |||||||||
|
|
___________________________
|
|
(1)
|
Adjustment of reorganization, restructuring and other related expenses in 2010 were mainly due to write-off of inventories in the amount of approximately $13 million related to the acquisitions of Soltam and ITL.
|
|
(2)
|
Adjustment of gain from changes in holdings in 2010 and 2009 were due to the impairment of ICI shares and in 2008 were due to impairment of ARS ($18.7 million) and the impairment of Sandel shares ($10.5 million).
|
|
(3)
|
Adjustment of gain from changes in holdings includes the income from the sale of Mediguide shares ($100 million in 2008, $1 million in 2009 and $12.6 million in 2010) and a gain of $4.8 million from a "step-up" in an investment in 2010.
|
|
Item 6.
|
Directors, Senior Management and Emp
loyee
s.
|
|
Name
|
Age
|
Director Since
|
||||||
|
Michael Federmann (Chairman)
|
67 | 2000 | ||||||
|
Moshe Arad
|
76 | 2005 | ||||||
|
Avraham Asheri
|
73 | 2000 | ||||||
|
Rina Baum
|
65 | 2001 | ||||||
|
David Federmann
|
36 | 2007 | ||||||
|
Yigal Ne’eman
|
69 | 2004 | ||||||
|
Yehoshua Gleitman (External Director)
|
61 | 2010 | ||||||
|
Dov Ninveh
|
63 | 2000 | ||||||
|
Dalia Rabin (External Director)
|
60 | 2010 | ||||||
|
Name
|
Age
|
Position
|
|||
|
Joseph Ackerman
|
61 |
President and Chief Executive Officer
|
|||
|
Elad Aharonson
|
37 |
Executive Vice President and General Manager – UAS Division
|
|||
|
David Block Temin
|
55 |
Executive Vice President, Chief Legal Officer and Chief Compliance Officer
|
|||
|
Guy Brill
|
59 |
Executive Vice President and Co-General Manager – Technologies and Operations Division
|
|||
|
Adi Dar
|
39 |
Executive Vice President and General Manager – Electro-Optics Elop Division
|
|||
|
Itzhak Dvir
|
63 |
Executive Vice President and Chief Operating Officer
|
|||
|
Jacob Gadot
|
63 |
Executive Vice President – International Marketing and Business Development
|
|||
|
Ran Galli
|
62 |
Executive Vice President – Strategic and Security Initiatives
|
|||
|
Joseph Gaspar
|
62 |
Executive Vice President and Chief Financial Officer
|
|||
|
Zeev Gofer
|
58 |
Executive Vice President – Strategic and Business Development - North America
|
|||
|
Dalia Gonen
|
59 |
Executive Vice President – Human Resources
|
|||
|
Ran Hellerstein
|
60 |
Executive Vice President and Co-General Manager – Aerospace Division
|
|||
|
Raanan Horowitz
|
50 |
President and Chief Executive Officer – Elbit Systems of America
|
|||
|
Bezhalel Machlis
|
47 |
Executive Vice President and General Manager – Land and C4I Division
|
|||
|
Ilan Pacholder
|
56 |
Executive Vice President – Mergers and Acquisitions, Offset and Financing
|
|||
|
Marco Rosenthal
|
63 |
Executive Vice President and Co-General Manager – Technologies and Operations Division
|
|||
|
Haim Rousso
|
64 |
Executive Vice President – Engineering and Technology Excellence
|
|||
|
Gideon Sheffer
|
62 |
Executive Vice President – Strategic Planning and Business Development – Israel
|
|||
|
Yoram Shmuely
|
50 |
Executive Vice President and Co-General Manager – Aerospace Division
|
|||
|
Udi Vered
|
52 |
Executive Vice President – Service Solutions
|
|||
|
Salaries, Directors’ Fees
Commissions and Bonuses
|
Pension, Retirement
and Similar Benefits
|
|||||||
|
(U.S. dollars in thousands)
|
||||||||
|
All directors (consisting of 11 persons)
|
$ | 342 | (*) | $ | — | |||
|
All officers (consisting of 20 persons)
|
$ | 10,455 | (**) | $ | 1,207 | |||
|
_________
|
|
(*)
|
Elbit Systems’ shareholders at the annual general shareholders meeting held in 2004 approved payment to directors thereafter in accordance with maximum regulatory rates payable to External Directors under Israeli law for companies similarly classified based on their shareholding equity. These rates were linked to the Israeli consumer price index and were so updated and paid by Elbit Systems through March 2008. At an extraordinary general shareholders meeting held in March 2008, our shareholders approved increasing compensation, effective April 1, 2008 (and thereafter so long as such approval has not been replaced or revoked by the shareholders) to our External Directors and to other directors meeting the director independence criteria of Nasdaq, each of whom has additional duties under applicable non-Israeli law. The increased compensation was consistent with amendments to Israeli law regarding compensation to External Directors who serve on the boards of “dual listed” companies, such as Elbit Systems. As a result, External Directors and other such “independent” directors are and will be entitled, so long as the above-mentioned resolution adopted in March 2008 is in effect, to an annual fee of NIS 110,329 (equal to approximately $29,563) and a per meeting fee of 2,427 NIS (equal to approximately $650), which reflect the fees levels previously approved at the 2008 Shareholders’ Extraordinary General Meeting and linked to the Israeli consumer price index. The other directors are paid the following compensation: an annual fee of NIS 54,473 (equal to approximately $14,596) and a per meeting fee of NIS 2,055 (equal to approximately $550), which reflect the fees levels previously approved at the 2004 annual general shareholders meeting and linked to the Israeli consumer price index. We currently intend to maintain such compensation rates to such directors. Compensation payments to directors are made either directly to the director or to his or her employing company.
|
|
(**)
|
We recorded an amount of approximately $5.2 million in 2010 as compensation costs related to stock options granted to our Executive Officers under our 2007 Employee Stock Option Plan. (See below “Share Ownership – Elbit Systems’ Stock Option Plans.”)
|
| Audit Committee : |
Financial Statements
Review Committee:
|
Corporate Governance and
Nominating Committee:
|
Compensation Committee:
|
|
Avraham Asheri (Chair)
|
Yehoshua Gleitman (Chair)
|
Yehoshua Gleitman (Chair)
|
Avraham Asheri (Chair)
|
|
Moshe Arad
|
Avraham Asheri
|
Avraham Asheri
|
Moshe Arad
|
|
Yehoshua Gleitman
|
Moshe Arad
|
Yigal Ne’eman
|
Yehoshua Gleitman
|
|
Yigal Ne’eman
|
Yigal Ne’eman
|
Dalia Rabin
|
|
|
Dalia Rabin
|
Dalia Rabin
|
|
Total Employees
|
U.S. Employees
|
|||||||
|
2010
|
12,317 | 1,963 | ||||||
|
2009
|
11,238 | 1,806 | ||||||
|
2008
|
10,876 | 1,826 | ||||||
|
|
(1)
|
50% of the options will be vested and exercisable from the second anniversary of the Commencement Date;
|
|
|
(2)
|
An additional 25% of the options will be vested and exercisable from the third anniversary of the Commencement Date; and
|
|
|
(3)
|
The remaining 25% of the options will be vested and exercisable from the fourth anniversary of the Commencement Date.
|
|
Item 7.
|
Major Share
h
olders and Related Party Transactions.
|
|
|
•
|
beneficial ownership of more than 5% of our outstanding ordinary shares; and
|
|
|
•
|
the number of ordinary shares beneficially owned by all of our officers and directors as a group.
|
|
Name of Beneficial Owner
|
Amount Owned
|
Percent of Ordinary Shares
|
||||||
|
Federmann Enterprises Ltd.
99 Hayarkon Street
Tel-Aviv, Israel
(2)
|
19,457,566 | 45.50 | % | |||||
|
Heris Aktiengesellschaft
c/o 99 Hayarkon Street
Tel-Aviv, Israel
|
3,836,458 | (3) | 8.97 | % | ||||
|
Migdal Insurance & Financial
Holdings Ltd.
4 Efal Street
Petach Tikva, Israel
|
2,205,655 | 5.15 | % | |||||
|
All officers and directors as
a group (29 persons)
|
171,799 | (4) | 0.40 | % | ||||
|
(1)
|
The total number of ordinary shares includes 23,021 ordinary shares held by one of our subsidiaries but excludes 385,900 ordinary shares held by us as treasury shares.
|
|
(2)
|
Federmann Enterprises Ltd. (FEL) owns our ordinary shares directly and indirectly through Heris Aktiengesellschaft (Heris) which is controlled by FEL. FEL is controlled by Beit Federmann Ltd. (BFL). BFL is controlled by Beit Bella Ltd. (BBL) and Beit Yekutiel Ltd. (BYL). Michael Federmann is the controlling shareholder of BBL and BYL. He is also the chairman of Elbit Systems’ Board and the chairman of the Board and the chief executive officer of FEL. Therefore, Mr. Federmann controls, directly and indirectly, the vote of ordinary shares owned by Heris and FEL.
|
|
(3)
|
The amount of ordinary shares owned by Heris is included in the amount of shares held by FEL as set forth in footnote (2) above.
|
|
(4)
|
This amount does not include any ordinary shares that may be deemed to be beneficially owned by Michael Federmann as described in footnote (2) above. The amount includes 105,905 ordinary shares underlying options that are currently exercisable or that will become exercisable within 60 days of February 28, 2011. A portion of the underlying options are “phantom options” or “cashless” options that have been calculated based on our February 28, 2011 closing share price on the TASE of $51.07.
|
|
February 28, 2011
|
February 28, 2010
|
May 31, 2009
|
May 31, 2008
|
|||||||||||||||||||||||||||||
|
Shares Owned
|
% of Shares Owned
|
Shares Owned
|
% of Shares Owned
|
Shares Owned
|
% of Shares Owned
|
Shares Owned
|
% of Shares Owned
|
|||||||||||||||||||||||||
|
FEL
|
19,457,566 | (1) | 45.50 | % | 19,342,625 | 45.49 | % | 19,342,625 | (2) | 45.91 | % | 19,183,763 | (3) | 45.57 | % | |||||||||||||||||
|
(1)
|
Reflects incidental purchases by FEL of shares in open market transactions during May 2010 – February 2011.
|
|
(2)
|
Reflects incidental purchases by FEL of shares in open market transactions during May 2008 – February 2009.
|
|
(3)
|
Reflects incidental purchases by FEL of shares in open market transactions during January – April 2008.
|
|
Item 8.
|
Financial
Info
rmation.
|
|
2008
|
$
1.42 per share
|
|
2009
|
$
1.82 per share
|
|
2010
|
$
1.44 per share
|
|
Item
9.
|
The Offer and Listing.
|
|
Nasdaq
|
TASE
(1)
|
|||||||||||||||
|
High
|
Low
|
High
|
Low
|
|||||||||||||
|
2006
|
$ | 34.03 | $ | 23.00 | $ | 33.60 | $ | 22.96 | ||||||||
|
2007
|
$ | 59.56 | $ | 32.32 | $ | 59.93 | $ | 32.47 | ||||||||
|
2008
|
$ | 63.40 | $ | 36.25 | $ | 62.64 | $ | 36.06 | ||||||||
|
2009
|
$ | 70.50 | $ | 40.50 | $ | 69.78 | $ | 40.27 | ||||||||
|
2010
|
$ | 66.65 | $ | 46.80 | $ | 65.69 | $ | 46.70 | ||||||||
|
Nasdaq
|
TASE
(1)
|
|||||||||||||||
|
High
|
Low
|
High
|
Low
|
|||||||||||||
|
2009
|
||||||||||||||||
|
First Quarter
|
$ | 49.94 | $ | 40.50 | $ | 43.56 | $ | 40.27 | ||||||||
|
Second Quarter
|
$ | 61.90 | $ | 45.72 | $ | 60.30 | $ | 44.75 | ||||||||
|
Third Quarter
|
$ | 70.50 | $ | 57.82 | $ | 69.78 | $ | 62.66 | ||||||||
|
Fourth Quarter
|
$ | 69.69 | $ | 60.12 | $ | 69.25 | $ | 59.36 | ||||||||
|
2010
|
||||||||||||||||
|
First Quarter
|
$ | 66.65 | $ | 59.27 | $ | 65.69 | $ | 58.67 | ||||||||
|
Second Quarter
|
$ | 65.35 | $ | 48.50 | $ | 64.97 | $ | 48.77 | ||||||||
|
Third Quarter
|
$ | 55.31 | $ | 49.35 | $ | 54.83 | $ | 48.33 | ||||||||
|
Fourth Quarter
|
$ | 55.71 | $ | 46.80 | $ | 55.13 | $ | 46.70 | ||||||||
|
2011
|
||||||||||||||||
|
First Quarter (through February 28, 2011)
|
$ | 55.94 | $ | 48.78 | $ | 56.09 | $ | 48.87 | ||||||||
|
Nasdaq
|
TASE
(1)
|
|||||||||||||||
|
High
|
Low
|
High
|
Low
|
|||||||||||||
|
September 2010
|
$ | 53.18 | $ | 50.38 | $ | 52.82 | $ | 50.91 | ||||||||
|
October 2010
|
$ | 55.75 | $ | 51.99 | $ | 55.14 | $ | 51.98 | ||||||||
|
November 2010
|
$ | 53.20 | $ | 46.80 | $ | 53.58 | $ | 46.70 | ||||||||
|
December 2010
|
$ | 52.95 | $ | 50.57 | $ | 53.21 | $ | 50.70 | ||||||||
|
January 2011
|
$ | 55.95 | $ | 48.78 | $ | 56.15 | $ | 49.72 | ||||||||
|
February 2011
|
$ | 51.81 | $ | 48.94 | $ | 52.88 | $ | 48.87 | ||||||||
|
__________
|
|
(1)
|
The closing prices of our ordinary shares on the TASE have been translated into U.S. dollars using the daily representative rate of exchange of the NIS to the U.S. dollar as published by the Bank of Israel for the applicable day of the high/low amount in the specified period.
|
|
Item 10.
|
Additional Infor
m
ation.
|
|
|
(1)
|
extraordinary transactions with an Office Holder or in which an Office Holder has a Personal Interest;
|
|
|
(2)
|
the grant of an exemption, insurance, undertaking to indemnify or indemnification under a permit to indemnify, to an Office Holder who is not a director;
|
|
|
(3)
|
material actions or arrangements that may otherwise be considered a breach of fiduciary duty of an Office Holder; or
|
|
|
(4)
|
terms of service of directors, including the grant of indemnification, exemption or insurance and terms of employment of directors in other roles.
|
|
|
(1)
|
a breach of fiduciary duty, except indemnification or insurance that provides coverage for a breach of a fiduciary duty to the company while acting in good faith and having reasonable cause to assume that such act would not prejudice the interests of the company;
|
|
|
(2)
|
a willful breach of the duty of care or reckless disregard for the circumstances or to the consequences of a breach of the duty of care other than mere negligence;
|
|
|
(3)
|
an act done with the intent to unlawfully realize a personal gain; or
|
|
|
(4)
|
a fine or monetary penalty imposed upon such Office Holder.
|
|
|
(1)
|
a breach of his or her duty of care to Elbit Systems or to another person;
|
|
|
(2)
|
a breach of his or her fiduciary duty to Elbit Systems, provided that the director or officer acted in good faith and had reasonable cause to assume that his or her act would not harm the interests of Elbit Systems; or
|
|
|
(3)
|
any other event for which insurance of a director or officer is permitted.
|
|
|
(1)
|
a monetary liability imposed on the director or officer or paid by him or her in favor of a third party under a judgment, including a judgment by way of compromise or a judgment of an arbitrator approved by a court; however, such undertaking will be limited to events which, in the Board’s opinion, are foreseeable in light of the Elbit Systems’ actual activities at the time of granting the obligation to indemnify, and to a sum or criteria as the Board deems reasonable under the circumstances, and the undertaking to indemnify will specify the aforementioned events and sum or criteria;
|
|
|
(2)
|
reasonable legal fees incurred by a director or officer in an investigation or proceeding conducted against him by an authority authorized to conduct such investigation or proceeding, provided that such investigation or proceeding (i) concludes without the filing of an indictment against the director or officer and without imposition of monetary payment in lieu of criminal proceedings, or (ii) concludes with imposing on the director or officer monetary payment in lieu of criminal proceedings, provided that the alleged criminal offense in question does not require proof of criminal intent;
|
|
|
(3)
|
reasonable expenses of the proceedings, including lawyers fees, expended by the director or officer or imposed on him or her by the court for:
|
|
|
(a)
|
proceedings issued against him or her by or on Elbit Systems’ behalf or by a third party;
|
|
|
(b)
|
criminal proceedings from which the director or officer was acquitted; or
|
|
|
(c)
|
criminal proceedings in which he or she was convicted but that do not require proof of criminal intent; or
|
|
|
(4)
|
any other liability or expense for which it is or may be permissible to indemnify a director or an officer.
|
|
|
•
|
such majority includes at least one-third of the total votes of shareholders who have no Personal Interest in the approval of the transaction and who are present and voting, in person, by proxy or by written ballot, at the meeting (abstentions not taken into account); or
|
|
|
•
|
the total number of votes of shareholders mentioned above that are voted against the transaction do not represent more than 1% of the total voting rights in the company.
|
|
|
(1)
|
Exemption from corporate tax for periods ranging between two – ten years depending on specific conditions; and
|
|
|
(2)
|
Reduced corporate tax rates for several years thereafter depending on certain conditions.
|
|
|
•
|
a citizen or individual resident of the United States for U.S. federal income tax purposes;
|
|
|
•
|
a corporation (or an entity taxable as a corporation for U.S. federal income tax purposes) created or organized in or under the laws of the United States or any political subdivision thereof (including the District of Columbia);
|
|
|
•
|
an estate whose income is subject to U.S. federal income taxation regardless of its source; or
|
|
|
•
|
a trust if (A) a U.S. court is able to exercise primary supervision over the trust’s administration and (B) one or more U.S. persons have the authority to control all of the trust’s substantial decisions.
|
|
Item 11.
|
Quantitative and Qualitative Disclosures About
Market Risk
.
|
|
Item 12.
|
Description of Securities
Othe
r than Equity Securities.
|
|
Item 13.
|
Defaults, Dividend Arrearages and Delinquencies.
|
|
Item 14.
|
Material
Modific
ations to the Rights of Security Holders and Use of Proceeds.
|
|
Item 15.
|
Controls and Procedures.
|
|
Item 16A.
|
Audit
Committee Financial
Expert.
|
|
Item 16B.
|
Code of Ethics.
|
|
Item 16C.
|
Principal Accoun
tan
t Fees and Services.
|
|
Year Ended December 31
|
||||||||
|
2010
|
2009
|
|||||||
|
(U.S. dollars in thousands)
|
||||||||
|
Audit Fees
|
$ | 3,152 | $ | 2,889 | ||||
|
Tax Fees
|
$ | 424 | $ | 489 | ||||
|
Total
|
$ | 3,576 | $ | 3,378 | ||||
|
Items 16D.
|
Exemptions from the Listing Standards
for Audit
Committees.
|
|
Items 16E.
|
Purchases of Equity Securities by the Issuer and Affiliated Purchasers.
|
|
Items 16F.
|
Changes in Registrant’s Certifying Accountant.
|
|
Items 16G.
|
Corporate Gove
rnanc
e.
|
|
Item 17.
|
Financial Statements.
|
|
Item 18.
|
Financial Statements.
|
|
Item 19.
|
Exh
ib
its.
|
|
|
(a)
|
Index to Financial Statements
|
|
Page
|
|
|
Report of Independent Registered Public Accounting Firm
|
F-2
|
|
Report of Independent Registered Public Accounting Firm on Internal Control over Financial Reporting
|
F-3
|
|
Consolidated Balance Sheets at December 31, 2010 and 2009
|
F-4
|
|
Consolidated Statements of Income
|
F-6
|
|
Consolidated Statements of Changes in Shareholders’ Equity
|
F-7
|
|
Consolidated Statements of Cash Flows
|
F-9
|
|
Notes to Consolidated Financial Statements
|
F-11
|
|
Schedule II – Valuation and Qualifying Accounts
|
S-1
|
|
|
(b)
|
Exhibits
|
|
1.1
|
Elbit Systems’ Memorandum of Association
(1)
|
|
1.2
|
Elbit Systems’ Restated Articles of Association
(2)
|
|
4.1
|
Elbit Systems 2007 Stock Option Plan
(3)
|
|
4.2
|
Elbit Systems’ Post Merger Stock Option Plan (Summary in English)
(1)
|
|
8
|
Primary Operating Subsidiaries of Elbit Systems
|
|
12.1
|
Certification of Chief Executive Officer of the Registrant pursuant to Section 302 of the Sarbanes-Oxley
Act of 2002
|
|
12.2
|
Certification of Chief Financial Officer of the Registrant pursuant to Section 302 of the Sarbanes-Oxley
Act of 2002
|
|
13.1
|
Certification of Chief Executive Officer of the Registrant pursuant to Section 906 of the Sarbanes-Oxley
Act of 2002
|
|
13.2
|
Certification of Chief Financial Officer of the Registrant pursuant to Section 906 of the Sarbanes-Oxley
Act of 2002
|
|
15.1
|
Consent of Kost Forer Gabbay & Kasierer
|
|
__________
|
|
(1)
|
Filed as an exhibit to Elbit Systems’ Annual Report on Form 20-F (File No. 0-28998) for the year ended December 31, 2000, which was filed with the Securities and Exchange Commission on April 5, 2001, and incorporated herein by reference.
|
|
(2)
|
Filed as an exhibit to Elbit Systems’ Report on Form 6-K for March 2008, which was filed by Elbit Systems with the Securities and Exchange Commission on March 26, 2008, and incorporated herein by reference.
|
|
(3)
|
Filed as an exhibit to Elbit Systems’ Report on Form 6-K for December 2006, which was filed by Elbit Systems with the Securities and Exchange Commission on December 7, 2006, and incorporated herein by reference.
|
|
ELBIT SYSTEMS LTD.
|
|||
|
|
By:
|
/s/ J OSEPH A CKERMAN | |
| Name: |
Joseph Ackerman
|
||
| Title: |
President and Chief Executive Officer
|
||
| (Principal Executive Officer) | |||
|
ELBIT SYSTEMS LTD. AND ITS SUBSIDIARIES
|
|
ELBIT SYSTEMS LTD. AND ITS SUBSIDIARIES
|
|
Page
|
|
|
F-2 – F-3
|
|
|
CONSOLIDATED FINANCIAL STATEMENTS:
|
|
|
F-4 - F-5
|
|
|
F-6
|
|
|
F-7 - F-8
|
|
|
F-9 - F-10
|
|
|
F-11 - F-66
|
|
Kost Forer Gabbay & Kasierer
3 Aminadav St.
Tel-Aviv 67067, Israel
Tel:
972 (3)6232525
Fax: 972 (3)5622555
www.ey.com/il
|
|
Kost Forer Gabbay & Kasierer
3 Aminadav St.
Tel-Aviv 67067, Israel
Tel:
972 (3)6232525
Fax: 972 (3)5622555
www.ey.com/il
|
|
|
|
U. S. dollars (In thousands)
|
|
December 31,
|
||||||||||||
|
Note
|
2010
|
2009
|
||||||||||
|
CURRENT ASSETS:
|
||||||||||||
|
Cash and cash equivalents
|
$ | 151,059 | $ | 140,709 | ||||||||
|
Short-term bank deposits
|
62,662 | 115,924 | ||||||||||
|
Available for sale and trading marketable securities
|
(9) | 824 | 23,639 | |||||||||
|
Trade and unbilled receivables, net
|
(3) | 702,364 | 652,524 | |||||||||
|
Other receivables and prepaid expenses
|
(4) | 166,124 | 115,856 | |||||||||
|
Inventories, net of customer advances
|
(5) | 665,270 | 569,848 | |||||||||
|
Total current assets
|
1,748,303 | 1,618,500 | ||||||||||
|
LONG-TERM INVESTMENTS AND RECEIVABLES:
|
||||||||||||
|
Investments in affiliated companies, partnership
and other companies
|
(6) | 88,116 | 88,759 | |||||||||
|
Available for sale marketable securities
|
(9) | 7,179 | 12,941 | |||||||||
|
Long-term trade and unbilled receivables
|
(7) | 90,343 | 16,949 | |||||||||
|
Long-term bank deposits and other receivables
|
(8) | 44,401 | 31,230 | |||||||||
|
Deferred income taxes, net
|
(18F) | 29,892 | 7,992 | |||||||||
|
Severance pay fund
|
(2S) | 302,351 | 274,136 | |||||||||
| 562,282 | 432,007 | |||||||||||
|
PROPERTY, PLANT AND EQUIPMENT, NET
|
(10) | 503,851 | 404,675 | |||||||||
|
GOODWILL
|
(11) | 483,071 | 337,312 | |||||||||
|
OTHER INTANGIBLE ASSETS, NET
|
(11) | 313,593 | 261,183 | |||||||||
| $ | 3,611,100 | $ | 3,053,677 | |||||||||
|
CONSOLIDATED BALANCE SHEETS
|
|
U. S. dollars (In thousands, except share data)
|
|
December 31,
|
|||||||||||
|
Note
|
2010
|
2009
|
|||||||||
|
CURRENT LIABILITIES:
|
|||||||||||
|
Short-term bank credit and loans
|
(12) | $ | 15,115 | $ | - | ||||||
|
Current maturities of long-term loans and Series A Notes
|
(15) | 43,093 | 2,663 | ||||||||
|
Trade payables
|
360,736 | 299,238 | |||||||||
|
Other payables and accrued expenses
|
(13) | 645,146 | 557,601 | ||||||||
|
Customer advances in excess of costs incurred on contracts
in progress
|
(14) | 302,691 | 367,137 | ||||||||
|
Total current liabilities
|
1,366,781 | 1,226,639 | |||||||||
|
LONG-TERM LIABILITIES:
|
|||||||||||
|
Long-term loans, net of current maturities
|
(15) | 292,039 | 389,222 | ||||||||
|
Series A Notes and convertible debentures, net of current
maturities
|
(16) | 273,357 | - | ||||||||
|
Accrued termination liabilities
|
395,303 | 350,240 | |||||||||
|
Deferred income taxes and tax liabilities, net
|
(18F) | 55,936 | 59,602 | ||||||||
|
Customer advances in excess of costs incurred on contracts
in progress
|
(14) | 177,191 | 142,566 | ||||||||
|
Other long term liabilities
|
45,042 | 28,214 | |||||||||
| 1,238,868 | 969,844 | ||||||||||
|
COMMITMENTS AND CONTINGENT LIABILITIES
|
(20) | ||||||||||
|
SHAREHOLDERS' EQUITY:
|
(21) | ||||||||||
|
Elbit Systems Ltd. shareholders' equity:
|
|||||||||||
|
Share capital:
|
|||||||||||
|
Ordinary shares of New Israeli Shekels ("NIS") 1 par value each;
Authorized – 80,000,000 shares as of
December 31, 2010 and 2009;
Issued 43,102,261 and 42, 939,816 shares as
of December 31, 2010 and 2009, respectively;
Outstanding 42,693,340 and 42,530,895 shares
as of December 31, 2010 and 2009, respectively
|
12,050 | 12,006 | |||||||||
|
Additional paid-in capital
|
281,594 | 272,127 | |||||||||
|
Treasury shares - 408,921 shares as of December 31, 2010
and 2009
|
(4,321 | ) | (4,321 | ) | |||||||
|
Accumulated other comprehensive loss
|
(18,460 | ) | (22,413 | ) | |||||||
|
Retained earnings
|
695,830 | 575,469 | |||||||||
|
Total Elbit Systems Ltd. shareholders' equity
|
966,693 | 832,868 | |||||||||
|
Non-controlling interests
|
38,758 | 24,326 | |||||||||
| 1,005,451 | 857,194 | ||||||||||
|
Total liabilities and shareholders' equity
|
$ | 3,611,100 | $ | 3,053,677 | |||||||
|
|
|
U. S. dollars (In thousands, except per share data)
|
|
Year ended December 31,
|
||||||||||||||||
|
Note
|
2010
|
2009
|
2008
|
|||||||||||||
|
Revenues
|
(22) | $ | 2,670,133 | $ | 2,832,437 | $ | 2,638,271 | |||||||||
|
Cost of revenues
|
1,872,263 | 1,982,954 | 1,870,830 | |||||||||||||
|
Gross profit
|
797,870 | 849,483 | 767,441 | |||||||||||||
|
Operating expenses:
|
||||||||||||||||
|
Research and development, net
|
(23) | 234,131 | 216,752 | 184,984 | ||||||||||||
|
Marketing and selling
|
229,942 | 250,963 | 198,274 | |||||||||||||
|
General and administrative
|
131,200 | 119,311 | 134,182 | |||||||||||||
|
Acquired
IPR&D
|
- | - | 1,000 | |||||||||||||
|
Other income, net
|
(1D(1)) | (4,756 | ) | - | - | |||||||||||
|
Total operating expenses
|
590,517 | 587,026 | 518,440 | |||||||||||||
|
Operating income
|
207,353 | 262,457 | 249,001 | |||||||||||||
|
Financial expenses, net
|
(24) | (21,251 | ) | (15,585 | ) | (36,815 | ) | |||||||||
|
Other income, net
|
(25) | 13,259 | 458 | 94,294 | ||||||||||||
|
Income
before income taxes
|
199,361 | 247,330 | 306,480 | |||||||||||||
|
Income taxes
|
(18D) | 24,037 | 38,109 | 54,367 | ||||||||||||
| 175,324 | 209,221 | 252,113 | ||||||||||||||
| Equity in net earnings of affiliated companies and partnership | (6B) | 19,343 | 19,292 | 14,435 | ||||||||||||
|
Net income
|
$ | 194,667 | $ | 228,513 | $ | 266,548 | ||||||||||
|
Less: Net income attributable to non-controlling interests
|
(11,169 | ) | (13,566 | ) | (62,372 | ) | ||||||||||
|
Net income attributable to Elbit Systems Ltd. shareholders
|
$ | 183,498 | $ | 214,947 | $ | 204,176 | ||||||||||
|
Earnings per share attributable to Elbit Systems Ltd. shareholders:
|
(21)
|
|||||||||||||||
|
Basic net earnings per share
|
$ | 4.30 | $ | 5.08 | $ | 4.85 | ||||||||||
|
Diluted net earnings per share
|
$ | 4.25 | $ | 5.00 | $ | 4.78 | ||||||||||
|
Weighted average number of shares used in computation of basic earnings per share
|
42,645 | 42,305 | 42,075 | |||||||||||||
|
Weighted average number of shares used in computation of diluted earnings per share
|
43,217 | 42,983 | 42,758 | |||||||||||||
|
Number of
outstanding
shares
|
Share
capital
|
Additional
paid-in
capital
|
Accumulated
other
comprehensive
income (loss)
|
Retained
earnings
|
Treasury
shares
|
Non-
controlling
interest
|
Total
shareholders'
equity
|
Total
comprehensive
income
|
||||||||||||||||||||||||||||
|
Balance as of January 1, 2008
|
42,059,752 | $ | 11,886 | $ | 294,862 | $ | (24,367 | ) | $ | 258,202 | $ | (4,321 | ) | $ | 20,085 | $ | 556,347 | |||||||||||||||||||
|
Exercise of options
|
19,700 | 6 | 182 | - | - | - | - | 188 | ||||||||||||||||||||||||||||
|
Tax benefit in respect of options exercised
|
- | - | 116 | - | - | - | - | 116 | ||||||||||||||||||||||||||||
|
Stock-based compensation
|
- | - | 5,067 | - | - | - | - | 5,067 | ||||||||||||||||||||||||||||
|
Dividends paid
|
- | - | - | - | (32,770 | ) | - | - | (32,770 | ) | ||||||||||||||||||||||||||
|
Purchase of subsidiary shares from non-
controlling interest in a subsidiary
|
- | - | - | - | - | - | (2,067 | ) | (2,067 | ) | ||||||||||||||||||||||||||
|
Other comprehensive income, net of tax:
|
||||||||||||||||||||||||||||||||||||
|
Unrealized gain on derivative instruments,
net of $2,397 tax expense
|
- | - | - | 34,293 | - | - | 106 | 34,399 | $ | 34,399 | ||||||||||||||||||||||||||
|
Foreign currency translation differences
|
- | - | - | (8,427 | ) | - | - | (3,836 | ) | (12,263 | ) | (12,263 | ) | |||||||||||||||||||||||
|
Unrealized pension loss, net of $9,480
tax income
|
- | - | - | (14,026 | ) | - | - | - | (14,026 | ) | (14,026 | ) | ||||||||||||||||||||||||
|
Unrealized loss on available for sale
securities, net of $113 tax expense
|
- | - | - | (1,046 | ) | - | - | (185 | ) | (1,231 | ) | (1,231 | ) | |||||||||||||||||||||||
|
Net income attributable to non-
controlling interests
|
- | - | - | - | - | - | 62,372 | 62,372 | 62,372 | |||||||||||||||||||||||||||
|
Net income
|
- | - | - | - | 204,176 | - | - | 204,176 | 204,176 | |||||||||||||||||||||||||||
|
Total comprehensive income
|
$ | 273,427 | ||||||||||||||||||||||||||||||||||
|
Balance as of December 31, 2008
|
42,079,452 | $ | 11,892 | $ | 300,227 | $ | (13,573 | ) | $ | 429,608 | $ | (4,321 | ) | $ | 76,475 | $ | 800,308 | |||||||||||||||||||
|
Exercise of options
|
451,443 | 114 | 9,757 | - | - | - | - | 9,871 | ||||||||||||||||||||||||||||
|
Stock-based compensation
|
- | - | 5,134 | - | - | - | - | 5,134 | ||||||||||||||||||||||||||||
|
Dividends paid
|
- | - | - | - | (76,172 | ) | - | - | (76,172 | ) | ||||||||||||||||||||||||||
|
Purchase of subsidiary shares from non-
controlling interest
|
- | - | (42,991 | ) | - | - | - | (67,259 | ) | (110,250 | ) | |||||||||||||||||||||||||
|
Other comprehensive income, net of tax:
|
||||||||||||||||||||||||||||||||||||
|
Unrealized loss on derivative instruments,
net of $749 tax income
|
- | - | - | (11,381 | ) | - | - | (97 | ) | (11,478 | ) | $ | (11,478 | ) | ||||||||||||||||||||||
|
Foreign currency translation differences
|
- | - | - | 1,367 | - | - | 1,517 | 2,884 | 2,884 | |||||||||||||||||||||||||||
|
Unrealized pension income, net of $1,473
tax expense
|
- | - | - | 1,910 | - | - | - | 1,910 | 1,910 | |||||||||||||||||||||||||||
|
Unrealized income on available for sale
securities, net of $1,103 tax expense
|
- | - | - | 6,350 | - | - | 124 | 6,474 | 6,474 | |||||||||||||||||||||||||||
|
Cumulative effect from adoption of
FSP 115-2 (codified in ASC 320-10, Investments –
Debt and Equity Securities), net of $1,772 tax expense
|
- | - | - | (7,086 | ) | 7,086 | - | - | - | - | ||||||||||||||||||||||||||
|
Net income attributable to non-
controlling interests
|
- | - | - | - | - | - | 13,566 | 13,566 | 13,566 | |||||||||||||||||||||||||||
|
Net income attributable to Elbit Systems Ltd. shareholders
|
- | - | - | - | 214,947 | - | - | 214,947 | 214,947 | |||||||||||||||||||||||||||
|
Total comprehensive income
|
$ | 228,303 | ||||||||||||||||||||||||||||||||||
|
Balance as of December 31, 2009
|
42,530,895 | $ | 12,006 | $ | 272,127 | $ | (22,413 | ) | $ | 575,469 | $ | (4,321 | ) | $ | 24,326 | $ | 857,194 | |||||||||||||||||||
|
STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY (CONT.)
|
|
U. S. dollars (In thousands, except share data)
|
|
Number of
outstanding
shares
|
Share
capital
|
Additional
paid-in
capital
|
Accumulated
other
comprehensive
income (loss)
|
Retained
earnings
|
Treasury
shares
|
Non-
controlling
interest
|
Total
shareholders'
equity
|
Total
comprehensive
income
|
||||||||||||||||||||||||||||
|
Balance as of January 1, 2010
|
42,530,895 | $ | 12,006 | $ | 272,127 | $ | (22,413 | ) | $ | 575,469 | $ | (4,321 | ) | $ | 24,326 | $ | 857,194 | |||||||||||||||||||
|
Exercise of options
|
162,445 | 44 | 3,546 | - | - | - | - | 3,590 | ||||||||||||||||||||||||||||
|
Stock-based compensation
|
- | - | 5,211 | - | - | - | - | 5,211 | ||||||||||||||||||||||||||||
|
Tax benefit in respect of options exercised
|
- | - | 710 | - | - | - | - | 710 | ||||||||||||||||||||||||||||
|
Dividends paid
|
- | - | - | - | (63,137 | ) | - | - | (63,137 | ) | ||||||||||||||||||||||||||
|
Fair value of non-controlling interests related to the acquisition of ITL
|
- | - | - | - | - | - | 4,298 | 4,298 | ||||||||||||||||||||||||||||
|
Other comprehensive income, net of tax:
|
||||||||||||||||||||||||||||||||||||
|
Unrealized gain on derivative instruments,
net of $308 tax expense
|
- | - | - | 6,668 | - | - | 119 | 6,787 | $ | 6,787 | ||||||||||||||||||||||||||
|
Foreign currency translation differences
|
- | - | - | 2,991 | - | - | (1,154 | ) | 1,837 | 1,837 | ||||||||||||||||||||||||||
|
Unrealized pension loss, net of $1,119
tax income
|
- | - | - | (2,781 | ) | - | - | - | (2,781 | ) | (2,781 | ) | ||||||||||||||||||||||||
|
Unrealized loss on available for sale
securities, net of $990 tax income
|
- | - | - | (2,925 | ) | - | - | - | (2,925 | ) | (2,925 | ) | ||||||||||||||||||||||||
|
Net income attributable to non-
controlling interests
|
- | - | - | - | - | - | 11,169 | 11,169 | 11,169 | |||||||||||||||||||||||||||
|
Net income attributable to Elbit Systems Ltd. shareholders
|
- | - | - | - | 183,498 | - | - | 183,498 | 183,498 | |||||||||||||||||||||||||||
|
Total comprehensive income
|
$ | 197,585 | ||||||||||||||||||||||||||||||||||
|
Balance as of December 31, 2010
|
42,693,340 | $ | 12,050 | $ | 281,594 | $ | (18,460 | ) | $ | 695,830 | $ | (4,321 | ) | $ | 38,758 | $ | 1,005,451 | |||||||||||||||||||
|
Accumulated other comprehensive loss, net of taxes
|
|
Year ended December 31,
|
||||||||||||
|
2010
|
2009
|
200
8
|
||||||||||
|
Accumulated gains on derivative instruments
|
$ | 9,911 | $ | 3,243 | $ | 14,624 | ||||||
|
Accumulated foreign currency translation differences
|
(1,564 | ) | (4,555 | ) | (5,922 | ) | ||||||
|
Accumulated unrealized losses on available for sale securities
|
(5,216 | ) | (2,291 | ) | (1,555 | ) | ||||||
|
Unrealized pension losses
|
(21,591 | ) | (18,810 | ) | (20,720 | ) | ||||||
|
Accumulated other comprehensive loss
|
$ | (18,460 | ) | $ | (22,413 | ) | $ | (13,573 | ) | |||
|
|
|
U. S. dollars (In thousands)
|
|
Year ended December 31,
|
||||||||||||
|
2010
|
2009
|
2008
|
||||||||||
|
CASH FLOWS FROM OPERATING ACTIVITIES
|
||||||||||||
|
Net income
|
$ | 194,667 | $ | 228,513 | $ | 266,548 | ||||||
|
Adjustments to reconcile net income to net cash provided by operating activities:
|
||||||||||||
|
Depreciation and amortization
|
132,141 | 123,473 | 129,437 | |||||||||
|
Write-off impairment
|
1,284 | 3,017 | 10,514 | |||||||||
|
Acquired IPR&D
|
- | - | 1,000 | |||||||||
|
Other-than-temporary impairment of available for sale marketable securities
|
- | - | 17,885 | |||||||||
|
Stock-based compensation
|
5,211 | 5,134 | 5,067 | |||||||||
|
Amortization of Series A Notes discount and related issuance costs
|
(258
|
) | - | - | ||||||||
|
Deferred income taxes and reserve, net
|
(28,162 | ) | 7,606 | (8,488 | ) | |||||||
|
Gain on sale of property, plant and equipment
|
(2,600 | ) | (723 | ) | (1 | ) | ||||||
|
Gain on sale of investment
|
(19,151 | ) | (2,734 | ) | (100,031 | ) | ||||||
|
Equity in net earnings of affiliated companies and partnership, net of dividend received(*)
|
(8,418 | ) | (1,824 | ) | (1,866 | ) | ||||||
|
Changes in operating assets and liabilities, net of amounts acquired:
|
||||||||||||
|
Increase in short and long-term trade receivables, and prepaid expenses
|
(84,708
|
) | (136,224 | ) | (39,698 | ) | ||||||
|
Decrease (increase) in inventories, net
|
(49,724 | ) | 75,431 | (169,482 | ) | |||||||
|
Increase in trade payables, other payables and accrued expenses
|
76,808 | 20,223 | 120,734 | |||||||||
|
Severance, pension and termination indemnities, net
|
4,160 | (16,773 | ) | 15,211 | ||||||||
|
Decrease in advances received from customers
|
(36,396 | ) | (95,397 | ) | (37,402 | ) | ||||||
|
Net cash provided by operating activities
|
184,854
|
209,722 | 209,428 | |||||||||
|
CASH FLOWS FROM INVESTING ACTIVITIES
|
||||||||||||
|
Purchase of property, plant and equipment
|
(138,644 | ) | (107,893 | ) | (129,241 | ) | ||||||
|
Acquisitions of subsidiaries and business operations (Schedule A)
|
(229,556 | ) | (48,234 | ) | (20,637 | ) | ||||||
|
Investments in affiliated companies and other companies
|
(4,956 | ) | (19,415 | ) | (4,001 | ) | ||||||
|
Proceed from sale of property, plant and equipment
|
11,841 | 9,055 | 8,779 | |||||||||
|
Proceed from sale of investments
|
27,941 | 33,026 | 50,254 | |||||||||
|
Investment in long-term deposits
|
(14,484 | ) | (24,004 | ) | (19,166 | ) | ||||||
|
Proceeds from sale of long-term deposits
|
30,240 | 12,994 | 939 | |||||||||
|
Investment in short-term deposits and available for sale securities
|
(189,345
|
) | (152,457 | ) | (62,518 | ) | ||||||
|
Proceeds from sale of short-term deposits and available for sale securities
|
252,550
|
99,625 | 3,884 | |||||||||
|
Net cash used in investing activities
|
(254,413 | ) | (197,303 | ) | (171,707 | ) | ||||||
|
CASH FLOWS FROM FINANCING ACTIVITIES
|
||||||||||||
|
Proceeds from exercise of options
|
3,590 | 9,871 | 188 | |||||||||
|
Purchase of non-controlling interests
|
- | (110,250 | ) | - | ||||||||
|
Repayment of long-term bank loans
|
(488,657 | ) | (148,652 | ) | (333,590 | ) | ||||||
|
Proceeds from long-term bank loans
|
387,692 | 256,354 | 183,211 | |||||||||
|
Proceeds from issuance of Series A Notes
|
283,213 | - | - | |||||||||
|
Series A Notes issuance costs
|
(2,530
|
) | - | - | ||||||||
|
Dividends paid
|
(63,137 | ) | (76,172 | ) | (32,770 | ) | ||||||
|
Tax benefit in respect of options exercised
|
710 | - | 116 | |||||||||
|
Change in short-term bank credit and loans, net
|
(40,972 | ) | (7,531 | ) | (13,008 | ) | ||||||
|
Net cash provided by (used in) financing activities
|
79,909
|
(76,380 | ) | (195,853 | ) | |||||||
|
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS
|
10,350 | (63,961 | ) | (158,132 | ) | |||||||
|
CASH AND CASH EQUIVALENTS AT THE BEGINNING OF THE YEAR
|
140,709 | 204,670 | 362,802 | |||||||||
|
CASH AND CASH EQUIVALENTS AT THE END OF THE YEAR
|
$ | 151,059 | $ | 140,709 | $ | 204,670 | ||||||
|
(*) Dividend received from affiliated companies and partnership
|
$ | 10,925 | $ | 17,468 | $ | 12,569 | ||||||
|
CONSOLIDATED STATEMENTS OF CASH FLOWS (CONT.)
|
|
U. S. dollars (In thousands)
|
|
Year ended December 31,
|
||||||||||||
|
2010
|
2009
|
2008
|
||||||||||
|
SUPPLEMENTAL CASH FLOW ACTIVITIES:
|
||||||||||||
|
Cash paid during the year for:
|
||||||||||||
|
Income taxes
|
$ | 60,759 | $ | 47,946 | $ | 30,827 | ||||||
|
Interest
|
$ | 13,524 | $ | 11,665 | $ | 21,356 | ||||||
|
SCHEDULE A:
|
||||||||||||
|
Acquisitions of subsidiaries and business operations (*)
|
||||||||||||
|
Estimated net fair value of assets acquired and liabilities assumed
at the date of acquisition was as follows:
|
||||||||||||
|
Working capital (deficit), net (excluding cash and cash equivalents)
|
$ | (57,937 | ) | $ | (3,979 | ) | $ | 3,378 | ||||
|
Property, plant and equipment
|
56,233 | 1,303 | 463 | |||||||||
|
Other long-term assets
|
16,008 | 855 | - | |||||||||
|
Goodwill and other intangible assets
|
261,910 | 51,427 | 13,886 | |||||||||
|
Deferred income taxes
|
(15,515 | ) | - | - | ||||||||
|
Long-term liabilities
|
(26,845 | ) | (1,372 | ) | (48 | ) | ||||||
|
Non controlling interest
|
(4,298 | ) | - | - | ||||||||
|
Equity acquired in subsidiaries
|
- | - | 2,958 | |||||||||
| $ | 229,556 | $ | 48,234 | $ | 20,637 | |||||||
|
(*)
|
See Notes 1(D) and 1(E)
|
|
NOTES TO THE CONSOLIDATED FINANCIAL
STATEMENTS
|
|
U. S. dollars (In thousands)
|
|
Note 1 -
|
GENERAL
|
|
|
A.
|
Elbit Systems Ltd. (“Elbit Systems”) is an Israeli corporation, 45.4% owned by the Federmann Group. Elbit Systems’ shares are traded on the Nasdaq National Market in the United States (“Nasdaq”) and on the Tel Aviv Stock Exchange (“TASE”). Elbit Systems and its subsidiaries (collectively the “Company”) are engaged mainly in the field of defense electronics, homeland security and commercial aviation. Elbit Systems’ principal wholly-owned subsidiaries are the Elbit Systems of America, LLC (“ESA”) companies, Elbit Systems Electro-Optics Industries Elop Ltd. (“Elop”) and Elbit Systems Land and C
4
I Ltd. (“ESLC”). Elbit Systems also owns 70% of Elisra Electronic Systems Ltd. (“Elisra”). See Note 27.
|
|
|
B.
|
A majority of the Company’s revenues are derived from direct or indirect sales to governments or to governmental agencies. As a result, a substantial portion of the Company’s sales is subject to the special risks associated with sales to governments or to governmental agencies. These risks include, among others, the dependency on the resources allocated
by governments to defense programs, changes in governmental priorities, changes in governmental registration, changes in governmental regulations and changes in governmental approvals regarding export licenses required for the Company’s products and for its suppliers. As for major customers, refer to Note 22(C).
|
|
|
C.
|
On June 9, 2010, the Company completed a public offering on the Tel-Aviv Stock Exchange of NIS 1.1 billion (approximately $283,000) Series A Notes (the "Series A Notes"). The Series A Notes were offered and sold in 2010 pursuant to a shelf prospectus that the Company filed in May 2010 with the Israeli Securities Authority and the Tel-Aviv Stock Exchange. The shelf prospectus allows the Company to offer and sell debt in Israel, from time to time, subject to a supplemental shelf offering report describing the terms of the securities offered and the specific details of the offering. The Series A Notes were not and will not be registered under the U.S. Securities Act of 1933, as amended (the "Securities Act"), and may not be offered or sold in the United States or to U.S. Persons (as defined in Regulation “S” promulgated under the Securities Act) without registration under the Securities Act or an exemption from the registration requirements of the Securities Act. See Note 16.
|
|
|
D.
|
During 2010, the Company completed the following acquisitions and investments:
|
|
|
(1)
|
On May 11, 2010, the Company's subsidiary, Elbit Security Systems Ltd. ("Elsec"), completed the acquisition of the balance of shares (81%) in Azimuth Technologies Ltd. ("Azimuth"), an Israeli based company, pursuant to the merger agreement signed by Azimuth and Elsec in January 2010. In November 2008, the Company purchased 19% of Azimuth shares. The aggregate purchase price for the 81% balance of Azimuth's shares was approximately $50,000, comprised of $41,500 in cash, and the remeasurement of its previously held 19% equity interest in Azimuth at its acquisition date fair value, using the quoted share price of Azimuth on Tel-Aviv Stock Exchange, to $8,500, and recognized gain of approximately $4,756 net of acquisition related in the amount of approximately $1,600, included in "Other income, net" as part of operating results. Azimuth and its wholly-owned U.K. subsidiary, specialize in the development of military systems that provide for improved target acquisition, fire coordination, navigation and orientation. The acquisition was accounted for using the purchase method as a business combination achieved in stages. The results of Azimuth were consolidated in the Company's financial statements commencing the date of acquisition. Revenues and earnings from the acquisition date through December 31, 2010, were immaterial to the consolidated results of the Company.
|
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONT.)
|
|
U. S. dollars (In thousands, except per share data)
|
|
Note 1 -
|
GENERAL (Cont.)
|
|
|
(2)
|
On October 14, 2010, the Company's subsidiaries Kinetics Ltd. ("Kinetics") and Elsec completed the acquisition of all the shares of Soltam Systems Ltd. ("Soltam"), Saymar Ltd. ("Saymar") and ITL Optronics Ltd. ("ITL"), that were held by Mikal Ltd. ("Mikal") and its subsidiaries. The Company's above-mentioned subsidiaries completed the acquisition of an 100% interest in Soltam and Saymar, and a 87.85% interest in ITL for a total consideration of approximately $80,500, of which $10,200 is contingent consideration on the occurrence of future events. Simultaneously with the completion of the acquisition, Kinetics sold its holding in Mikal (approximately 19%). See Note 6(B)(2)
On February 9, 2011, Elsec completed its cash tender offer for the balance of the ordinary shares of ITL, held by the public, in consideration of $5,900 (See Note 27(A)).
Based on the preliminary purchase price allocation ("PPA") performed by an independent advisor, the PPA was attributed to the fair value of assets and liabilities assumed as follows:
|
|
Fair value
|
Expected useful lives
|
||||
|
Working capital, net
|
$ | (59,650 | ) | ||
|
Long-term assets and investments
|
8,166 | ||||
|
Property, plant and equipment
|
50,750 | ||||
|
Long-term liabilities
|
(44,948 | ) | |||
|
Technology
|
17,300 |
10 years
|
|||
|
IPR&D
|
8,900 |
10 years
|
|||
|
Customer relationships and backlog
|
11,400 |
5-10 years
|
|||
|
Trade name
|
3,100 |
8 years
|
|||
|
Licenses
|
1,020 |
7 years
|
|||
|
Non-competition
|
700 |
4 years
|
|||
|
Non-controlling interest
|
(4,592 | ) | |||
|
Deferred taxes
|
(5,866 | ) | |||
|
Goodwill
|
94,292 | ||||
| $ | 80,572 | ||||
|
|
(3)
|
On December 1, 2010, the Company completed the acquisition of Ares Aerospacial e Defesa S.A ("Ares") and Periscopio Equipamentos Optronicos S.A ("Periscopio") for a purchase price of approximately $38,000. Ares and Perscopio are involved in the area of defense electronic systems and are located in Brazil. Revenues and earnings from the acquisition date through December 31, 2010, were immaterial to the consolidated results of the Company. The Company allocated the acquired assets and liabilities assumed based on a preliminary PPA performed by an independent advisor.
|
|
|
(4)
|
On December 15, 2010, the Company's U.S. subsidiary ESA acquired all the shares of M7 Aerospace LP ("M7 Aerospace") for a purchase price of approximately $85,000. M7 Aerospace is an integrated service company, offering a full suite of aviation services in the areas of Aerostructures Manufacturing, Government Logistics Support Services, Maintenance, Repair and Overhaul, Engineering Services, Aircraft Parts and Support, Supply Chain Management and Purchasing.
|
|
|
ELBIT SYSTEMS LTD. AND ITS SUBSIDIARIES
|
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONT.)
|
|
U. S. dollars (In thousands, except per share data)
|
|
Note 1 -
|
GENERAL (Cont.)
|
|
Fair Value
|
Expected useful lives
|
||||
|
Working capital
|
$ | 30,959 | |||
|
Long-term assets and investments
|
17 | ||||
|
Property, plant and equipment
|
2,654 | ||||
|
Long-term liabilities
|
(1,925 | ) | |||
|
Technology
|
13,800 |
15 years
|
|||
|
Customer relationships and backlog
|
7,100 |
5 years
|
|||
|
Brand name
|
1,900 |
2 years
|
|||
|
Goodwill
|
29,911 | ||||
| $ | 84,416 | ||||
|
|
E.
|
During 2009, the Company completed the following acquisitions and investments:
|
|
(1)
|
On February 24, 2009, the Company's subsidiary ESLC acquired all of the shares of Shiron Satellite Communications (1996) Ltd. ("Shiron"), a private-owned Israeli company engaged in the broadband communication market, for a purchase price of approximately $16,000. The results of Shiron were consolidated in the Company's financial statements commencing the date of acquisition.
|
|
(2)
|
On April 7, 2009, Elbit Systems completed the purchase of the additional shares of its previously 51%-owned subsidiary Kinetics Ltd. ("Kinetics"). Elbit Systems purchased the remaining 49% of the shares from Kinetics' non-controlling shareholders for a maximum total consideration of $118,000, of which $110,250 was paid in cash upon closing, and the remaining balance was subject to Kinetics' 2009 financial results
.
Based on Kinetics 2009 actual results, the final purchase price was set as $110,250 and the additional amount will not be paid. As this was an equity transaction between the parent and Kinetics' non-controlling shareholders, the Company reduced its shareholders' equity for the excess costs over book value related to minority interest in Kinetics (which amounted to approximately $43,000), as required in accordance with ASC 810, "Consolidation".
|
|
(3)
|
On June 15, 2009, the Company signed an agreement with Mikal Ltd. ("Mikal") and its shareholders. The transaction provided for two stages. In the initial stage, the Company loaned to Mikal $18,000. On September 14, 2009, after receiving authorization from the Israeli Antitrust Authority, the loan was converted to ordinary shares. The Mikal group was engaged in the fields of artillery, armored fighting vehicles and optronics.
See Note 1(D)(2).
|
|
(4)
|
On November 19, 2009, Elbit Systems completed the acquisition of the assets and business of BVR Systems (1998) Ltd. ("BVR") for a purchase price of approximately $35,000. BVR was engaged in the development and production of training, simulation and debriefing systems for air, sea and ground forces.
|
|
|
ELBIT SYSTEMS LTD. AND ITS SUBSIDIARIES
|
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONT.)
|
|
U. S. dollars (In thousands, except per share data)
|
|
Note 1 -
|
GENERAL (Cont.)
|
|
|
F.
|
On December 22, 2008, the Company’s 41.3%-owned subsidiary (on a fully diluted basis), MediGuide Inc. (“Mediguide”), signed a definitive agreement with St. Jude Medical to sell to St. Jude Medical all of the outstanding shares of MediGuide for $283,000 in cash and the assumption of net liabilities totaling approximately $17,000. Under the transaction, St. Jude Medical paid $138,000 of the purchase price in December 2008 and $110,000 in November 2009, with the balance due in a payment of up to $35,000 in April 2010.
As a result of the above, the Company included in its 2008 results a gain, before income taxes, of $100,031. The gain was included in "Other Income, net". In 2009, the Company recorded an additional gain of $1,105 resulting from the second payment deduction of the expected transaction expenses. In 2010, upon the payment of the Company's share in the contingent proceeds in March 2010, the Company recorded a gain before income taxes of approximately $12,800.
The gain from the sale included in other income, net (See Note 25).
Proceeds received by the Company amounted to $50,254, $50,878 and $12,800 in 2008, 2009 and 2010, respectively.
|
|
|
ELBIT SYSTEMS LTD. AND ITS SUBSIDIARIES
|
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONT.)
|
|
U. S. dollars (In thousands)
|
|
Note 2 -
|
SIGNIFICANT ACCOUNTING POLICIES
|
|
|
A.
|
USE OF ESTIMATES
The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. The most significant assumptions are employed in estimates used in determining values of intangible assets, sales and return accruals, legal contingencies, tax assets and tax liabilities, stock-based compensation costs, retirement and post-retirement benefits (including the actuarial assumptions), financial instruments with no observable market quotes, as well as in estimates used in applying the revenue recognition policy. Actual results may differ from estimated results.
|
|
|
B.
|
ADOPTION OF NEW ACCOUNTING POLICIES
|
|
|
(1)
|
In July 2010, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2010-20, “Disclosures about the Credit Quality of Financing Receivables and the Allowance for Credit Losses", which is intended to provide financial statement users with greater transparency about an entity’s allowance for credit losses and the credit quality of its financial receivables. ASU 2010-20 is effective for the Company from January 1, 2010. As the ASU specifically excludes short-term trade accounts receivable, the adoption of the standard did not have a significant impact on the Company’s consolidated financial statements.
|
|
|
(2)
|
Effective January 1, 2010, the Company adopted the new guidance contained in ASC 810 for the consolidation of variable interest entities. This new guidance replaces the prior quantitative approach for identifying which enterprise should consolidate a variable interest entity, which was based on which enterprise was exposed to a majority of the risks and rewards, with a qualitative approach, based on which enterprise has both (1) the power to direct the economically significant activities of the entity and (2) the obligation to absorb losses of, or the right to receive benefits from, the entity that could potentially be significant to the variable interest entity. Determination about whether an enterprise should consolidate a variable interest entity is required to be evaluated continuously as changes to existing relationships or future transactions. The adoption of this standard did not have a material impact on our financial position or results of operations.
|
|
|
C.
|
FUNCTIONAL CURRENCY
The Company’s revenues are generated mainly in U.S. dollars. In addition, most of the Company’s costs are incurred in U.S. dollars. The Company’s management believes that the U.S. dollar is the primary currency of the economic environment in which the Company operates. Thus, the functional and reporting currency of the Company is the U.S. dollar.
Transactions and balances of the Company and certain subsidiaries, which are denominated in other currencies, have been remeasured into U.S. dollars in accordance with principles set forth in ASC 830, “Foreign Currency Matters”. All exchange gains and losses from the remeasurement mentioned above are reflected in the statement of income as financial expenses or income, as appropriate.
|
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONT.)
|
|
U. S. dollars (In thousands)
|
|
Note 2 -
|
SIGNIFICANT ACCOUNTING POLICIES (Cont.)
|
|
|
C.
|
FUNCTIONAL CURRENCY (Cont.)
For those foreign subsidiaries and investees whose functional currency has been determined to be other than the U.S. dollar, assets and liabilities are translated at year-end exchange rates, and statement of income items are translated at average exchange rates prevailing during the year. Resulting translation differences are recorded as a separate component of accumulated other comprehensive income in shareholders’ equity.
|
|
|
D.
|
PRINCIPLES OF CONSOLIDATION
The consolidated financial statements include the accounts of Elbit Systems and its wholly and majority-owned subsidiaries.
Intercompany transactions and balances, including profit from intercompany sales not yet realized outside the Company, have been eliminated upon consolidation.
On January 1, 2009, the Company adopted an amendment to ASC 810, “Consolidation”, according to which a non-controlling interest in a subsidiary is an ownership interest in the consolidated entity that should be reported as a separate component of equity in the consolidated financial statements. As such, changes in the parent’s ownership interest with no change of control are treated as equity transactions, rather than step acquisitions or dilution gains or losses. The amendment clarifies that losses of partially owned consolidated subsidiaries shall continue to be allocated to the non-controlling interests even when their investment was already reduced to zero.
The amendment applies prospectively, except for the presentation and disclosure requirements, which are applied retrospectively to all periods presented. As a result, upon adoption, the Company retroactively reclassified the “Minority Interests” balance previously included in a mezzanine section of the consolidated balance sheet to be presented in a new caption in total shareholders’ equity, “Non-controlling Interest”. The adoption also impacted certain captions previously used on the consolidated statement of income, largely identifying net income including the portion attributable to non-controlling interest and net income attributable to Elbit Systems Ltd.’s shareholders. This amendment required the Company to classify non-controlling interest as part of the consolidated net income ($62,372 for the year ended December 31, 2008).
The net income amounts the Company has previously reported are now presented as "Net income attributable to Elbit Systems Ltd. shareholders", and, as required, earnings per share continue to reflect amounts attributable only to Elbit Systems Ltd. shareholders. Similarly, in the statements of changes in shareholders’ equity, the Company distinguished between equity amounts attributable to Elbit Systems Ltd. shareholders and amounts attributable to the non-controlling interest. Additional disclosures required by this amendment are also included in Note 21, shareholders' equity.
|
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONT.)
|
|
U. S. dollars (In thousands)
|
|
Note 2 -
|
SIGNIFICANT ACCOUNTING POLICIES (Cont.)
|
|
E.
|
BUSINESS COMBINATIONS
Effective January 1, 2009, the Company adopted the amended ASC 805, “Business Combinations”. ASC 805 requires recognition of assets acquired, liabilities assumed, and non-controlling interest in the acquiree at the acquisition date, measured at their fair values as of that date. This ASC also requires the fair value of acquired in-process research and development (“IPR&D”) to be recorded as intangibles with indefinite lives, contingent consideration to be recorded on the acquisition date, and restructuring and acquisition-related deal costs to be expensed as incurred. Any excess of the fair value of net assets acquired over purchase price and any subsequent changes in estimated contingencies are to be recorded in earnings. In addition, changes in valuation allowance related to acquired deferred tax assets and in acquired income tax position are to be recognized in earnings.
ASC 805 is applied prospectively for all business combinations occurring after January 1, 2009, except for changes in valuation allowance related to deferred tax assets and changes in acquired income tax position originating from business combinations that occurred prior to the effective date of this ASC, which are recognized in earnings following the adoption date.
|
|
F.
|
CASH AND CASH EQUIVALENTS
Cash equivalents are short-term highly liquid investments that are readily convertible to cash with original maturities of three months or less, when purchased.
|
|
G.
|
SHORT-TERM BANK DEPOSITS
Short-term bank deposits are deposits with original maturities of more than three months but less than one year. The short–term bank deposits are presented at their cost, which approximates fair value.
|
|
H.
|
AVAILABLE-FOR-SALE MARKETABLE SECURITIES
The Company accounts for all its investments in debt securities and for investments in marketable equity securities of entities in which it does not have significant influence, in accordance with ASC 320, "Investments - Debt and Equity Securities". The Company classifies all debt securities and marketable equity securities as “available-for-sale”. All of the Company’s investments in available-for-sale securities are reported at fair value. Unrealized gains and losses are comprised of the difference between fair value and the cost of such securities and are recognized, net of tax, as accumulated other comprehensive income (“OCI”) in shareholders’ equity.
Prior to 2009, declines in fair value of available-for-sale debt and equity securities that were considered other-than-temporary, based on criteria described in SAB 59, "Accounting for Non-current Marketing Equitable Securities", were charged to earnings.
|
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONT.)
|
|
U. S. dollars (In thousands)
|
|
Note 2 -
|
SIGNIFICANT ACCOUNTING POLICIES (Cont.)
|
|
H.
|
AVAILABLE-FOR-SALE MARKETABLE SECURITIES
(Cont.)
In 2009, the Company adopted a new guidance that changed the impairment and presentation model for its available-for-sale debt securities. Under the amended impairment model, an other-than-temporary impairment (“OTTI”) loss is recognized in earnings if the entity has the intent to sell the debt security, or if it is more likely than not that it will be required to sell the debt security before recovery of its amortized cost basis. However, if an entity does not expect to sell a debt security, it will still need to evaluate expected cash flows to be received and determine if a credit loss exists. In the event of a credit loss, only the amount of impairment associated with the credit loss is recognized currently in earnings. Amounts relating to factors other than credit losses are recorded in other comprehensive income.
Upon the adoption of the above mentioned new guidance, the Company reclassified a non-credit related amount of $7,086, net of tax of $1,772, for OTTI losses recognized in earning prior to January 1, 2009, as a cumulative effect adjustment that increased retained earnings and decreased OCI at January 1, 2009. As of December 31, 2010, the Company evaluated debt securities classified as available for sale for OTTI and the existence of credit losses. The cumulative amounts related to the Company’s credit loss portion of the OTTI losses on debt securities held as of December 31, 2010, that the Company does not intend to sell and it is not more likely than not that the Company will be required to sell the security prior to recovery of the amortized cost basis is $19,883.
|
|
I.
|
INVENTORIES
Inventories are stated at the lower of cost or market value. Inventory write-offs are provided to cover risks arising from slow-moving items or technological obsolescence for which recoverability is not probable.
Cost is determined as follows:
|
|
·
|
Raw materials using the average or FIFO cost method.
|
|
·
|
Work in progress:
|
|
·
|
Costs incurred on long-term contracts in progress include direct labor, material, subcontractors, other direct costs and an allocation of overheads, which represent recoverable costs incurred for production, allocable operating overhead cost and, where appropriate, research and development costs (see Note 2(W)).
|
|
·
|
Labor overhead is generally included on a basis of updated hourly rates and is allocated to each project according to the amount of hours expended. Material overhead is generally allocated to each project based on the value of direct material that is charged to the project.
|
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONT.)
|
|
U. S. dollars (In thousands)
|
|
Note 2 -
|
SIGNIFICANT ACCOUNTING POLICIES (Cont.)
|
|
J.
|
INVESTMENT IN AFFILIATED COMPANIES, A PARTNERSHIP AND OTHER COMPANIES
Investments in affiliated companies and a partnership that are not controlled but over which the Company can exercise significant influence (generally, entities in which the Company holds approximately between 20% and 50% of the voting rights of the investee) are presented using the equity method of accounting. Profits on intercompany sales, not realized outside the Company, are eliminated. The Company discontinues applying the equity method when its investment (including advances and loans) is reduced to zero and the Company has not guaranteed obligations of the affiliate or otherwise committed to provide further financial support to the affiliate.
Investments in preferred shares, which are not in substance common stock, are recorded on a cost basis according to ASC 323-10-15-13, “Investments-Equity Method and Joint Ventures-In-substance Common Stock” and ASC 323-10-40-1, "Investment-Equity Method and Joint Ventures-Investee Capital Transactions."
A change in the Company’s proportionate share of an investee's equity, resulting from issuance of common or in-substance common shares by the investee to third parties, is recorded as a gain or loss in the consolidated income statements in accordance with ASC 323-10-40-1, "Investment-Equity Method and Joint Ventures-Investee Capital Transactions."
Investments in non-marketable equity securities of entities in which the Company does not have control or the ability to exercise significant influence over their operation and financial policies, are recorded at cost (generally when the Company holds less than 20% of the voting rights).
Management evaluates investments in affiliated companies, partnerships and other non-marketable equity securities for evidence of other-than-temporary declines in value. Such evaluation is dependent on the specific facts and circumstances. Accordingly, in determining whether other-than-temporary declines exist, management evaluates indicators for other-than-temporary declines and evaluates financial information (e.g. budgets, business plans, financial statements, etc.). During 2009, an impairment loss of $665 related to the investment in Chip PC was recognized (see Note 6(B)(5)). During 2008, an impairment loss of $10,514 related to the investment in Sandel Avionics Inc. was recognized (See Note 6(C)(2)).
|
|
K.
|
VARIABLE INTEREST ENTITIES
ASC 810-10, "Consolidation" provides a framework for identifying Variable Interest Entities (“VIEs”) and determining when a company should include the assets, liabilities, non-controlling interests and results of activities of a VIE in its consolidated financial statements.
The Company’s assessment of whether an entity is a VIE and the determination of the primary beneficiary is judgmental in nature and involves the use of significant estimates and assumptions. Those include, among others, forecasted cash flows, their respective probabilities and the economic value of certain preference rights. In addition, such assessment also involves estimates of whether a group entity can finance its current activities, until it reaches profitability, without additional subordinated financial support
.
|
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONT.)
|
|
U. S. dollars (In thousands)
|
|
Note 2 -
|
SIGNIFICANT ACCOUNTING POLICIES (Cont.)
|
|
K.
|
VARIABLE INTEREST ENTITIES (Cont.)
UAV Tactical Systems Ltd. (“U-TacS”), in the U.K. is considered to be a variable interest entity. As Elbit Systems is the primary beneficiary and has both the power to direct its activities and absorb the majority of its loss or right to majority of its earnings based upon holding the majority voting rights in U-TacS (51%), U-TacS is consolidated in the Company’s financial statements.
In November 2010, the Company, through its wholly-owned subsidiary, Kinetics Ltd. ("Kinetics"), signed an agreement to invest in Pearls of Wisdom Advanced Technologies Ltd. ("Pearls of Wisdom"), an amount of up to $18,000. The investment will be performed in several stages over several years and the Company's holdings in Pearls of Wisdom will increase gradually. The Company's initial ownership percentage is less than 50%
Pearls of Wisdom is considered to be a variable interest entity. The Company has determined that it is not the primary beneficiary as it lacks the powers to direct the activities of Pearls of Wisdom that most significantly impact the entity's economic performance.
|
|
L.
|
LONG-TERM RECEIVABLES
|
|
M.
|
LONG-TERM BANK DEPOSITS
|
|
N.
|
PROPERTY, PLANT AND EQUIPMENT
|
|
%
|
|||||
|
Buildings and leasehold improvements (*)
|
2-33 | ||||
|
Instruments, machinery and equipment
|
3-33 | ||||
|
Office furniture and other
|
6-33 | ||||
|
Motor vehicles
|
12-33 |
(Mainly 15%)
|
|||
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONT.)
|
|
U. S. dollars (In thousands)
|
|
Note 2 -
|
SIGNIFICANT ACCOUNTING POLICIES (Cont.)
|
|
O.
|
INVESTMENT GRANTS
As a governmental incentive for industrial companies in Israel, the “Investment Center”, which is a branch of the Israel Ministry of Industry and Trade, permits industrial companies to submit a request to qualify as an “Approved Enterprise”. An Approved Enterprise is entitled to certain benefits in respect of capital investments. The benefits may be in the form of reduced tax rates and of capital grants received as a percentage of the investments of the Approved Enterprise. The amount of a capital grant is determined as a percentage of the Approved Enterprise investment in property, plant and equipment. These capital grants are non-royalty bearing and are not conditioned on the results of operations. As the capital grants are a direct participation in the cost of the acquisition of property, plant and equipment, they are offset against the cost of property, plant and equipment.
|
|
P.
|
OTHER INTANGIBLE ASSETS
Other identifiable intangible assets mainly consist of purchased technology, customer relations and trademarks. These intangible assets are stated at cost net of accumulated amortization and impairments, and are amortized over their useful life using the straight-line method, or the accelerated method, which ever better reflects the applicable expected utilization pattern.
|
|
Q.
|
IMPAIRMENT OF LONG-LIVED ASSETS
The Company’s long-lived assets and finite-lived intangible assets are reviewed for impairment in accordance with ASC 360-10-35 “Property, Plant and Equipment – Subsequent Measurement” whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets (or assets group) to be held and used is measured by a comparison of the carrying amount of an asset to the future undiscounted cash flows expected to be generated by the asset. If an asset is determined to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the asset exceeds its fair value. For each of the three years in the period ended December 31, 2010, no material impairment has been identified.
As required by ASC 820, "Fair Value Measurements", the Company applies assumptions that marketplace participants would consider in determining the fair value of long lived assets (or assets groups).
|
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONT.)
|
|
U. S. dollars (In thousands)
|
|
Note 2 -
|
SIGNIFICANT ACCOUNTING POLICIES (Cont.)
|
|
R.
|
GOODWILL IMPAIRMENT
Goodwill is subject to an annual impairment test at the reporting unit level (or more frequently if impairment indicators arise).
The Company identified several reporting units based on the guidance of ASC 350, “Intangibles – Goodwill and Other”.
ASC 350 prescribes a two-phase process for impairment testing of goodwill. The first phase screens for impairment, while the second phase (if necessary) measures impairment.
Goodwill impairment is deemed to exist if the net book value of a reporting unit exceeds its estimated fair value. In such case, the second phase is then performed, and the Company measures impairment by comparing the carrying amount of the reporting unit's goodwill to the implied fair value of that goodwill. An impairment loss is recognized in an amount equal to the excess. For each of the three years in the period ended December 31, 2010, no material impairment losses have been identified.
As required by ASC 820, "Fair Value Measurements", the Company applies assumptions that market place participants would consider in determining the fair value of each reporting unit.
|
|
S.
|
SEVERANCE PAY
Elbit Systems' and its Israeli subsidiaries' obligations for severance pay are calculated pursuant to Israel's Severance Pay Law based on the most recent salary of the employees multiplied by the number of years of employment, as of the balance sheet date and are presented on an undiscounted basis (the “Shut Down Method”). Employees are entitled to one month's salary for each year of employment or a portion thereof. The obligation is provided by monthly deposits with insurance policies and by an accrual. The value of these policies is recorded as an asset on the Company's balance sheet. The deposited funds may be withdrawn only upon the fulfillment of the obligation, pursuant to the Severance Pay Law or labor agreements. The value of the deposited funds is based on the cash surrender value of these policies and includes profits (or losses) accumulated to balance sheet date.
Elbit Systems and its Israeli subsidiaries have
entered into an agreement with some of their employees implementing Section 14 of the Severance Pay Law and the General Approval of the Labor Minister dated June 30, 1998, issued in accordance to the said Section 14, mandating that upon termination of such employees' employment, all the amounts accrued in their insurance policies shall be released to them. The severance pay liabilities and deposits
covered by these plans are not reflected in the balance sheet as the severance pay risks have been irrevocably transferred to the severance funds.
Severance pay expenses for the years ended December 31, 2010, 2009 and 2008 amounted to approximately $50,228, $42,999 and $51,567, respectively.
|
|
T.
|
PENSION AND OTHER POSTRETIREMENT BENEFITS
The Company accounts for its obligations for pension, and other postretirement benefits, in accordance with ASC 715, “Compensation – Retirement Benefits” (See Note 17).
|
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONT.)
|
|
U. S. dollars (In thousands)
|
|
Note 2 -
|
SIGNIFICANT ACCOUNTING POLICIES (Cont.)
|
|
U.
|
REVENUE RECOGNITION
The Company generates revenues principally from long-term contracts involving the design, development, manufacture and integration of defense systems and products. In addition, to a minor extent, the Company provides support and services for such systems and products.
Revenues from long-term contracts are recognized primarily using ASC 605-35, “Construction-Type and Production-Type Contracts”, according to which revenues are recognized on the percentage-of-completion basis.
Sales under long-term fixed-price contracts which provide for a substantial level of development efforts in relation to total contract efforts are recorded using the cost-to-cost method of accounting as the basis to measure progress toward completing the contract and recognizing revenues using the percentage of completion basis. According to this method, sales and profits are recorded based on the ratio of costs incurred to estimated total costs at completion. In certain circumstances, when measuring progress toward completion, the Company considers other factors, such as achievement of performance milestones.
Sales and anticipated profit under long-term fixed-price contracts which provide for a substantial level of production effort are recorded on a percentage-of-completion basis, using the units-of-delivery as the basis to measure progress toward completing the contract and recognizing revenues. In certain circumstances, which involve long-term fixed-price production type contracts for non-homogenous units or small quantities of units, or when the achievement of performance milestones provides a more reliable and objective measure of the extent of progress toward completion, revenue is recognized based on the achievement of performance milestones.
Sales and anticipated profit under long-term fixed-price contracts that involve both development and production efforts are recorded using the cost-to-cost method and units-of-delivery method as applicable to each phase of the contract, as the basis to measure progress toward completion. In addition, when measuring progress toward completion under the development portion of the contract, in certain circumstances, the Company considers other factors, such as achievement of performance milestones.
The percentage-of-completion method of accounting requires management to estimate the cost and gross profit margin for each individual contract. Estimated gross profit or loss from long-term contracts may change due to differences between actual performance and original estimated forecasts. Such changes in estimated gross profit are recorded in results of operations when they are reasonably determinable by management, on a cumulative catch-up basis. Anticipated losses on contracts are charged to earnings when determined to be probable.
Sales under cost-reimbursement-type contracts are recorded as costs are incurred. Applicable estimated profits are included in earnings in the proportion that incurred costs bear to total estimated costs.
Amounts representing contract change orders, claims or other items are included in sales only when they can be reliably estimated and realization is probable. Penalties and awards applicable to performance on contracts are considered in estimating sales and profit rates and are recorded when they are probable and there is sufficient information to assess anticipated contract performance.
|
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONT.)
|
|
U. S. dollars (In thousands)
|
|
Note 2 -
|
SIGNIFICANT ACCOUNTING POLICIES (Cont.)
|
|
U.
|
REVENUE RECOGNITION (Cont.)
The Company believes that the use of the percentage-of-completion method is appropriate as the Company has the ability to make reasonably dependable estimates of the extent of progress towards completion, contract revenues and contract costs. In addition, contracts executed include provisions that clearly specify the enforceable rights regarding services to be provided and received by the parties to the contracts, the consideration to be exchanged and the manner and terms of settlement. In all cases, revenue is recognized when the Company expects to perform its contractual obligations, and its customers are expected to satisfy their obligations under the contract.
Management reviews periodically the estimates of progress towards completion and project costs. These estimates are determined based on engineering estimates and past experience, by personnel having the appropriate authority and expertise to make reasonable estimates of the related costs. Such engineering estimates are reviewed periodically for each specific contract by professional personnel from various disciplines within the organization. These estimates take into consideration the probability of achievement of certain milestones, as well as other factors that might impact the contract’s completion
and project cost.
A number of internal and external factors affect our cost estimates, including labor rates, estimated future prices of material, revised estimates of uncompleted work, efficiency variances, linkage to indices and exchange rates, customer specifications and testing requirement changes. If any of the above factors were to change, or if different assumptions were used in estimating progress cost and measuring progress towards completion, it is possible that materially different amounts would be reported in the Company’s consolidated financial statements.
In certain circumstances, sales under short-term fixed-price production type contracts or sale of products are accounted for in accordance with SAB No. 104, "Revenue Recognition in Financial Statements" ("SAB 104"), and recognized when all the following criteria are met: persuasive evidence of an arrangement exists, delivery has occurred, the seller's price to the buyer is fixed or determinable, no further obligation exists and collectability is reasonably assured.
In cases where the contract involves the delivery of products and performance of services, or other obligations (See Note 20(B)), the Company follows the guidelines specified in ASC 605-25, “Multiple-Element Arrangements”, in order to allocate the contract consideration between the identified different elements.
Service revenues include contracts primarily for the provision of supplies or services other than associated with design, development or production activities. It may be a stand-alone service contract or a service element, which was separated from the design, development or production contract according to the criteria established in ASC 605-25. Service contracts primarily include operation and maintenance contracts, outsourcing-type arrangements, return and repair contracts, training, installation services, etc. Revenue from services were less than 10% of consolidated revenues in each of the fiscal years 2008, 2009 and 2010.
As for research and development costs accounted for as contract costs refer to Note 2(W).
|
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONT.)
|
|
U. S. dollars (In thousands)
|
|
Note 2 -
|
SIGNIFICANT ACCOUNTING POLICIES (Cont.)
|
|
V.
|
WARRANTY
The Company estimates the costs that may be incurred under its basic warranty. Such costs are: (1) estimated as part of the total contract’s cost or (2) recorded as a liability at the time revenue for delivered products is recognized. The specific terms and conditions of those warranties vary depending upon the product sold and the country in which the Company does business. Factors that affect the Company’s warranty cost include the number of delivered products, engineering estimates and anticipated rates of warranty claims. The Company periodically assesses the adequacy of its recorded warranty cost and adjusts the amount as necessary. Specific warranty reserves are recorded in the period defects or potential products failures are identified and recorded based on estimates made by management. The estimates are evaluated on a periodic basis.
Changes in the Company’s provision for warranty, which is included in other payables and accrued expenses in the Balance Sheet, are as follows:
|
|
2010
|
2009
|
|||||||
|
Balance, at January 1
|
$ | 126,783 | $ | 92,301 | ||||
|
Warranties issued during the year
|
69,213 | 65,493 | ||||||
|
Warranties related to acquisitions
|
19,015 | - | ||||||
|
Reduction due to warranties forfeited or paid during the year
|
(50,233 | ) | (31,011 | ) | ||||
|
Balance, at December 31
|
$ | 164,778 | $ | 126,783 | ||||
|
W.
|
RESEARCH AND DEVELOPMENT COSTS
Research and development costs, net of participation grants, include costs incurred for independent research and development and bid and proposal efforts and are expensed as incurred unless the costs are related to certain contractual arrangements which are recorded as part of cost of sales, over the period that revenue is recognized, consistent with the Company’s revenue recognition accounting policy. The Company does not have significant stand-alone research and development arrangements performed for others.
The Company has certain research and development contractual arrangements that meet the requirements for best efforts research and development accounting. Accordingly, the amounts funded by the customer are recognized as an offset to its research and development expenses rather than as contract revenues.
Elbit Systems and certain Israeli subsidiaries receive grants (mainly royalty-bearing) from the Israeli Chief Scientist’s Office ("OCS") and from other sources for the purpose of partially funding approved research and development projects. The grants are not to be repaid, but instead Elbit Systems and certain Israeli subsidiaries are obliged to pay royalties as a percentage of future sales if and when sales from the funded projects are generated. These grants are recognized as a deduction from research and development costs at the time the applicable entity is entitled to such grants on the basis of the research and development costs incurred. Since the payment of royalties is not probable when the grants are received, the Company records a liability in the amount of the estimated royalties for each individual contract, when the related revenues are recognized, as part of cost of revenues. For more information regarding OCS royalties’ commitment, please see Note 20(A).
|
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONT.)
|
|
U. S. dollars (In thousands)
|
|
Note 2 -
|
SIGNIFICANT ACCOUNTING POLICIES (Cont.)
|
|
X.
|
INCOME TAXES
The Company accounts for income taxes and uncertain tax positions in accordance with ASC 740, "Income Taxes". This guidance prescribes the use of the liability method whereby deferred tax asset and liability account balances are determined based on differences between financial reporting and tax bases of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. The Company provides a valuation allowance, if necessary, to reduce deferred tax assets to amounts that are more likely than not to be realized. As part of the determination of its tax liability, management exercises considerable judgment in evaluating tax positions taken by the Company in determining the income tax provision and establishes reserves for tax contingencies.
The Company records interest and penalties related to its unrecognized tax benefit or exposures in the financial statements as income tax expense.
|
|
Y.
|
CONCENTRATION OF CREDIT RISKS
Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents, short and long-term deposits, marketable securities and trade receivables.
The majority of the Company’s cash and cash equivalents and short and long-term deposits are invested with major banks mainly in Israel and the United States. Deposits in the U.S. may be in excess of insured limits and are not insured in other jurisdictions.
Management believes that the financial institutions that hold the Company's investments have a high credit rating.
The Company’s trade receivables are derived primarily from sales to large and stable customers and governments located mainly in Israel, the United States and Europe. The Company performs ongoing credit evaluations of its customers and has not experienced in recent years any unexpected material losses. An allowance for doubtful accounts is recognized with respect to those amounts that the Company has determined to be doubtful of collection.
The Company entered into foreign exchange forward contracts, cross currency interest rate swaps and option strategies (together “derivative instruments”) intended to protect against the increase in value of forecasted non-dollar currency cash flows and interest as applicable. These derivative instruments are designed to effectively hedge the Company’s non-dollar currency and interest rates exposures (See Note 2(Z)).
|
|
Z.
|
DERIVATIVE FINANCIAL INSTRUMENTS
The Company accounts for derivatives and hedging based on ASC 815, “Derivatives and Hedging”, which requires the Company to recognize all derivatives on the balance sheet at fair value. If a derivative meets the definition of a cash flow hedge and is so designated, changes in the fair value of the derivative will be recognized in other comprehensive income until the hedged item is recognized in earnings. The ineffective portion of a derivative’s change in fair value is recognized in earnings. If a derivative does not meet the definition of a hedge, the changes in the fair value are included in earnings in "Financial income (expenses), net", in each reporting period (See Note 24).
As part of its hedging strategy, the Company enters into forward exchange contracts in order to protect the Company from the risk that the eventual dollar cash flows from the sale and buy of products to international customers will be adversely affected by changes in exchange rates.
|
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONT.)
|
|
U. S. dollars (In thousands)
|
|
Note 2 -
|
SIGNIFICANT ACCOUNTING POLICIES (Cont.)
|
|
Z.
|
DERIVATIVE FINANCIAL INSTRUMENTS (Cont.)
The Company also enters into forward exchange contracts and options strategies in order to limit the exposure to exchange rate fluctuation associated with payroll expenses mainly incurred in NIS. Such forward contracts on payroll expenses that were entered into in 2010 are designated as cash flow hedges. For such contracts entered into prior to 2010, the Company elected not to follow the designation and documentation processes required to qualify for the hedge accounting method, and any gain or loss derived from such instruments is recognized immediately as "Financial income (expenses), net."
In connection with the issuance of the NIS 1.1 billion Series A Notes at the Tel Aviv Stock Exchange in 2010 (See Note 16), the Company entered into a ten-year cross-currency interest rate swap transaction with a notional principal of NIS 1.1 billion to effectively hedge the effect of interest and exchange rate difference from NIS Series A Notes. The cross currency interest rate swap effectively converts the fixed interest rate of the debt to a floating interest rate. The terms of the swap agreement substantially match the terms of the debt. Under the terms of the swap agreement, the Company will receive interest payments semi-annually in NIS at an annual rate of 4.84% on the notional principal and will pay interest semi-annually in U.S. Dollars at an annual weighted rate of 1.65% over the six-month LIBOR on the notional principal. The swap agreements are designated as a fair value hedge. The gains and losses related to changes in the fair value of the interest rate swaps are included in interest expense and substantially offset changes in the fair value of the hedged portion of the underlying hedged Series A notes.
|
|
AA.
|
STOCK-BASED COMPENSATION
The Company accounts for share-based arrangements under ASC 718, “Compensation – Stock Compensation”, which requires all share-based payments, including grants of employee stock options, to be recognized in the income statement based on their fair values.
The fair value of employee stock options is estimated at the grant date using a lattice-based option valuation model with the following weighted average assumptions:
|
|
2010
|
2009
|
2008
|
||||||||||
|
Divided yield
|
2.20% | 2.31% | 1.84% | |||||||||
|
Expected volatility
|
31.92% | 39.37% | 33.72% | |||||||||
|
Risk-free interest rate
|
1.56% | 2.43% | 2.79% | |||||||||
|
Expected life
|
4 years
|
4 years
|
4 years
|
|||||||||
|
Forfeiture rate
|
0.56% | 0.56% | 0.56% | |||||||||
|
Suboptimal factor
|
1.75 | 1.75 | 1.75 | |||||||||
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONT.)
|
|
U. S. dollars (In thousands)
|
|
Note 2 -
|
SIGNIFICANT ACCOUNTING POLICIES (Cont.)
|
|
AB.
|
FAIR VALUE OF FINANCIAL INSTRUMENTS
The carrying amount of cash and cash equivalents, short-term bank deposits, trade receivables, short-term bank credit and loans and trade payables approximate their fair values due to the short-term maturities of such instruments.
The fair value of long-term loans is estimated by discounting the future cash flows using current interest rates for loans of similar terms and maturities. The carrying amount of the long-term loans approximates their fair value.
As of December 31, 2010, the fair value of the Series A Notes based on quoted market price of the Tel-Aviv Stock Exchange was approximately $309,600.
The Company accounts for certain assets and liabilities at fair value under ASC 820, “Fair Value Measurements and Disclosures”. Fair value is an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or a liability.
The hierarchy below lists three levels of fair value based on the extent to which inputs used in measuring fair value are observable in the market. The Company categorizes each of its fair value measurements in one of these three levels based on the lowest level input that is significant to the fair value measurement in its entirety.
The three levels of inputs that may be used to measure fair value are as follows:
Level 1 - Observable inputs that reflect quoted prices (unadjusted) for identical assets or liabilities in active markets;
Level 2 - Includes other inputs that are directly or indirectly observable in the marketplace, other than quoted prices included in Level 1, such as quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets with insufficient volume or infrequent transactions, or other inputs that are observable (model-derived valuations in which significant inputs are observable), or can be derived principally from or corroborated by observable market data; and
Level 3 - Unobservable inputs which are supported by little or no market activity.
The Company's cross-currency interest rate swaps are valued under an income approach using industry-standard models that consider various assumptions, including time value, volatility factors, current market and contractual prices for the underlying, and counterparty non-performance risk. Substantially all of these assumptions are observable in the marketplace throughout the full term of the instruments, can be derived from observable data or are supported by observable levels at which transactions are executed in the marketplace.
The Company measures its marketable equity securities, debt securities and foreign currency derivative instruments at fair value. Marketable equity securities and government debt securities are classified within Level 1. The Company’s investments in Auction Rate Securities (“ARS”) and Collateralized Debt Obligations (“CDOs”) are classified within Level 3 because they are valued using valuation techniques with significant unobservable inputs. The Company’s foreign currency derivative instruments are classified within Level 2 when the valuation inputs are based on quoted prices and market observable data of similar instruments and in Level 3 when valuation inputs are based on significant unobservable data.
|
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONT.)
|
|
U. S. dollars (In thousands)
|
|
Note 2 -
|
SIGNIFICANT ACCOUNTING POLICIES (Cont.)
|
|
AB.
|
FAIR VALUE OF FINANCIAL INSTRUMENTS (Cont.)
Assets and liabilities measured at fair value on a recurring basis are summarized below:
|
|
Fair value measurement at
December 31, 2010 using
|
||||||||||||
|
Description of
|
Quoted Prices
in Active
Markets for
Identical Assets
(Level 1)
|
Significant
Other
Observable
Inputs
(Level 2)
|
Significant
Unobservable
Inputs
(Level 3)
|
|||||||||
|
Assets
|
||||||||||||
|
Debt securities:
|
||||||||||||
|
Government bonds
|
$ | 824 | $ | - | $ | - | ||||||
|
ARS and CDOs
|
- | - | 7,179 | |||||||||
|
Foreign currency option contracts
|
- | 19,100 | - | |||||||||
|
Cross currency interest rate swap
|
- | 20,377 | - | |||||||||
|
Liabilities
|
||||||||||||
|
Foreign currency derivative contracts
|
- | (8,219 | ) | (51 | ) | |||||||
|
Total
|
$ | 824 | $ | 31,258 | $ | 7,128 | ||||||
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONT.)
|
|
U. S. dollars (In thousands)
|
|
Note 2 -
|
SIGNIFICANT ACCOUNTING POLICIES (Cont.)
|
|
AC.
|
BASIC AND DILUTED NET EARNINGS PER SHARE
Basic earnings per share are computed based on the weighted average number of outstanding ordinary shares during each year. Diluted earnings per share are computed based on the weighted average number of outstanding ordinary shares during each year, plus dilutive potential ordinary shares considered outstanding during the year. Outstanding stock options are excluded from the calculation of the diluted earnings per ordinary share when their effect is anti-dilutive.
The weighted average number of shares related to outstanding anti-dilutive stock options excluded from the calculations of diluted net earnings per share was 23,041, 22,599 and 35,489 for the years 2010, 2009 and 2008, respectively.
|
|
AD.
|
IMPACT OF RECENTLY ISSUED ACCOUNTING STANDARDS
In October 2009, the FASB issued an update to ASC 605-25, "Revenue Recognition – Multiple-Element Arrangements", that provides amendments to the criteria for separating consideration in multiple-deliverable arrangements to:
|
|
|
(i)
|
Provide updated guidance on whether multiple deliverables exist, how the deliverables in an arrangement should be separated and how the consideration should be allocated;
|
|
|
(ii)
|
Require an entity to allocate revenue in an arrangement using estimated selling prices (“ESP”) of deliverables if a vendor does not have vendor-specific objective evidence of selling price (“VSOE”) or third-party evidence of selling price (“TPE”);
|
|
|
(iii)
|
Eliminate the use of the residual method and require an entity to allocate revenue using the relative selling price method; and
|
|
(iv)
|
Require expanded disclosures of qualitative and quantitative information regarding application of the multiple-deliverable revenue arrangement guidance.
|
|
AE.
|
RECLASSIFICATIONS
Certain financial statement data for prior years has been reclassified to conform to current year financial statement presentation
.
|
|
|
ELBIT SYSTEMS LTD. AND ITS SUBSIDIARIES
|
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONT.)
|
|
U. S. dollars (In thousands)
|
|
Note 3 -
|
TRADE AND UNBILLED RECEIVABLES, NET
|
|
December 31,
|
||||||||
|
2010
|
2009
|
|||||||
|
Receivables (*)
|
$ | 519,250 | $ | 529,614 | ||||
|
Unbilled receivables
|
194,329 | 130,795 | ||||||
|
Less – allowance for doubtful accounts
|
(11,215 | ) | (7,885 | ) | ||||
| $ | 702,364 | $ | 652,524 | |||||
|
(*)Includes affiliated companies
|
$ | 19,308 | $ | 18,207 | ||||
|
December 31,
|
||||||||
|
2010
|
2009
|
|||||||
|
Deferred income taxes, net
|
$ | 29,263 | $ | 25,030 | ||||
|
Prepaid expenses
|
36,564 | 36,054 | ||||||
|
Government institutions
|
40,154 | 21,018 | ||||||
|
Derivative instruments
|
28,571 | 18,219 | ||||||
|
Held for sale investment
(*)
|
14,727 | - | ||||||
|
Others
|
16,845 | 15,535 | ||||||
| $ | 166,124 | $ | 115,856 | |||||
|
|
(*)
Fraser-Volpe LLC ("FV") is a U.S. company held by ITL. ITL is in a potential process of selling its holding in FV
|
|
December 31,
|
||||||||
|
2010
|
2009
|
|||||||
|
Cost incurred on long-term contracts in progress
|
$ | 763,791 | $ | 718,134 | ||||
|
Raw materials
|
82,236 | 61,175 | ||||||
|
Advances to suppliers and subcontractors
|
50,839 | 36,638 | ||||||
| 896,866 | 815,947 | |||||||
|
Less -
|
||||||||
|
Cost incurred on contracts in progress deducted
from customer
advances
|
55,957 | 71,740 | ||||||
|
Advances received from customers (*)
|
101,231 | 113,511 | ||||||
|
Provision for losses on long-term contracts
|
74,408 | 60,848 | ||||||
| $ | 665,270 | $ | 569,848 | |||||
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONT.)
|
|
U. S. dollars (In thousands)
|
|
Note 6 -
|
INVESTMENTS IN AFFILIATED COMPANIES, PARTNERSHIP AND OTHER COMPANIES
|
|
|
A.
|
Investments in affiliated companies:
|
|
December 31,
|
||||||||
|
2010
|
2009
|
|||||||
|
Companies accounted for under the equity method
|
$ | 84,371 | $ | 85,014 | ||||
|
Companies accounted for on a cost basis
|
3,745 | 3,745 | ||||||
| $ | 88,116 | $ | 88,759 | |||||
|
|
B.
|
Investments in companies accounted for under the equity method:
|
|
December 31,
|
||||||||
|
2010
|
2009
|
|||||||
|
SCD
(1)
|
$ | 58,815 | $ | 48,169 | ||||
|
Mikal
(2)
|
- | 17,274 | ||||||
|
VSI
(3)
|
4,181 | 4,826 | ||||||
|
Opgal
(4)
|
13,000 | 9,809 | ||||||
|
Others
|
8,375 | 4,936 | ||||||
| $ | 84,371 | $ | 85,014 | |||||
|
|
(1)
|
Semi Conductor Devices (“SCD”) is an Israeli partnership, held 50% by the Company and 50% by Rafael Advanced Defense Systems Ltd. (“Rafael”). SCD is engaged in the development and production of various thermal detectors and laser diodes. SCD is jointly controlled and therefore is not consolidated in the Company’s financial statements.
|
|
|
(2)
|
Mikal is an Israeli company. During 2009 approximately 19% of its shares were acquired by the Company's subsidiary Kinetics, for approximately $18,000. The Company had significant influence in Mikal due to its representation on the Board of Directors and, as such, the investment was recorded according to the equity method of accounting. During October 2010, Kinetics sold its holdings in Mikal, as part of the consideration in the purchase of Mikal's holdings in Soltam, Saymar and ITL (See Note 1(D)(2)).
|
|
|
(3)
|
Vision Systems International LLC (“VSI”) based in San Jose, is a California limited liability company that is held 50% by ESA and 50% by a subsidiary of Rockwell Collins Inc. VSI operates in the area of helmet mounted display systems for fixed-wing military aircraft. VSI is jointly controlled and therefore is not consolidated in the Company’s financial statements.
|
|
|
(4)
|
Opgal Optronics Industries Ltd. (“Opgal”) is an Israeli company owned 50.1% by the Company and 49.9% by a subsidiary of Rafael. Opgal focuses mainly on commercial applications of thermal imaging and electro-optic technologies. The Company jointly controls Opgal with Rafael, and therefore Opgal is not consolidated in the Company’s financial statements.
|
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONT.)
|
|
U. S. dollars (In thousands)
|
|
Note 6 -
|
INVESTMENTS IN AFFILIATED COMPANIES, PARTNERSHIP AND OTHER COMPANIES (Cont.)
|
|
|
B.
|
Investments in companies accounted for under the equity method (Cont.)
|
|
|
(5)
|
Chip PC Ltd. (“Chip PC”) is an Israeli company, of which approximately 19% (16.3% on a fully diluted basis) is held by the Company. Chip PC develops and manufactures “Post PC” solutions, focused on enabling server-based-computing technologies to replace traditional PCs and deploy and control large numbers of workstations. In July 2007, Chip PC completed an initial public offering (“IPO”) on the Tel Aviv Stock Exchange (“TASE”). Following the offer, Chip PC became a publicly-traded company registered in Israel. The Company has significant influence in Chip PC due to its representatives on the Board of Directors and as such the investment is recorded according to the equity method of accounting. As of December 31, 2008, the Company identified impairment indicators in Chip PC and wrote-down the investment in Chip PC to its fair market value of $665, recognizing an impairment loss of approximately $800, included in equity in net earnings of affiliated companies. During 2009, the Company wrote-off the balance of its investment in Chip PC.
|
|
|
(6)
|
Equity in net earnings of affiliated companies is as follows:
|
|
Year ended December 31,
|
||||||||||||
|
2010
|
2009
|
2008
|
||||||||||
|
SCD
|
$ | 11,470 | $ | 12,603 | $ | 8,682 | ||||||
|
VSI
|
6,265 | 4,942 | 4,338 | |||||||||
|
Others
|
1,608 | 1,747 | 1,415 | |||||||||
| $ | 19,343 | $ | 19,292 | $ | 14,435 | |||||||
|
|
(7)
|
The summarized aggregate financial information of companies accounted for under the equity method is as follows:
Balance Sheet Information:
|
|
December 31,
|
||||||||
|
2010
|
2009
|
|||||||
|
Current assets
|
$ | 278,141 | $ | 193,787 | ||||
|
Non-current assets
|
69,507 | 46,696 | ||||||
|
Total assets
|
$ | 347,648 | $ | 240,483 | ||||
|
Current liabilities
|
$ | 186,555 | $ | 109,069 | ||||
|
Non-current liabilities
|
34,688 | 32,976 | ||||||
|
Shareholders’ equity
|
126,405 | 98,438 | ||||||
| $ | 347,648 | $ | 240,483 | |||||
|
Year ended December 31,
|
||||||||||||
|
2010
|
2009
|
2008
|
||||||||||
|
Revenues
|
$ | 476,286 | $ | 361,283 | $ | 326,702 | ||||||
|
Gross profit
|
$ | 137,228 | $ | 110,699 | $ | 98,291 | ||||||
|
Net income
|
$ | 36,728 | $ | 31,489 | $ | 32,914 | ||||||
|
|
(8)
|
See Note 20(E) for guarantees.
|
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONT.)
|
|
U. S. dollars (In thousands)
|
|
Note 6 -
|
INVESTMENTS IN AFFILIATED COMPANIES, PARTNERSHIP AND OTHER COMPANIES (Cont.)
|
|
|
C.
|
Investments in companies accounted for on a cost basis
|
|
December 31,
|
||||||||
|
2010
|
2009
|
|||||||
|
ISI
(1)
|
$ | 1,830 | $ | 1,830 | ||||
|
Sandel
(2)
|
1,900 | 1,900 | ||||||
|
Others
|
15 | 15 | ||||||
| $ | 3,745 | $ | 3,745 | |||||
|
|
(1)
|
ImageSat International N.V. (“ISI”), held 14% (10% on a fully diluted basis) by the Company, is engaged in the operation of satellite photography formations and commercial delivery of satellite photography for civilian purposes. See also Note 20(C)(2).
|
|
|
(2)
|
Sandel Avionics, Inc. (“Sandel”) based in Vista, California, produces specialized integrated display systems and other products for the commercial aviation market. In 2006, ESA’s subsidiary Kollsman, Inc. (“Kollsman”) acquired Preferred B Shares of Sandel, which constituted a 20% interest in Sandel on a fully diluted and as converted basis. The investment in Sandel was accounted on a cost basis in accordance with ASC 323-10. During the fourth quarter of 2008, the fair value of Sandel decreased as a result of a decrease in Sandel’s backlog and estimated future cash flows. During 2008, based on a valuation prepared by an independent appraiser, the Company recognized an other-than-temporary impairment loss of approximately $10,514 pre-tax of its investment in Sandel, which was classified in "Other income, net" in the Consolidated Statement of Income. In March 2011, the investment in Sandel was realized for consideration of $3,000.
|
|
December 31,
|
||||||||
|
2010
|
2009
|
|||||||
|
Receivables
|
$ | 16,211 | $ | 2,269 | ||||
|
Unbilled receivables
|
74,132 | 14,680 | ||||||
| $ | 90,343 | $ | 16,949 | |||||
|
December 31,
|
||||||||
|
2010
|
2009
|
|||||||
|
Restricted deposits with banks
(1)
|
$ | 25,032 | $ | 23,065 | ||||
|
Hedging receivables related to Series A Notes (See Note 16)
|
10,907 | - | ||||||
|
Deposit with banks and other long-term receivables
(2)
|
8,462 | 8,165 | ||||||
| $ | 44,401 | $ | 31,230 | |||||
|
(1)
|
Restricted deposits in respect of an issued bank guarantee.
|
|
(2)
|
Includes long-term balances of non-qualified deferred compensation plan structured under Section 409A in the amount of $5,604 and $4,841 as of December 31, 2010 and 2009, respectively (See Note 17).
|
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONT.)
|
|
U. S. dollars (In thousands)
|
|
December 31,
|
||||||||||||||||||||||||
|
2010
|
2009
|
|||||||||||||||||||||||
|
Amortized
cost
|
Gross
unrealized
gains (losses),
net
|
Estimated
fair
market
value
|
Amortized
cost
|
Gross
unrealized
gains (losses),
net
|
Estimated
fair
market
value
|
|||||||||||||||||||
|
Government bonds
|
$ | - | $ | - | $ | - | $ | 22,206 | $ | 694 | $ | 22,900 | ||||||||||||
|
Marketable equity securities
|
- | - | - | 3,427 | 2,069 | 5,496 | ||||||||||||||||||
|
ARS and CDOs (*)
|
11,792 | (4,613 | ) | 7,179 | 11,792 | (4,413 | ) | 7,445 | ||||||||||||||||
| $ | 11,792 | $ | (4,613 | ) | $ | 7,179 | $ | 37,425 | $ | (1,650 | ) | $ | 35,841 | |||||||||||
|
(*)
|
ARS and CDOs held as a result of the acquisition of Tadiran Communication Ltd. ("Tadiran") during 2007 are private placement securities with long-term contractual maturities. The Company's investments in ARS represent interests in collateralized debt obligations supported by pools of residential and commercial mortgages or credit cards, insurance securitizations and other structured credits, including corporate bonds. ARS’ interest rates are reset through a “dutch” auction each month. The monthly auctions historically have provided a liquid market for these securities. CDOs are collateralized debt obligations formed for the purpose of the proceeds in a portfolio of asset-backed securities and related synthetic securities. Some of the underlying collateral for the ARS and CDOs held by the Company consists of sub-prime mortgages.
With the liquidity issues experienced in global credit and capital markets, the ARS have experienced multiple failed auctions as the amount of securities submitted for sale has exceeded the amount of purchase orders. In addition, no payment on any class of the Company’s holdings in CDOs is made until all accrued and unpaid interest of each class that has seniority and that remain outstanding had been paid in full.
In 2010, while the Company continued to earn interest on the ARS at the contractual rates, their estimated market value no longer approximated par value. In addition, some of the Company’s CDOs currently have no or only limited market. As there was insufficient observable market information available to determine the fair value of most of the ARS and CDOs, their fair value was determined using an independent third party valuator (See note 2(AB)).
|
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONT.)
|
|
U. S. dollars (In thousands)
|
|
Note 10 -
|
PROPERTY, PLANT AND EQUIPMENT, NET
|
|
December 31,
|
||||||||
|
2010
|
2009
|
|||||||
|
Cost
(1)
:
|
||||||||
|
Land, buildings and leasehold improvements
(2)
|
$ | 349,696 | $ | 260,991 | ||||
|
Instruments, machinery and equipment
(3)
|
587,679 | 529,163 | ||||||
|
Office furniture and other
|
72,613 | 60,541 | ||||||
|
Motor vehicles
|
102,841 | 90,526 | ||||||
| 1,112,829 | 941,221 | |||||||
|
Accumulated depreciation
|
(608,978 | ) | (536,546 | ) | ||||
|
Depreciated cost
|
$ | 503,851 | $ | 404,675 | ||||
|
|
(1)
|
Net of investment grants received (mainly for instruments, machinery and equipment) in the amounts of $29,084 and $26,093 as of December 31, 2010 and 2009, respectively.
|
|
|
(2)
|
Set forth below is additional information regarding the real estate owned or leased by the Company (in square feet):
|
|
Israel
(a)
|
U.S.
(b)
|
Other Countries
(c)
|
||||||||||
|
Owned
|
2,215,000 | 713,000 | 1,063,000 | |||||||||
|
Leased
|
2,038,000 | 611,000 | 300,000 | |||||||||
|
|
(a)
|
Includes offices, development and engineering facilities, manufacturing facilities, maintenance facilities, hangar facilities and a landing strip in various locations in Israel used by Elbit Systems' Israeli subsidiaries.
|
|
|
(b)
|
Includes offices, development and engineering facilities, manufacturing facilities and maintenance facilities of Elbit Systems of America in Texas, New Hampshire, Florida, Alabama, Virginia, Georgia and Kansas.
|
|
|
(c)
|
Includes offices, design and engineering facilities and manufacturing facilities, mainly in the U.K., Romania, Belgium, Germany, Brazil and South Korea.
|
|
|
(3)
|
Includes equipment produced by the Company for its own use in the aggregate amount of $167,248 and $169,270 as of December 31, 2010 and 2009, respectively.
|
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONT.)
|
|
U. S. dollars (In thousands)
|
|
A.
|
Composition:
|
|
Weighted average
|
||||||||||||
|
useful lives
|
December 31,
|
|||||||||||
|
Identifiable intangible assets
|
2010
|
2009
|
||||||||||
|
Original cost:
|
||||||||||||
|
Technology
(1)
|
12 | $ | 248,868 | $ | 187,422 | |||||||
|
Customer relations
(2)
|
6 | 200,336 | 171,011 | |||||||||
|
Trade marks and other
(3)
|
14 | 64,442 | 55,206 | |||||||||
| 513,646 | 413,639 | |||||||||||
|
Accumulated amortization:
|
||||||||||||
|
Technology
|
98,814 | 81,820 | ||||||||||
|
Customer relations
|
86,166 | 59,654 | ||||||||||
|
Trademarks and other
|
15,073 | 10,982 | ||||||||||
| 200,053 | 152,456 | |||||||||||
|
Amortized cost
|
$ | 313,593 | $ | 261,183 | ||||||||
|
(1)
|
The technology acquired consists of the major items as follows:
|
|
(2)
|
Includes mainly customer relations resulting from the acquisition of Tadiran ($137,300) and FTL ($9,000) in 2007. The Company performed its annual impairment test on goodwill and other intangibles and determined that an impairment of the ICI customer relationships intangible asset in the amount of $1,392 existed as of December 31, 2009 (recorded in M&A expenses). The primary impairment was the result of significantly lower margins expected for the remaining acquired customers.
|
|
(3)
|
Includes trademarks in the amount of $8,000 acquired in the merger with Elop in 2000, and an amount of $33,200 that was allocated to trademarks resulting mainly from the acquisition of Tadiran in 2005 – 2007.
|
|
B.
|
Amortization expenses amounted to $47,729, $42,601 and $40,140 for the years ended December 31, 2010, 2009 and 2008, respectively.
|
|
C.
|
The estimated aggregate amortization expense for each of the five succeeding fiscal years :
|
|
2011
|
$ | 52,844 | ||
|
2012
|
45,064 | |||
|
2013
|
40,259 | |||
|
2014
|
37,645 | |||
|
2015
|
29,542 | |||
|
2016 and after
|
108,241 |
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONT.)
|
|
U. S. dollars (In thousands)
|
|
D.
|
Changes in goodwill, during 2010 are as follows:
|
|
2010
|
||||
|
Balance, at January 1,
|
$ | 337,312 | ||
|
Adjustment in respect of previous acquistions
(1)
|
(24,729 | ) | ||
|
Net translation differences
(2)
|
(319 | ) | ||
|
Goodwill acquired during the year
:
|
||||
|
Azimuth
|
19,583 | |||
|
Soltam
|
50,668 | |||
|
Saymar
|
4,291 | |||
|
ITL
|
24,740 | |||
|
Ares and Periscopio
|
27,509 | |||
|
M7 Aerospace
|
29,911 | |||
|
European subsidiaries
|
14,822 | |||
|
Impairment
(3)
|
(717 | ) | ||
|
Balance, at December 31,
|
$ | 483,071 | ||
|
(1)
|
In 2010, the Company adjusted deferred income taxes related to previous acquisitions made during 2007.
|
|
(2)
|
Foreign currency translation differences resulting from goodwill allocated to reporting units, whose functional currency has been determined to be other than the U.S. dollar.
|
|
(3)
|
In 2010, the Company wrote-off part of its investment in ICI.
|
|
|
December 31,
|
|||||||||||
|
Interest %
|
2010
|
2009
|
||||||||||
|
Short-term loans
|
3-7.45% | $ | 10,537 | $ | - | |||||||
|
Short-term bank credit
|
0-6.23% | 4,578 | - | |||||||||
| $ | 15,115 | $ | - | |||||||||
|
Weighted average interest rate
|
2.82% | |||||||||||
|
December 31,
|
||||||||
|
2010
|
2009
|
|||||||
|
Payroll and related expenses
|
$ | 141,965 | $ | 122,497 | ||||
|
Provision for vacation pay
|
44,876 | 34,319 | ||||||
|
Provision for income taxes, net of advances
|
14,949 | 14,872 | ||||||
|
Other income taxes liabilities
|
25,921 | 21,490 | ||||||
|
Value added tax (“VAT”) payable
|
7,245 | 4,356 | ||||||
|
Provisions for royalties
|
32,217 | 33,048 | ||||||
|
Provision for warranty
|
164,778 | 126,783 | ||||||
|
Derivative instruments
|
8,366 | 10,699 | ||||||
|
Provision for losses on long-term contracts
|
61,663 | 75,493 | ||||||
|
Others (*)
|
143,166 | 114,044 | ||||||
| $ | 645,146 | $ | 557,601 | |||||
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONT.)
|
|
U. S. dollars (In thousands)
|
|
Note 14 -
|
CUSTOMER ADVANCES IN EXCESS OF COSTS INCURRED ON CONTRACTS IN PROGRESS
|
|
December 31,
|
||||||||
|
2010
|
2009
|
|||||||
|
Advances received
|
$ | 637,070 | $ | 694,954 | ||||
|
Less -
|
||||||||
|
Advances presented under long-term liabilities
|
177,191 | 142,566 | ||||||
|
Advances deducted from inventories
|
101,231 | 113,511 | ||||||
| 358,648 | 438,877 | |||||||
|
Less -
|
||||||||
|
Costs incurred on contracts in progress (See Note 5)
|
55,957 | 71,740 | ||||||
| $ | 302,691 | $ | 367,137 | |||||
|
Years of
|
December 31,
|
||||||||||||
|
Currency
|
Interest %
|
maturity
|
2010
|
2009
|
|||||||||
|
Long-term bank loans
|
U.S. dollars
|
Libor +
1.25-2.55%
|
mainly 2-3
|
$ | 276,702 | $ | 365,232 | ||||||
|
Other
|
Libor + 1.65-4%
|
mainly 1-3
|
20,694 | 22,663 | |||||||||
|
Other long-term loans
|
NIS
|
Prime + 1.5%
|
3 | 2,873 | 3,200 | ||||||||
|
Other
|
Libor + 1.7-4%
|
mainly 1-3
|
1,289 | 790 | |||||||||
| 301,558 | 391,885 | ||||||||||||
|
Less-current maturities
|
9,519 | 2,663 | |||||||||||
| $ | 292,039 | $ | 389,222 | ||||||||||
|
2011 – current maturities
|
$ | 9,519 | ||
|
2012
|
193,755 | |||
|
2013
|
97,803 | |||
|
2014
|
194 | |||
|
2015
|
194 | |||
|
2016 and after
|
93 | |||
| $ | 301,558 |
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONT.)
|
|
U. S. dollars (In thousands)
|
|
December 31,
2010
|
||||
|
Series A Notes
(1)
|
$ | 309,946 | ||
|
Convertible debentures
(2)
|
2,993 | |||
|
Less –
Current maturities
|
(33,574 | ) | ||
|
Carrying amount adjustments on Series A Notes
(*)
|
(4,011 | ) | ||
|
Discount on Series A Notes
|
(1,997 | ) | ||
| $ | 273,357 | |||
|
(*)
|
As a result of fair value hedge accounting, described below, and in Notes 2(Z) and 2(AB). The carrying value of the Series A Notes is adjusted for changes in the interest rates.
|
|
|
(1)
|
In June 2010, the Company issued Series A Notes in the aggregate principle amount of NIS 1.1 billion (approximately $283,000), payable in 10 equal annual installments on June 30 of each of the years 2011 through 2020. The Series A Notes bear a fixed interest rate of 4.84% per annum, payable on June 30 and December 30 of each of the years 2010 through 2020 (the first interest payment was made on December 30, 2010, and the last interest payment will be made on June 30, 2020). During 2010, the Company recorded $4,395 as interest expenses. Debt issuance costs were approximately $2,530, of which $2,164 was allocated to the Series A Notes discount, and $366 was allocated to deferred issuance costs and are amortized as financial expense over the term of the Series A Notes due in 2020. Amortization of discount and deferred financing costs amount to $258, as of December 31, 2010.
The Series A Notes (principal and interest) are not linked to any currency or index. The Series A Notes are unsecured, non convertible and do not restrict the Company's ability to issue additional notes of any class or distribute dividends in the future. There are no covenants on the Series A Notes. The Series A Notes are listed for trading on the Tel-Aviv Stock Exchange.
On May 13, 2010, Midroog Ltd., an Israeli rating agency, announced that it assigned its "Aa1" rating (local scale) to unsecured notes to be issued by the Company, which include the Series A Notes.
The Company also entered into ten-year cross currency interest rate swap transactions in order to effectively hedge the effect of interest and exchange rate differences resulting from the NIS Series A Notes. Under the cross currency interest rate swaps, the Company will receive fixed NIS at a rate of 4.84% on NIS 1.1 billion and pay floating six-month USD LIBOR + an average spread of 1.65% on $287,000, which reflects the U.S. dollar value of the Series A Notes on the specific dates the transactions were entered. Both the debt and the swap instruments will pay semi-annual coupons on June 30 and December 31. The purpose of these transactions was to convert the NIS fixed rate Series A Notes into USD LIBOR (6 months) floating rate obligations. As a result of these agreements, the Company is currently paying an effective interest rate of six-month LIBOR (0.45% at December 31, 2010) plus an average of 1.65% on the principal amount, as compared to the original 4.84% fixed rate. The above transactions qualify for fair value hedge accounting.
|
|
|
(2)
|
Convertible debentures were issued by ITL in July 2005. The convertible debentures bear a fixed interest of 4% per annum. The debentures are paid annually and the last payment is in July 2011.
|
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONT.)
|
|
U. S. dollars (In thousands)
|
|
December 31, 2010
|
||||
|
2011(current maturities)
|
$ | 33,574 | ||
|
2012
|
30,581 | |||
|
2013
|
30,581 | |||
|
2014
|
30,581 | |||
|
2015
|
30,581 | |||
|
2016 and after
|
152,905 | |||
|
Note 17 -
|
BENEFIT PLANS AND OBLIGATIONS FOR TERMINATION INDEMNITY
|
|
a)
|
ESA has three defined benefit pension plans (the “Plans”) which cover the employees of EFW and Kollsman. Monthly benefits are based on years of benefit service and annual compensation. Annual contributions to the Plans are determined using the unit credit actuarial cost method and are equal to or exceed the minimum required by law. Pension fund assets of the Plans are invested primarily in stock, bonds and cash through a financial institution, as the investment manager of the Plans’ assets. Pension expense is allocated between cost of sales and general and administrative expenses, depending on the responsibilities of the employee. The measurement date for the EFW and Kollsman benefit obligation is December 31. In November 2008, ESA ratified a new union agreement, which resulted in a higher multiplier for benefit payments.
|
|
b)
|
Telefunken Radio Communication Systems GmbH & Co. (“Telefunken”), a wholly-owned German subsidiary, has mainly one defined benefit pension plan (the “P3-plan”) which covers all employees. The P3-plan provides for yearly cash balance credits equal to a percentage of a participant’s compensation which accumulate together with the respective interest credits on the employee’s cash balance accounts. In case of an insured event (retirement, death, disability) the benefits can be paid as a lump sum, in installments or as a life-long annuity. The P3-plan is an unfunded plan.
|
|
|
c)
|
A wholly-owned European subsidiary in Belgium has a defined benefit pension plan, which is divided into two categories:
|
|
|
1)
|
Normal retirement benefit plan, with eligibility at age 65. The lump sum is based on employee contributions of 2% of the final pensionable salary up to certain breakpoint, plus 6% exceeding the breakpoint at a maximum of 5% of pensionable salary, and the employer contributions, with a maximum of 40 years. The vested benefit is equal to retirement benefit calculated with the pensionable salary and pensionable service observed at the date of leaving service.
|
|
|
2)
|
Pre-retirement death benefit to employees.
|
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONT.)
|
|
U. S. dollars (In thousands)
|
|
December 31,
|
||||||||
|
Changes in benefit obligation
:
|
2010
|
2009
|
||||||
|
Benefit obligation at beginning of year
|
$ | 103,134 | $ | 89,857 | ||||
|
Service cost
|
7,031 | 6,694 | ||||||
|
Interest cost
|
5,858 | 5,427 | ||||||
|
Amendments
|
- | 117 | ||||||
|
Exchange rate differences
|
(1,023 | ) | (382 | ) | ||||
|
Actuarial losses
|
7,374 | 4,159 | ||||||
|
Benefits paid
|
(2,391 | ) | (2,027 | ) | ||||
|
Effect of settlement commitment
|
- | (711 | ) | |||||
|
Benefit obligation at end of year
|
$ |
119,983
|
$ | 103,134 | ||||
|
Changes in Plan Assets
:
|
||||||||
|
Fair value of Plans assets at beginning of year
|
62,790 | 45,375 | ||||||
|
Actual return on Plan assets (net of expenses)
|
6,326 | 8,301 | ||||||
|
Employer contribution
|
2,679 | 11,079 | ||||||
|
Benefits paid
|
(2,302 | ) | (1,965 | ) | ||||
|
Fair value of Plans assets at end of year
|
$ | 69,493 | $ | 62,790 | ||||
|
Accrued benefit cost, end of year
:
|
||||||||
|
Funded status
|
(50,490 | ) | (40,344 | ) | ||||
|
Unrecognized net actuarial loss
|
34,972 | 31,198 | ||||||
|
Unrecognized prior service cost
|
684 | 790 | ||||||
| $ | (14,834 | ) | $ | (8,356 | ) | |||
|
Amount recognized in the statement of financial position
:
|
||||||||
|
Accrued benefit liability, current
|
(39 | ) | (39 | ) | ||||
|
Accrued benefit liability, non-current
|
(50,451 | ) | (40,305 | ) | ||||
|
Accumulated other comprehensive income, pre-tax
|
35,656 | 31,988 | ||||||
|
Net amount recognized
|
$ | (14,834 | ) | $ | (8,356 | ) | ||
|
Year ended
December 31,
|
||||||||||||
|
2010
|
2009
|
2008
|
||||||||||
|
Components of the Plans' net periodic pension cost
:
|
||||||||||||
|
Service cost
|
$ | 7,031 | $ | 6,694 | $ | 5,883 | ||||||
|
Interest cost
|
5,858 | 5,427 | 4,529 | |||||||||
|
Expected return on Plans' assets
|
(4,914 | ) | (3,915 | ) | (4,565 | ) | ||||||
|
Amortization of prior service cost
|
95 | 97 | (110 | ) | ||||||||
|
Amortization of transition amount
|
(130 | ) | (120 | ) | 60 | |||||||
|
Amortization of net actuarial loss
|
1,769 | 2,282 | 369 | |||||||||
|
Total net periodic benefit cost
|
$ | 9,709 | $ | 10,465 | $ | 6,166 | ||||||
|
Additional information
|
||||||||||||
|
Accumulated benefit obligation
|
$ | 112,643 | $ | 95,877 | $ | 83,779 | ||||||
|
December 31,
|
||||||||
|
Weighted average assumption
s:
|
2010
|
2009
|
||||||
|
Discount rate as of December 31
|
5.38 | % | 5.90 | % | ||||
|
Expected long-term rate of return on Plan’s assets
|
7.30 | % | 7.75 | % | ||||
|
Rate of compensation increase
|
2.67 | % | 2.90 | % | ||||
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONT.)
|
|
U. S. dollars (In thousands)
|
|
2010
|
2009
|
|||||||
|
Asset Category
|
||||||||
|
Equity Securities
|
58.1 | % | 54.1 | % | ||||
|
Debt Securities
|
33.6 | % | 35.6 | % | ||||
|
Other
|
8.3 | % | 10.3 | % | ||||
|
Total
|
100.0 | % | 100.0 | % | ||||
|
2010
|
2009
|
|||||||
|
Asset Category
|
||||||||
|
Equity Securities
|
60.0 | % | 60.0 | % | ||||
|
Debt Securities
|
37.0 | % | 37.0 | % | ||||
|
Other
|
3.0 | % | 3.0 | % | ||||
|
Total
|
100.0 | % | 100.0 | % | ||||
|
Quoted Prices in Active Markets for Identical Assets
|
Significant Observable Inputs
|
Significant Unobservable Inputs
|
||||||||||||||
|
Asset Category
|
Total
|
(Level 1)
|
(Level 2)
|
(Level 3)
|
||||||||||||
|
Cash
|
$ | 110 | $ | 110 | $ | - | $ | - | ||||||||
|
Cash Equivalents
:
|
||||||||||||||||
|
Money Market Funds (a)
|
2,766 | 2,766 | - | - | ||||||||||||
|
Fixed Income Securities
:
|
||||||||||||||||
|
U.S. Treasuries
|
2,898 | 1,672 | 1,226 | - | ||||||||||||
|
Corporate Bonds (b)
|
2,729 | - | 2,729 | - | ||||||||||||
|
International Bonds (c)
|
544 | - | 544 | - | ||||||||||||
|
Mutual Funds (d)
|
16,986 | 16,986 | - | - | ||||||||||||
|
Equity Securities
:
|
||||||||||||||||
|
U.S. Companies (e)
|
3,780 | 3,780 | - | - | ||||||||||||
|
International Companies (f)
|
2,252 | 2,252 | - | - | ||||||||||||
|
Mutual Funds (g)
|
37,275 | 37,275 | - | - | ||||||||||||
|
Real Estate
|
153 | - | 153 | - | ||||||||||||
|
Total
|
$ | 69,493 | $ | 64,841 | $ | 4,652 | $ | - | ||||||||
|
(a)
|
This category includes highly liquid daily traded cash-like vehicles.
|
|
(b)
|
This category represents investment grade bonds at purchase issued by corporations from diverse industries.
|
|
(c)
|
This category represents investment grade bonds from non-U.S. corporations and sovereign debt.
|
|
(d)
|
This category invests in highly liquid diverse mutual funds representing a diverse offering of debt issuance.
|
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONT.)
|
|
U. S. dollars (In thousands)
|
|
(e)
|
This category represents common stocks that are traded on major exchanges.
|
|
(f)
|
This represents common stocks of companies domiciled outside of the U.S.; they can be represented by ordinary shares or ADRs.
|
|
(g)
|
This category represents highly liquid diverse equity mutual funds of varying asset classes and styles.
|
|
December 31
|
December 31
|
|||||||
|
2010
|
2009
|
|||||||
|
Change in Benefit Obligation
:
|
||||||||
|
Benefit obligation at beginning of period
|
$ | 2,419 | $ | 2,547 | ||||
|
Service cost
|
208 | 202 | ||||||
|
Interest cost
|
138 | 156 | ||||||
|
Actuarial (gain) loss
|
216 | (402 | ) | |||||
|
Employee contribution
|
21 | 17 | ||||||
|
Benefits paid
|
(88 | ) | (101 | ) | ||||
|
Benefit obligation at end of period
|
$ | 2,914 | $ | 2,419 | ||||
|
Change in Plan Assets
:
|
||||||||
|
Fair value of plan assets at beginning of period
|
$ | - | $ | - | ||||
|
Employer contribution
|
67 | 84 | ||||||
|
Employee contribution
|
21 | 17 | ||||||
|
Benefits paid
|
(88 | ) | (101 | ) | ||||
|
Fair value of plan assets at end of period
|
$ | - | $ | - | ||||
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONT.)
|
|
U. S. dollars (In thousands)
|
|
Year ended December 31,
|
||||||||
|
2010
|
2009
|
|||||||
|
Accrued benefit cost, end of period
:
|
||||||||
|
Funded status
|
$ | (2,914 | ) | $ | (2,419 | ) | ||
|
Unrecognized net actuarial gain
|
540 | 332 | ||||||
|
Unrecognized prior service cost
|
74 | 224 | ||||||
|
Accrued benefit cost, end of period
|
$ | (2,300 | ) | $ | (1,863 | ) | ||
|
Amounts recognized in the statement of financial position
:
|
||||||||
|
Accrued benefit liability, current
|
(122 | ) | (102 | ) | ||||
|
Accrued benefit liability, non-current
|
(2,792 | ) | (2,317 | ) | ||||
|
Accumulated other comprehensive loss, pretax
|
614 | 556 | ||||||
|
Net amount recognized
|
$ | (2,300 | ) | $ | (1,863 | ) | ||
|
Components of net periodic pension cost (for period)
:
|
||||||||
|
Service cost
|
$ | 208 | $ | 202 | ||||
|
Interest cost
|
138 | 157 | ||||||
|
Amortization of prior service cost
|
150 | 150 | ||||||
|
Amortization of net actuarial (gain) loss
|
7 | 42 | ||||||
|
Total net periodic benefit cost
|
$ | 503 | $ | 551 | ||||
|
Assumptions as of end of period
:
|
||||||||
|
Discount rate
|
5.32 | % | 5.38 | % | ||||
|
Health care cost trend rate assumed for next year
|
8.00 | % | 7.50 | % | ||||
|
Ultimate health care cost trend rate
|
5.00 | % | 5.00 | % | ||||
|
1% increase
|
1% decrease
|
|||||||
|
Net periodic benefit cost
|
$ | 41 | $ | 36 | ||||
|
Benefit obligation
|
$ | 244 | $ | 219 | ||||
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONT.)
|
|
U. S. dollars (In thousands)
|
|
|
A.
|
APPLICABLE TAX LAWS
|
|
|
(1)
|
Israeli Corporate Income Tax Rates
|
|
|
(2)
|
Measurement of taxable income under Israel’s Income Tax (Inflationary Adjustments) Law, 1985:
|
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONT.)
|
|
U. S. dollars (In thousands)
|
|
|
A.
|
APPLICABLE TAX LAWS (Cont.)
|
|
|
(3)
|
Tax benefits under Israel’s Law for the Encouragement of Industry (Taxes), 1969:
|
|
|
(4)
|
Tax benefits under Israel’s Law for the Encouragement of Capital Investments, 1969:
Elbit Systems and certain of its Israeli subsidiaries (“the companies”) operations have been granted “Approved Enterprise” status under Israel’s Law for the Encouragement of Capital Investments, 1959 (the "Law”).
Accordingly, certain income of the companies derived from the “Approved Enterprise” programs is tax exempt for two-years and subject to reduced tax rates of 25% for a five-year to eight-year period or tax exempt for a ten-year period, commencing in the first year in which the companies had taxable income (limited to twelve years from commencement of production or fourteen years from the date of approval, whichever is earlier).
An Amendment to the law from 2005 defines the "Privileged Enterprise" status rather than the previous terminology of "Approved Enterprise" and limits the scope of enterprises which may qualify for "Privileged Enterprise" status by setting criteria such as that at least 25% of the Privileged Enterprise program's income be derived from export. Additionally, the 2005 Amendment enacted major changes in the manner in which tax benefits are awarded under the Law so that companies no longer require an Investment Center approval in order to qualify for tax benefits.
As a result of the 2005-Amendment, tax-exempt income generated under Elbit Systems and certain of its Israeli subsidiaries Privileged Enterprise programs will be subject to tax upon dividend distribution or complete liquidation.
The entitlement to the above benefits is subject to the companies' fulfilling the conditions specified in the Law, regulations promulgated thereunder and the letters of approval for the specific investments in "Approved Enterprises". In the event of failure to comply with these conditions, the benefits may be canceled and the companies may be required to refund the amount of the benefits, in whole or in part, including interest. (For liens – see Note 20(J)). As of December 31, 2010, the Company’s management believes that the companies are meeting all conditions of the Law and letters of approval.
As of December 31, 2010, the tax benefits for the Company’s Approved Enterprise and Privileged Enterprise existing programs will expire within the period of 2011 to 2018.
As of December 31, 2010, retained earnings of the Company included approximately $481,481 in tax-exempt profits earned by the company's "Approved Enterprises" and “Privileged Enterprises”. If the retained tax-exempt income is distributed, with respect to the “Approved Enterprises” and the "Privileged Enterprises", it would be taxed at the corporate tax rate applicable to such profits as if the Company had not elected the alternative tax benefits track (currently - 25%), and an income tax liability would be incurred of approximately $120,370 as of December 31, 2010.
|
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONT.)
|
|
U. S. dollars (In thousands)
|
|
|
A.
|
APPLICABLE TAX LAWS (Cont.)
The company’s boards of directors have decided that their policy is not to declare dividends out of such tax-exempt income. Accordingly, no deferred income taxes have been provided on exempt income attributable to the companies’ “Approved Enterprises” and “Privileged Enterprise”, as such retained earnings are essentially permanent in duration.
In Israel, income from sources other than the “Approved Enterprise” and “Privileged Enterprise” during the benefit period will be subject to tax at the regular corporate tax rate (See Note 18(A)(1)).
Since the companies are operating under more than one approval, and since part of their taxable income is not entitled to tax benefits under the Law and is taxed at the regular tax rates, the effective tax rate is the result of a weighted combination of the various applicable rates and tax exemptions, and the computation is made for income derived from each approval on the basis of formulas specified in the law and in the approvals.
In January 2011, the Knesset enacted a reform to the Law, effective January 2011. According to the reform a flat rate tax would apply to companies eligible for the “Preferred Enterprise” status. In order to be eligible for a Preferred Enterprise status, a company must meet minimum requirements to establish that it contributes to the country’s economic growth and is a competitive factor for the Gross Domestic Product (a competitive enterprise).
Israeli companies which currently benefit from an Approved or Privileged Enterprise status and meet the criteria for qualification as a Preferred Enterprise can elect to apply the new Preferred Enterprise benefits by waiving their benefits under the Approved and Privileged Enterprise status.
Benefits granted to a Preferred Enterprise include reduced and gradually decreasing tax rates. In peripheral regions (Development Area A) the reduced tax rate will be 10% in 2011 and 2012, 7% in 2013 and 2014 and 6% starting from 2015. In other regions the tax rate will be 15% in 2011 and 2012, 12.5% in 2013 and 2014 and 12% starting from 2015. Preferred Enterprises in peripheral regions will be eligible for Investment Center grants, as well as the applicable reduced tax rates.
A distribution from a Preferred Enterprise out of the “Preferred Income” would be subject to 15% withholding tax for Israeli-resident individuals and non-Israeli residents (subject to applicable treaty rates). A distribution from a Preferred Enterprise out of the “Preferred Income” would be exempt from withholding tax for an Israeli-resident company. A company electing to waive its Privileged Enterprise or Approved Enterprise status through June 30, 2015 may distribute “Approved Income” or “Privileged Income” subject to 15% withholding tax for Israeli resident individuals and non-Israeli residents (subject to applicable treaty rates) and exempt from withholding tax for an Israeli-resident company. Nonetheless, a distribution from income exempt under Privileged Enterprise and Approved Enterprise programs will subject the exempt income to tax at the reduced corporate income tax rates pertaining to the Privileged Enterprise and Approved Enterprise programs upon distribution, or complete liquidation in the case of a Privileged Enterprise’s exempt income.
|
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONT.)
|
|
U. S. dollars (In thousands)
|
|
|
A.
|
APPLICABLE TAX LAWS (Cont.)
The net effect of the 2011 amendment on the deferred tax balances of the Company will be recognized in the period of enactment of the amendment (first quarter of 2011). The Company estimates that the implementation of the 2011-amendment by the Israeli subsidiaries would not lead to a material net effect on the Company's 2011 results.
|
|
|
B.
|
NON – ISRAELI SUBSIDIARIES
Non-Israeli subsidiaries are taxed based on tax laws in their countries of residence.
|
|
|
C.
|
INCOME BEFORE TAXES ON INCOME
|
|
Year ended
December 31,
|
||||||||||||
|
2010
|
2009
|
2008
|
||||||||||
|
Income before taxes on income:
|
||||||||||||
|
Domestic
|
$ | 160,749 | $ | 186,444 | $ | 257,139 | ||||||
|
Foreign
|
38,612 | 60,886 | 49,341 | |||||||||
| $ | 199,361 | $ | 247,330 | $ | 306,480 | |||||||
|
|
D.
|
TAXES ON INCOME
|
|
Year ended
December 31,
|
||||||||||||
|
2010
|
2009
|
2008
|
||||||||||
|
Taxes on income:
|
||||||||||||
|
Current taxes:
|
||||||||||||
|
Domestic
|
$ | 26,842 | $ | 30,006 | $ | 46,443 | ||||||
|
Foreign
|
16,616 | 15,350 | 14,245 | |||||||||
| 43,458 | 45,356 | 60,688 | ||||||||||
|
Adjustment for previous years:
|
||||||||||||
|
Domestic
|
(3,889 | ) | (6,491 | ) | 2,025 | |||||||
|
Foreign
|
1,885 | 91 | (146 | ) | ||||||||
| (2,004 | ) | (6,400 | ) | 1,879 | ||||||||
|
Deferred income taxes:
|
||||||||||||
|
Domestic
|
(10,303 | ) | (3,763 | ) | (8,691 | ) | ||||||
|
Foreign
|
(7,114 | ) | 2,916 | 491 | ||||||||
| (17,417 | ) | (847 | ) | (8,200 | ) | |||||||
| $ | 24,037 | $ | 38,109 | $ | 54,367 | |||||||
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONT.)
|
|
U. S. dollars (In thousands)
|
|
|
E.
|
UNCERTAIN TAX POSITIONS
|
|
|
A reconciliation of the beginning and ending amount of unrecognized tax benefits is as follows:
|
|
2010
|
2009
|
|||||||
|
Balance at the beginning of the year
|
$ | 33,348 | $ | 27,754 | ||||
|
Additions related to interest
|
1,801 | 3,093 | ||||||
|
Additions based on tax positions taken during a prior period
|
6,022 | 2,324 | ||||||
|
Reduction related to tax positions taken during a prior period
|
(4,252 | ) | (3,498 | ) | ||||
|
Reductions related to settlement of tax matters
|
(1,508 | ) | (6,341 | ) | ||||
|
Additions based on tax positions taken during the current period
|
6,862 | 10,332 | ||||||
|
Reduction related to a lapse of applicable statute of limitation
|
- | (316 | ) | |||||
|
Additions related to acquisitions
|
4,344 | - | ||||||
|
Balance at the end of the year
|
$ | 46,617 | $ | 33,348 | ||||
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONT.)
|
|
U. S. dollars (In thousands)
|
|
F.
|
DEFERRED INCOME TAXES
Deferred income taxes reflect the net tax effect of temporary differences between the carrying amount of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Significant components of net deferred tax assets and liabilities are based on separate tax jurisdiction as follows:
|
|
Deferred
Tax Asset
(Liability)
|
||||||||||||
|
Total
|
Current
|
Non-current
|
||||||||||
|
As of December 31, 2010
|
||||||||||||
|
Deferred tax assets:
|
||||||||||||
|
Reserves and allowances
|
$ | 26,992 | $ | 19,776 | $ | 7,216 | ||||||
|
Inventory allowances
|
4,251 | 4,251 | - | |||||||||
|
Property, plant and equipment
|
4,858 | 1,187 | 3,671 | |||||||||
|
Others
|
4,530 | 2,116 | 2,414 | |||||||||
|
Net operating loss carry forwards
|
18,684 | 2,093 | 16,591 | |||||||||
| 59,315 | 29,423 | 29,892 | ||||||||||
|
Valuation allowance
|
(160 | ) | (160 | ) | - | |||||||
|
Net deferred tax assets
|
59,155 | 29,263 | 29,892 | |||||||||
|
Deferred tax liabilities:
|
||||||||||||
|
Intangible assets
|
(48,610 | ) | - | (48,610 | ) | |||||||
|
Property, plant and equipment
|
(12,463 | ) | - | (12,463 | ) | |||||||
|
Reserves and allowances
|
25,833 | - | 25,833 | |||||||||
| (35,240 | ) | - | (35,240 | ) | ||||||||
|
Net deferred tax assets (liabilities)
|
$ | 23,915 | $ | 29,263 | $ | (5,348 | ) | |||||
|
As of December 31, 2009
|
||||||||||||
|
Deferred tax assets:
|
||||||||||||
|
Reserves and allowances
|
$ | 30,786 | $ | 18,562 | $ | 12,224 | ||||||
|
Inventory allowances
|
6,091 | 6,091 | - | |||||||||
|
Investment in affiliates
|
7,011 | 7,011 | - | |||||||||
|
Others
|
3,015 | 1,443 | 1,572 | |||||||||
|
Net operating loss carry forwards
|
20,895 | 6,825 | 14,070 | |||||||||
| 67,798 | 39,932 | 27,866 | ||||||||||
|
Valuation allowance
|
(34,776 | ) | (14,902 | ) | (19,874 | ) | ||||||
|
Net deferred tax assets
|
33,022 | 25,030 | 7,992 | |||||||||
|
Deferred tax liabilities:
|
||||||||||||
|
Intangible assets
|
(51,396 | ) | - | (51,396 | ) | |||||||
|
Property, plant and equipment
|
(10,024 | ) | - | (10,024 | ) | |||||||
|
Reserves and allowances
|
13,675 | - | 13,675 | |||||||||
| (47,745 | ) | - | (47,745 | ) | ||||||||
|
Net deferred tax assets (liabilities)
|
$ | (14,723 | ) | $ | 25,030 | $ | (39,753 | ) | ||||
|
(1)
|
The current tax asset is included in other receivables and prepaid expenses.
|
|
(2)
|
The non-current deferred tax asset is included in deferred income taxes, net.
|
|
(3)
|
The non-current deferred tax liability is included in deferred income and tax liabilities, net.
|
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONT.)
|
|
U. S. dollars (In thousands)
|
|
G.
|
As of December 31, 2010, Elbit Systems’ Israeli subsidiaries have estimated total available carry forward tax losses of approximately $136,886, and its non-Israeli subsidiaries have estimated available carry forward tax losses of approximately $28,990. These losses of the Israeli subsidiaries can be offset against future taxable profits for an indefinite period. Deferred tax assets in respect of the above carry forward losses amount to approximately $21,666 in respect of which a valuation allowance has been recorded in the amount of approximately $160.
|
|
H.
|
Reconciliation of the theoretical tax expense, assuming all income is taxed at the statutory rate applicable to income of the Company, and the actual tax expense as reported in the statements of operations, is as follows:
|
|
Year ended December 31,
|
||||||||||||
|
2010
|
2009
|
2008
|
||||||||||
|
Income before taxes as reported in the
consolidated statements of income
|
$ | 199,361 | $ | 247,330 | $ | 306,480 | ||||||
|
Statutory tax rate
|
25 | % | 26 | % | 27 | % | ||||||
|
Theoretical tax expense
|
$ | 49,840 | $ | 64,306 | $ | 82,750 | ||||||
|
Tax benefit arising from reduced rate as an “Approved
and Privileged Enterprise” and other tax benefits (*)
|
(20,528 | ) | (31,712 | ) | (44,002 | ) | ||||||
|
Tax adjustment in respect of different tax rates for
foreign subsidiaries
|
5,382 | 5,663 | 331 | |||||||||
|
Operating carry forward losses for which valuation
allowance was provided
|
(8,066 | ) | (1,506 | ) | 1,215 | |||||||
|
Increase in taxes resulting from non-deductible expenses
|
3,020 | 3,133 | 6,775 | |||||||||
|
Difference in basis of measurement for financial
reporting and tax return purposes
|
(3,370 | ) | 4,124 | 6,117 | ||||||||
|
Taxes in respect of prior years
(**)
|
(2,003 | ) | (6,400 | ) | 1,879 | |||||||
|
Other differences, net
|
(238 | ) | 501 | (698 | ) | |||||||
|
Actual tax expenses
|
$ | 24,037 | $ | 38,109 | $ | 54,367 | ||||||
|
Effective tax rate
|
12.06 | % | 15.4 | % | 17.7 | % | ||||||
|
(*) Net earnings per share – amounts of the benefit
resulting from the Approved and Privileged Enterprises
|
||||||||||||
|
Basic
|
$ |
0.48
|
$ | 0.75 | $ | 1.05 | ||||||
|
Diluted
|
$ |
0.47
|
$ | 0.74 | $ | 1.03 | ||||||
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONT.)
|
|
U. S. dollars (In thousands)
|
|
|
I.
|
Final tax assessments have been received by the Company up to and including the tax year ended December 31, 2005 and by certain subsidiaries, for the years 2002 - 2007 (subsidiaries that were incorporated after 2000 have not received final assessments).
|
|
|
A.
|
Derivative financial instruments are presented as other assets or other payables. For asset derivatives and liability derivatives, respectively, the fair value of the Company's outstanding derivative instruments as of December 31, 2010 and December 31, 2009 is summarized below:
|
|
Asset Derivatives (*)
|
Liability Derivatives (**)
|
|||||||||||||||
|
December 31,
2010
|
December 31, 2009
|
December 31,
2010
|
December 31,
2009
|
|||||||||||||
|
Derivatives designated as hedging instruments
|
||||||||||||||||
|
Foreign exchange contracts
|
$ | 16,897 | $ | 10,819 | $ | 5,509 | $ | 6,292 | ||||||||
|
Cross-currency interest rate swaps
|
20,377
|
- | - | - | ||||||||||||
|
37,274
|
10,819 | 5,509 | 6,292 | |||||||||||||
|
Derivatives not designated as hedging instruments
|
||||||||||||||||
|
Foreign exchange contracts
|
2,044 | 7,096 | 2,710 | 4,407 | ||||||||||||
|
Options exchange contracts
|
159 | 304 | 51 | - | ||||||||||||
| $ | 2,203 | $ | 7,400 | $ | 2,761 | $ | 4,407 | |||||||||
|
(*)
|
Presented as part of other assets.
|
|
(**)
|
Presented as part of other payables.
|
|
|
B.
|
The effect of derivative instruments on cash flow hedging and the relationship between income and other comprehensive income for the years ended December 31, 2010 and December 31, 2009, is summarized below:
|
|
Gain (Loss) Recognized
in Other Comprehensive
Income on Effective-
Portion of Derivative, net
|
Gain (Loss) on Effective Portion
of Derivative Reclassified from Accumulated Other Comprehensive Income (*)
|
Ineffective Portion of Gain (Loss)
of Derivative and Amount Excluded from Effectiveness Testing Recognized in Income (**)
|
||||||||||||||||||||||
|
December 31,
2010
|
December 31,
2009
|
December 31,
2010
|
December 31,
2009
|
December 31,
2010
|
December 31,
2009
|
|||||||||||||||||||
|
Derivatives designated
as hedging instruments
|
||||||||||||||||||||||||
|
Foreign exchange
contracts
|
$ | 20,002 | $ | (10,339 | ) | $ | - | $ | 5,102 | $ | - | $ | - | |||||||||||
|
Others
|
- | - | 10,115 | (152 | ) | 2,034 | (3,062 | ) | ||||||||||||||||
| $ | 20,002 | $ | (10,339 | ) | $ | 10,115 | $ | 4,950 | $ | 2,034 | $ | (3,062 | ) | |||||||||||
|
Derivatives not
designated as hedging instruments
|
||||||||||||||||||||||||
|
Foreign exchange
contracts
|
$ | - | $ | - | $ | - | $ | - | $ | 751 | $ | 678 | ||||||||||||
|
(*)
|
Presented as part of revenues/cost of sales
|
|
(**)
|
Presented as part of financial expenses
|
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONT.)
|
|
U. S. dollars (In thousands)
|
|
|
C.
|
The notional amounts of outstanding foreign exchange forward contracts at December 31, 2010 and December 31, 2009, is summarized below:
|
|
Forward contracts
|
||||||||||||||||
|
Buy
|
Sell
|
|||||||||||||||
|
December 31,
2010
|
December 31, 2009
|
December 31,
2010
|
December 31, 2009
|
|||||||||||||
|
Euro
|
$ | 16,076 | $ | 22,313 | $ | 240,830 | $ | 152,603 | ||||||||
|
GBP
|
20,475 | 21,086 | 85,980 | 78,725 | ||||||||||||
|
NIS
|
114,284 | 219,200 | - | - | ||||||||||||
|
Other
|
30,412 | - | 54,572 | 15,613 | ||||||||||||
| $ | 181,247 | $ | 262,599 | $ | 381,382 | $ | 246,941 | |||||||||
|
Options
|
||||||||||||||||
|
Buy
|
Sell
|
|||||||||||||||
|
December 31,
2010
|
December 31,
2009
|
December 31,
2010
|
December 31,
2009
|
|||||||||||||
|
NIS
|
$ | 6,000 | $ | 42,650 | $ | 6,000 | $ | 42,650 | ||||||||
|
|
A.
|
ROYALTY COMMITMENTS
Elbit Systems and certain Israeli subsidiaries partially finance their research and development expenditures under programs sponsored by the OCS for the support of research and development activities conducted in Israel. At the time the participations were received, successful development of the related projects was not assured.
In exchange for participation in the programs by the OCS, Elbit Systems and the subsidiaries agreed to pay 2% - 5% of total sales of products developed within the framework of these programs. The royalties will be paid up to a maximum amount equaling 100% to 150% of the grants provided by the OCS, linked to the dollar and for grants received after January 1, 1999, also bearing annual interest at a rate based on LIBOR. The obligation to pay these royalties is contingent on actual sales of the products, and in the absence of such sales payment of royalties is not required.
In some cases, the Government of Israel’s participation (through the OCS) is subject to export sales or other conditions. The maximum amount of royalties is increased in the event of production outside of Israel.
Elbit Systems and certain of its subsidiaries may also be obligated to pay certain amounts to the Israeli Ministry of Defense and others on certain sales including sales resulting from the development of certain technologies.
Royalties’ expenses amounted to $3,012, $5,317 and $3,292 in 2010, 2009 and 2008, respectively.
|
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONT.)
|
|
U. S. dollars (In thousands)
|
|
B.
|
COMMITMENTS IN RESPECT OF LONG-TERM PROJECTS
In connection with projects in certain countries, Elbit Systems and some of its subsidiaries have entered and may enter in the future into "buy-back" or "offset" agreements, required by a number of the Company’s customers for these projects as a condition to the Company obtaining orders for its products and services. These agreements are customary in the Company’s industry and are designed to facilitate economic flow back (buy-back) and/or technology transfer to businesses or government agencies in the applicable country.
These commitments may be satisfied by the Company’s placement of direct work or vendor orders for supplies and/or services, transfer of technology, investments or other forms of assistance in the applicable country. The buy-back rules and regulations, as well as the underlying contracts, may differ from one country to another. The ability to fulfill the buy-back obligations may depend, among other things, on the availability of local suppliers with sufficient capability to meet our requirements and which are competitive in cost, quality and schedule. In certain cases, the Company’s commitments may also be satisfied through transactions conducted by other parties.
The Company does not commit to buy-back agreements until orders for its products or services are definitive, but in some cases the orders for the Company’s products or services may become effective only after the Company’s corresponding buy-back commitments are in effect. Buy-back programs generally extend at least over the relevant commercial contract period and may provide for penalties in the event the Company fails to perform in accordance with buy-back requirements. In some cases the Company provides guarantees in connection with the performance of its buy-back obligations.
Should the Company be unable to meet such obligations it may be subject to contractual penalties, and its chances of receiving additional business from the applicable customers could be reduced or, in certain cases, eliminated.
At December 31, 2010, the Company had outstanding buy-back obligations totaling approximately $784,000 that extend through 2020.
|
|
C.
|
LEGAL CLAIMS
|
|
|
(1)
|
Elbit Systems and its subsidiaries are involved in legal claims arising in the ordinary course of business, including claims by employees, consultants and others. The Company’s management, based on the opinion of its legal counsel, believes that the financial impact for the settlement of such claims in excess of the accruals recorded in the financial statements will not have a material adverse effect on the financial position or results of operations of the Company.
|
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONT.)
|
|
U. S. dollars (In thousands)
|
|
C.
|
LEGAL CLAIMS (Cont.)
|
|
|
(2)
|
Between 2007 and January 2010, various claims were filed in the U.S. District Court for the Southern District of New York (the “Federal SDNY”) and the Supreme Court of the State of New York, County of New York (“New York State Court”) by certain minority security holders of ImageSat International N.V. (“ImageSat”) against ImageSat, Israel Aerospace Industries Ltd. (“IAI”), Elbit Systems, Elbit Systems Electro-optics Elop Ltd. (“Elop”) and certain current and former officers and directors of ImageSat. The former directors include, among others, Michael Federmann, Joseph Ackerman and Joseph Gaspar (currently Elbit Systems’ Board Chairman, Chief Executive Officer and Chief Financial Officer, respectively), who at various times in the past served as Elop’s nominee to ImageSat’s board of directors. ImageSat’s largest shareholder is IAI, holding approximately 46% of ImageSat’s issued share capital. Elop holds approximately 14% (7% on a fully diluted basis) of ImageSat’s issued share capital and is entitled to nominate one director to ImageSat’s board. The claims contained various allegations that the defendants breached their fiduciary and/or contractual obligations to the detriment of the plaintiffs. The claim alleged various causes of action and damages aggregating hundreds of millions of dollars, not all of which were alleged against Elbit Systems, Elop and/or each of the individual defendants. As of March 8, 2011, all of the above-mentioned claims have been dismissed by the Federal SDNY and the New York State Court (and applicable appellate courts) on the grounds of forum non-conveniens, except for two remaining proceedings in the New York State Court by certain of the plaintiffs, claiming a breach of the Security Holders Agreement between various security holders of ImageSat, including Elop, based on an alleged failure to appoint independent directors to the ImageSat board of directors. Elbit Systems and Elop believe such claims are baseless and have filed corresponding responses to the Court.
In April 2010, Elbit Systems and Elop were served with an Application to Approve a Derivative Action (the Application) filed in the District Court of Petach Tikva, Israel, by certain minority shareholders of ImageSat. The Application names a number of respondents, including among others, ImageSat, IAI, Elop, Elbit Systems and several former directors of ImageSat, including, among others, Michael Federmann, Joseph Ackerman and Joseph Gaspar (Elbit Systems, Elop and the above-named former directors are referred to as the “Elbit Defendants”). The Application requests the Court to approve the filing of a derivative action on behalf of ImageSat for alleged breaches by some of the respondents of the applicants’ rights as minority shareholders in ImageSat. The nature of the allegations is substantially similar to those previously made by the applicants in various claims referred to above made in federal and state courts in New York. In July 2010, the Elbit Defendants filed motions to dismiss the Application on various grounds relating both to Netherland Antilles and Israeli law. The Elbit Defendants believe that there is no merit to the allegations made against them in this claim. IAI has agreed to indemnify Elbit Systems, Elop and the directors nominated by Elop to ImageSat’s board, for any losses arising out of any of the foregoing claims or legal proceedings, net of insurance proceeds received from ImageSat’s insurance policies and any indemnification proceeds received from ImageSat.
|
|
|
ELBIT SYSTEMS LTD. AND ITS SUBSIDIARIES
|
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONT.)
|
|
U. S. dollars (In thousands)
|
|
C.
|
LEGAL CLAIMS (Cont.)
|
|
|
(3)
|
In December 2009, a claim in the amount of approximately $10 million was filed in the District Court – Central District of Israel by Pinpoint Advance Corporation (“Pinpoint”) and four of its founders against two of our Israeli subsidiaries, Elbit Systems Holdings (1997) Ltd. and Kinetics Ltd. (“Kinetics”), as well as against one of the Company officers, Jacob Gadot. Pinpoint is a special purpose acquisition company that was in negotiations with the Company and other Kinetics’ shareholders regarding the sale of shares in Kinetics during 2008. The transaction was not completed and negotiations were terminated. Pinpoint claims that the agreement was completed and thus entered into effect. Alternatively, Pinpoint claims that our decision not to complete the agreement was made in bad faith, and that under the circumstances Pinpoint and its founders are entitled to pecuniary compensation equal to their rights and entitlements under the alleged breached contract. The Company believes there is no merit to the allegations made in the claim and has responded accordingly to the Court. In March 2010, the Court requested the parties to attempt mediation, and a mediation process is ongoing.
|
|
(4)
|
In May 2009, Elbit Systems filed a claim in the U.S. District Court for the Southern District of Illinois against Credit Suisse Group (“CSG”). The complaint seeks to recover approximately $16 million that Elbit Systems believes was fraudulently obtained by CSG and by its subsidiary Credit Suisse Securities (USA) from Tadiran Communications Ltd. (“Tadiran Communications”) in 2007 in connection with auction rate securities purchased by Tadiran Communications through CSG. In 2008, Tadiran Communication was merged into Elbit Systems, and Tadiran Communications’ activities are currently performed as part of Elbit Systems wholly-owned Israeli subsidiary, Elbit Systems Land and C4I Ltd. CSG filed a motion to dismiss the claim based on a release signed by Tadiran Communications in 2007. In December 2009, the case was moved to the Federal Southern District of New York. In July 2010, the Court ordered the parties to continue discovery regarding the release and ruled that the meaning and scope of the release will be decided in a hearing on summary judgment rather than on a motion to dismiss.
|
|
D.
|
LEASE COMMITMENTS
The future minimum lease commitments of the Company under various non-cancelable operating lease agreements in respect of premises, motor vehicles and office equipment as of December 31, 2010 are as follows:
|
|
2011
|
$ | 34,802 | ||
|
2012
|
25,487 | |||
|
2013
|
15,548 | |||
|
2014
|
10,892 | |||
|
2015
|
4,921 | |||
|
2016 and thereafter
|
8,218 | |||
| $ | 99,868 |
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONT.)
|
|
U. S. dollars (In thousands)
|
|
|
E
.
|
GUARANTEES
|
|
|
(1)
|
As of December 31, 2010, guarantees in the amount of approximately $967,000 were issued by banks on behalf of Company’s entities mainly in order to secure certain advances from customers and performance bonds.
|
|
|
(2)
|
Elbit Systems has provided, on a proportional basis to its ownership interest, guarantees for one of its 50% - owned foreign investees in respect of credit lines granted to it by banks amounting to $2,200 as of December 31, 2010 (2009 - $3,400). The guarantee will exist as long as the credit lines are in effect. Elbit Systems would be liable under the guarantee for any debt for which the investee would be in default under the terms of the credit line. The fair value of such guarantee as of December 31, 2010 is not material.
|
|
F.
|
COVENANTS
In connection with bank credits and loans, including performance guarantees issued by banks and bank guarantees in order to secure certain advances from customers, the Company and certain subsidiaries are obligated to meet certain financial covenants. Such covenants include requirements for shareholders' equity, current ratio, operating profit margin, tangible net worth, EBITDA, interest coverage ratio and total leverage. As of December 31, 2010, Elbit Systems and its subsidiaries were in full compliance with all covenants.
|
|
|
G.
|
CONTINGENT LIABILITIES AND GUARANTEES
As a result of cancellation of the export authorization in 2006 to a foreign country (hereinafter: "the Customer"), Elisra and one of its subsidiaries were forced to terminate four projects. Most of the activity in respect of the projects, the total volume of which amounts to approximately $40,000 has already been executed and the deliveries have been made to the Customer. For those projects, Elisra and its subsidiary provided to the Customer advance and performance guarantees, issued by banks and financial institutions, in the total amount of approximately $7,000 as of December 31, 2007.
On July 28, 2008, the subsidiary received an approval from the Customer for the completion of the subsidiary's obligations in two of the abovementioned projects, the total volume of which amounts to approximately $16,400. On September 22, 2008, the subsidiary received confirmation from a financial institution, stating that the advance and performance guarantees issued by said institution, in the amount of $6,700 are null and void.
As of December 31, 2009, there are two remaining projects, the total volume of which amounts to approximately $23,000. Elisra provided the Customer advance and performance guarantees related to the abovementioned projects in the amount of approximately $5,000.
Elisra’s management, based on the opinion of legal counsel, believes that termination of the projects under such circumstances constitutes a termination by mutual agreement due to force majeure, which provides a mechanism for mutual settlement between the parties.
Elisra’s management, based on the opinion of its legal counsel, believes that the financial impact of the termination of the two projects in excess of the accruals recorded in the financial statements will not have a material adverse effect on the financial position or results of operations of Elisra.
|
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONT.)
|
|
U. S. dollars (In thousands)
|
|
H.
|
CONTRACTUAL OBLIGATIONS
Substantially all of the Company’s purchase commitments relate to obligations under purchase orders and subcontracts entered into by the Company. These purchase orders and subcontracts are typically in standard formats proposed by the Company, with the subcontracts and purchase orders also reflecting provisions from the Company’s applicable prime contract that apply to flow down to subcontractors and vendors. The terms typically included in these purchase orders and subcontracts are consistent with Uniform Commercial Code provisions in the United States for sales of goods, as well as with specific terms called for by its customers in international contracts. These terms include the Company’s right to terminate the purchase order or subcontract in the event of the vendor’s or subcontractor’s default, as well as the Company’s right to terminate the order or subcontract for the Company’s convenience (or if the Company’s prime contractor has so terminated the prime contract). Such purchase orders and subcontracts typically are not subject to variable price provisions. As of December 31, 2010 and 2009, the purchase commitments were $1,046,000 and $876,000, respectively.
|
|
I.
|
In order to secure bank loans and bank guarantees in the amount of $967,000 as of December 31, 2010, certain Company entities recorded fixed liens on most of their machinery and equipment, mortgages on most of their real estate and floating charges on most of their assets.
|
|
J.
|
A lien on the Company’s Approved Enterprises has been registered in favor of the State of Israel (see Note 18(A)(4) above).
|
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONT.)
|
|
U. S. dollars (In thousands, except share and share data)
|
|
A.
|
SHARE CAPITAL
Ordinary shares confer upon their holders voting rights and the right to receive dividends.
|
|
B.
|
2000 EMPLOYEE STOCK OPTION PLAN
In 2000, Elbit Systems adopted an employee stock option plan for Company employees comprising options to purchase up to 2,500,000 ordinary shares. The exercise price approximates the market price of the shares at the grant date. The plan included an additional 2,500,000 options issuable as “phantom” share options that grant the option holders a number of shares reflecting the benefit component of the options exercised, as calculated at the exercise date, in consideration for their par value only. The options vest over a period of one to four years from the date of grant and expire no later than six years from the date of grant or 90 days after the employee’s termination of employment with Elbit Systems or its subsidiaries.
|
|
C.
|
2007 STOCK OPTION PLAN
In January 2007, Elbit Systems’ shareholders approved Elbit Systems’ 2007 Option Plan (the “Plan”). The purpose of the Plan is to provide the benefits arising from ownership of share capital by Elbit Systems’ and certain of its subsidiaries employees, who are expected to contribute to the Company’s future growth and success. The options were allocated, subject to the required approvals, in two tracks as follows: (i) Regular Options - up to 1,250,000 options exercisable into 1,250,000 shares of Elbit Systems in consideration for the exercise price, all or any portion of which may be granted as Incentive Stock Options (“Regular Options”) and (ii) Cashless Options - up to 1,250,000 options, which entitle the participant to exercise options for an amount reflecting only the benefit factor (“Cashless Options”). Each of the participants is granted an equal amount of Regular Options and Cashless Options. The exercise price for Israeli participants is the average closing price of Elbit Systems’ share during 30 trading days preceding the options grant date. The exercise price of options granted to a non-Israeli participant residing in the United States is the fair market value of the share on the day the options were granted.
According to the Plan, the options granted on a certain date (the “Commencement Date”) will become vested and exercisable in accordance with the following vesting schedule:
|
|
(1)
|
Fifty percent (50%) of the options will be vested and exercisable from the second anniversary of the Commencement Date;
|
|
(2)
|
An additional twenty-five percent (25%) of the options will be vested and exercisable from the third anniversary of the Commencement Date; and
|
|
(3)
|
The remaining twenty-five (25%) of the options will be vested and exercisable from the fourth anniversary of the Commencement Date.
|
|
|
ELBIT SYSTEMS LTD. AND ITS SUBSIDIARIES
|
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONT.)
|
|
U. S. dollars (In thousands, except share and per share data)
|
|
D.
|
A summary of Elbit Systems’ share option activity under the plans is as follows:
|
|
2010
|
2009
|
2008
|
||||||||||||||||||||||
|
Number
of
options
|
Weighted
average
exercise
price
|
Number
of
options
|
Weighted
average
exercise
price
|
Number
of
options
|
Weighted
average
exercise
price
|
|||||||||||||||||||
|
Outstanding –
beginning of the year
|
1,858,250 | $ | 35.24 | 2,454,851 | $ | 33.96 | 2,386,826 | $ | 32.51 | |||||||||||||||
|
Granted
|
28,000 | 52.23 | 58,500 | 50.33 | 135,800 | 56.15 | ||||||||||||||||||
|
Exercised
|
(223,019 | ) | 32.53 | (619,451 | ) | 31.62 | (22,675 | ) | 15.96 | |||||||||||||||
|
Forfeited
|
(27,926 | ) | 31.91 | (35,650 | ) | 34.53 | (45,100 | ) | 33.12 | |||||||||||||||
|
Outstanding –
end of the year
|
1,635,305 | 35.96 | 1,858,250 | 35.24 | 2,454,851 | 33.96 | ||||||||||||||||||
|
Options exercisable at
the end of the year
|
963,289 | $ | 34.70 | 586,626 | $ | 32.55 | 82,951 | $ | 16.84 | |||||||||||||||
|
|
E.
|
The options outstanding as of December 31, 2010, have been separated into ranges of exercise prices, as follows:
|
|
Options outstanding
|
Options exercisable
|
||||||||||||||||||||
|
Exercise price
|
Number
of
options
|
Weighted
average
remaining
contractual
life (years)
|
Weighted
average
exercise
price
per share
|
Number
of
options
|
Weighted
average
exercise
price
per share
|
||||||||||||||||
| $14.76 - $19.36 | 14,500 | 0.91 | $ | 19.36 | 14,500 | $ | 19.36 | ||||||||||||||
| $33.10 - $63.85 | 1,620,805 | 1.26 | $ | 36.11 | 948,789 | $ | 34.94 | ||||||||||||||
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONT.)
|
|
U. S. dollars (In thousands, except share and per share data)
|
|
Year ended December 31,
|
||||||||||||
|
2010
|
2009
|
2008
|
||||||||||
|
Cost of revenues
|
$ | 2,353 | $ | 2,397 | $ | 2,349 | ||||||
|
R&D and marketing expenses
|
954 | 1,048 | 897 | |||||||||
|
General and administration expenses
|
1,904 | 1,689 | 1,821 | |||||||||
| $ | 5,211 | $ | 5,134 | $ | 5,067 | |||||||
|
F.
|
The weighted average exercise price and fair value of options granted during the years ended December 31, 2010, 2009 and 2008 were:
|
|
Less than market price
|
||||||||||||
|
Year ended December 31,
|
||||||||||||
|
2010
|
2009
|
2008
|
||||||||||
|
Weighted average exercise price
per share
|
$ | 52.23 | $ | 50.33 | $ | 56.15 | ||||||
|
Weighted average fair value on
grant date
|
$ | 11.99 | $ | 16.61 | $ | 13.87 | ||||||
|
G.
|
Computation of basic and diluted net earnings per share:
|
|
Year ended
December 31, 2010
|
Year ended
December 31, 2009
|
Year ended
December 31, 2008
|
||||||||||||||||||||||||||||||||||
|
Net income
to shareholders
of ordinary
shares
|
Weighted
average
number
of
shares (*)
|
Per
Share
amount
|
Net income
to shareholders
of ordinary
shares
|
Weighted
average
number of
shares (*)
|
Per
Share
amount
|
Net income
to shareholders
of ordinary
shares
|
Weighted
average
number
of
shares (*)
|
Per
Share
amount
|
||||||||||||||||||||||||||||
|
Basic net earnings
|
$ | 183,498 | 42,645 | $ | 4.30 | $ | 214,947 | 42,305 | $ | 5.08 | $ | 204,176 | 42,075 | $ | 4.85 | |||||||||||||||||||||
|
Effect of dilutive
securities:
|
||||||||||||||||||||||||||||||||||||
|
Employee stock
options
|
- | 573 | - | 678 | - | 683 | ||||||||||||||||||||||||||||||
|
Diluted net
earnings
|
$ | 183,498 | 43,218 | $ | 4.25 | $ | 214,947 | 42,983 | $ | 5.00 | $ | 204,176 | 42,758 | $ | 4.78 | |||||||||||||||||||||
|
H.
|
In December 2007, Elbit Systems U.S. Corp ("ESC"), a wholly-owned U.S. subsidiary of Elbit Systems, adopted a Stock Appreciation Rights Plan for Non-Employee Directors of Elbit Systems of America, LLC (the "SAR Plan"). ESC owns the shares of ESA. The purpose of the SAR Plan is to facilitate the retention of qualified and experienced persons to serve as "Non-Employee Directors" of ESA by providing them additional financial incentives. A "Non-Employee Director" is a director of ESA who is not an officer or employee of ESA, or any of its affiliated companies.
|
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONT.)
|
|
U. S. dollars (In thousands)
|
|
|
Under the Plan, the Board of ESC may grant Stock Appreciation Rights ("SARs") from time to time to Non-Employee Directors of ESA. A SAR is a right that, in accordance with the terms of the SAR Plan, entitles the holder to receive, on the exercise date of the SAR, cash in an amount equal to the excess of the "Fair Market Value" of the "Stock" corresponding to the SAR at the time of exercise of the SAR over the "Initial Value of the Stock". "Stock" means Elbit Systems Ordinary Shares. Each SAR corresponds to a share of Stock. "Fair Market Value" with respect to the Stock means the closing price of the Stock on the Nasdaq on the applicable date. "Initial Value" of a SAR means the Fair Market Value of one share of Stock on the grant date of the SAR.
|
|
|
A SAR may only be exercised after it becomes vested. 25% of any SAR's granted are exercisable on the first anniversary from the grant date and an additional 25% on each of the three subsequent anniversaries. The maximum term of a SAR is five years from the grant date.SAR's do not provide any rights as a shareholder in the Stock.
SARs are considered liabilities under ASC 718 and as such compensation cost for each period until settlement is based on the change (or a portion of the change, depending on the percentage of the requisite service that has been rendered) in the fair value of the SARs for each reporting period.
A summary of Elbit Systems' SAR activity under the plan is as follows:
|
|
Year ended December 31, 2010
|
||||||||
|
Number of options
|
Weighted average
Exercise price per share
|
|||||||
|
Outstanding – beginning of the year
|
30,000 | $ | 58.64 | |||||
|
Granted
|
- | - | ||||||
|
Outstanding – end of the year
|
30,000 | $ | 58.64 | |||||
|
Rights exercisable at the end of the year
|
12,750 | $ | 59.79 | |||||
|
I
.
|
TREASURY SHARES
Elbit Systems’ shares held by Elbit Systems and its subsidiaries are presented at cost and deducted from shareholders’ equity.
|
|
J.
|
DIVIDEND POLICY
Dividends declared by Elbit Systems are paid subject to statutory limitations. Elbit Systems’ Board of Directors has determined not to declare dividends out of tax exempt earnings.
|
|
|
A.
|
Revenues are attributed to geographic areas based on location of the end customers as follows:
|
|
Year ended December 31,
|
||||||||||||
|
2010
|
2009
|
2008
|
||||||||||
|
Europe
|
$ | 541,749 | $ | 728,232 | $ | 653,043 | ||||||
|
U.S.
|
843,985 | 813,460 | 907,098 | |||||||||
|
Israel
|
650,956 | 627,251 | 474,405 | |||||||||
|
Others
(*)
|
633,443 | 663,494 | 603,725 | |||||||||
| $ | 2,670,133 | $ | 2,832,437 | $ | 2,638,271 | |||||||
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONT.)
|
|
U. S. dollars (In thousands)
|
|
B.
|
Revenues are generated by the following areas of operations:
|
|
Year ended December 31,
|
||||||||||||
|
2010
|
2009
|
2008
|
||||||||||
|
Airborne systems
|
$ | 791,111 | $ | 693,229 | $ | 634,714 | ||||||
|
Land vehicles systems
|
363,245 | 449,712 | 699,485 | |||||||||
|
C
4
ISR systems
|
1,019,068 | 1,168,848 | 844,456 | |||||||||
|
Electro-optical systems
|
368,808 | 406,396 | 336,702 | |||||||||
|
Others
(*)
|
127,901 | 114,252 | 122,914 | |||||||||
| $ | 2,670,133 | $ | 2,832,437 | $ | 2,638,271 | |||||||
|
|
C.
|
Major customer data as a percentage of total revenues:
|
|
Year ended December 31,
|
||||||||||||
|
2010
|
2009
|
2008
|
||||||||||
|
Israeli Ministry Of Defense
|
23 | % | 21 | % | 19 | % | ||||||
|
U.S. Government
|
7 | % | 6 | % | 5 | % | ||||||
|
D.
|
Long-lived assets by geographic areas:
|
|
Year ended December 31,
|
||||||||||||
|
2010
|
2009
|
2008
|
||||||||||
|
Israel
|
$ | 985,953 | $ | 753,477 | $ | 707,427 | ||||||
|
U.S.
|
225,217 | 185,134 | 195,752 | |||||||||
|
Others
|
89,345 | 69,400 | 75,190 | |||||||||
| $ | 1,300,515 | $ | 1,008,011 | $ | 978,369 | |||||||
|
Year ended December 31,
|
||||||||||||
|
2010
|
2009
|
2008
|
||||||||||
|
Total expenses
|
$ | 268,578 | $ | 245,812 | $ | 217,176 | ||||||
|
Less – grants and participations
|
(34,447 | ) | (29,060 | ) | (32,192 | ) | ||||||
| $ | 234,131 | $ | 216,752 | $ | 184,984 | |||||||
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONT.)
|
|
U. S. dollars (In thousands)
|
|
Year ended December 31,
|
||||||||||||
|
2010
|
2009
|
2008
|
||||||||||
|
Expenses:
|
||||||||||||
|
Interest on long-term bank debt
|
$ | (6,968 | ) | $ | (8,723 | ) | $ | (17,898 | ) | |||
|
Interest on Series A Notes, net
|
(4,395 | ) | - | - | ||||||||
|
Interest on short-term bank credit and loans
|
(1,699 | ) | (1,445 | ) | (3,145 | ) | ||||||
|
Impairment of auction rate securities
|
- | - | (18,714 | ) | ||||||||
|
Loss from exchange rate differences
|
(9,117 | ) | (699 | ) | (815 | ) | ||||||
|
Others
|
(4,330 | ) | (12,260 | ) | (11,345 | ) | ||||||
| (26,509 | ) | (23,127 | ) | (51,917 | ) | |||||||
|
Income:
|
||||||||||||
|
Interest on cash, cash equivalents
and bank deposits
|
3,224 | 3,020 | 9,292 | |||||||||
|
Gain on marketable securities
|
- | 1,292 | 2,480 | |||||||||
|
Others
|
2,034 | 3,230 | 3,330 | |||||||||
| 5,258 | 7,542 | 15,102 | ||||||||||
| $ | (21,251 | ) | $ | (15,585 | ) | $ | ( 36,815 | ) | ||||
|
Year ended December 31,
|
||||||||||||
|
2010
|
2009
|
2008
|
||||||||||
|
Gain from sale of Mediguide shares
(1)
|
$ | 12,809 | $ | 1,105 | $ | 100,031 | ||||||
|
Impairment of investment
(2)
|
- | - | (10,514 | ) | ||||||||
|
Gain in respect of fire damages in Elisra
(3)
|
- | - | 4,087 | |||||||||
|
Others
|
450 | (647 | ) | 690 | ||||||||
| $ | 13,259 | $ | 458 | $ | 94,294 | |||||||
|
(1)
|
On December 22, 2008, the Company sold all of its shares in Mediguide (see Note 1(F)).
|
|
(2)
|
Impairment of Sandel shares during 2008 (see Note 6(C)(2)).
|
|
(3)
|
On March 17, 2008, the Company recorded a gain of $4,087 as a result of the settlement agreement between Elisra and Phoenix.
|
|
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONT.)
|
|
U. S. dollars (In thousands)
|
|
Transactions:
|
Year ended December 31,
|
|||||||||||
|
2010
|
2009
|
2008
|
||||||||||
|
Income -
|
||||||||||||
|
Sales to affiliated companies (*)
|
$ | 33,124 | $ | 39,929 | $ | 20,561 | ||||||
|
Participation in expenses
|
3,955 | $ | 4,217 | $ | 3,372 | |||||||
|
Cost and expenses -
|
||||||||||||
|
Supplies from affiliated companies (**)
|
$ | 57,339 | $ | 64,058 | $ | 51,703 | ||||||
|
Balances:
|
December 31,
|
||||||||
|
2010
|
2009
|
||||||||
|
Trade receivables and other receivables (*)
|
$ | 20,970 | $ | 20,384 | |||||
|
Trade payables (**)
|
$ | 30,955 | $ | 20,591 | |||||
|
(*)
|
The significant sales include sales of helmet mounted cueing systems purchased from the Company by VSI.
|
|
(**)
|
Includes electro-optics components and sensors, purchased by the Company from SCD, and electro-optics products purchased by the Company from Opgal.
|
|
|
A.
|
On February 9, 2011, the Company completed its cash tender offer (the "Tender Offer") issued by its wholly-owned subsidiary, Elbit Security Systems Ltd.("Elsec"), for the balance of the ordinary shares of I.T.L Optronics Ltd.("ITL"), which prior to the completion of the offer was a publically traded company in Israel, held 87.85% by Elsec. As a result, ITL became a private, wholly-owned subsidiary of Elsec. The total amount paid for the ITL shares, related to the offer, was approximately $5,900 (approximately $3.4 per share).
|
|
|
B.
|
On February 22, 2011, the Company reached an agreement to acquire the remaining 30% of the shares of Elisra held by Elta Systems Ltd. (“Elta”) for $67,500. The Company currently owns 70 % of Elisra’s shares and following the acquisition, Elisra will become a wholly-owned subsidiary of the Company.
|
|
Column A
|
Column B
|
Column C
|
Column D
|
Column E
|
||||||||||||||||
|
Description
|
Balance at
Beginning
of Period
|
Additions
(Charged to
Costs and
Expenses)
|
Deductions
(Write-Offs
and Actual
Losses
Incurred)
|
Additions
Resulting
from
Acquisitions
|
Balance at
End of Period
|
|||||||||||||||
|
Year Ended December 31, 2010:
|
||||||||||||||||||||
|
Provisions for Losses on Long-Term Contracts (*)
|
136,341 | 35,443 | 36,360 | 646 | 136,070 | |||||||||||||||
|
Provisions for Claims and Potential Contractual Penalties and Others
|
5,864 | 1,262 | 1,103 | 595 | 6,618 | |||||||||||||||
|
Allowance for Doubtful Accounts
|
7,885 | 904 | 349 | 2,775 | 11,215 | |||||||||||||||
|
Valuation Allowance on Deferred Taxes (**)
|
34,776 | — | 34,616 | -- | 160 | |||||||||||||||
|
Year Ended December 31, 2009:
|
||||||||||||||||||||
|
Provisions for Losses on Long-Term Contracts (*)
|
99,323 | 67,725 | 30,707 | — | 136,341 | |||||||||||||||
|
Provisions for Claims and Potential Contractual Penalties and Others
|
3,025 | 4,928 | 2,109 | — | 5,864 | |||||||||||||||
|
Allowance for Doubtful Accounts
|
5,471 | 2,726 | 312 | — | 7,885 | |||||||||||||||
|
Valuation Allowance on Deferred Taxes
|
36,282 | — | 1,506 | — | 34,776 | |||||||||||||||
|
Year Ended December 31, 2008:
|
||||||||||||||||||||
|
Provisions for Losses on Long-Term Contracts (*)
|
52,601 | 60,552 | 14,257 | 427 | 99,323 | |||||||||||||||
|
Provisions for Claims and Potential Contractual Penalties and Others
|
9,044 | 537 | 6,556 | — | 3,025 | |||||||||||||||
|
Allowance for Doubtful Accounts
|
3,794 | 1,794 | 117 | — | 5,471 | |||||||||||||||
|
Valuation Allowance on Deferred Taxes
|
54,635 | — | 18,353 | — | 36,282 | |||||||||||||||
|
*
|
An amount of $49,537, $60,848 and $74,407 as of December 31, 2008, 2009 and 2010, respectively, is presented as a deduction from inventories, and an amount of $49,786, $75,493 and $61,663 as of December 31, 2008, 2009 and 2010, respectively, is presented as part of other accrued expenses in the category of “Cost Provisions and Other.”
|
|
**
|
An amount of $21.5 million was deducted as a result of a prior year adjustment.
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|